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8Abbreviations
AGC     automatic gain control
BSA     bovine serum albumin
CID     collision-induced dissociation (fragmentation technique)
Da     Dalton (unit of protein size)
ECD     electron capture dissociation (fragmentation technique)
ELISA     enzyme-linked immuno sorbent assay
ESI     electrospray ionization
ETD      electron transfer dissociation (fragmentation technique)
FDR     false discovery rate
FT     Fourier-transform
FWHM     full weight at half maximum (unit of resolution)
HCD     higher collision dissociation (fragmentation technique)
ICAT     isotope-coded affinity tag (chemical labeling)
ICR     ion-cyclotron resonance (type of mass spectrometer)
ID     inner diameter
IRMPD     infrared multiphoton dissociation (fragmentation technique)
IT     ion trap (type of mass spectrometer)
LC     liquid chromatography
LCM     laser capture microdissection
LM     lock mass
LOD     limit of detection
LTQ-FT     linear ion trap - fourier transform mass spectrometer (type of mass spectrometer)
m/z      mass to charge ratio
MALDI     matrix-assisted laser desorption/ionization
MMD     maximum mass deviation
MRM     multireaction monitoring
MS     mass spectrometry
MS/MS     fragmentation
MuDPIT     multidimensional protein identification technology
MW      molecular weight
PC     peak capacity
PCM     polydimethylcyclosiloxane (background ions)
PCR     polymerase chain reaction
PMF     peptide mass fingerprinting
ppb      parts per billion
ppm     parts per million
PTM     post-translational modification
QQQ     triple quadrupole (type of mass spectrometer)
RPLC     reverse phase liquid chromatography
S/N     signal to noise
SCX     strong cation exchange chromatography
SDS PAGE     sodium dodecyl sulfate polyacrylamide gel electrophoresis
SILAC     stable isotope labeling by amino acids in cell culture (metabolic labeling)
SIM     selected ion monitoring
SUMO     small ubiquitin like modifier (post-translational modification)
TOF     time-of-flight (type of mass spectrometer)
UPLC     ultrahigh pressure liquid chromatography
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From protein to proteome
For decades, biochemists and molecular biologists have been trying to understand the structure, location, and function of biomolecules in 
the cell. Small-scale experiments, focused on the activity of single genes or 
proteins, have so far been the norm. However, in the past decades it has become 
increasingly clear that such targeted experiments are insufficient to tackle the 
whole complexity of problems posed by biological systems. In order to obtain 
more comprehensive knowledge about biological systems like a cell or tissue, 
large-scale global analyses are required. 
The system-level studies of biological 
networks received a boost from the Human 
Genome Project, the consortium that 
first sequenced all hereditary information 
encoded in the DNA of a human cell. The 
knowledge of the complete genome led to 
better understanding of genes and their 
context, as well as creating the opportunity 
to study the effect of disturbances like 
ligands, knock-downs of selected gene 
products, and mutations on the global gene 
expression level. 
However, as the hereditary information 
encoded in the DNA is – in the overwhelming 
majority of cases – executed by the inter-
play of transcription, transcript processing, 
translation and post-translational process-
ing, studying this process at the transcrip-
tional level alone is frequently insufficient to 
elucidate the phenotypic reaction of a cell to 
a given stimulus or disturbance. As a result 
the demand increased for comprehensive 
studies of general effector molecules of bio-
logical processes themselves: polypeptides 
or proteins. Several consortia were founded 
with the aim to analyze their localization and 
abundance level by e.g. immunohistochem-
istry and western blotting1. 
In addition to large scale analysis with 
antibody-based techniques, Mass Spectro-
metry (MS) became increasingly popular for 
protein expression studies. Initially, MS was 
mainly used to characterize purified proteins 
from gel-bands, but gradually it started to 
be applied in combination with liquid chro-
matography, enabling both identification 
and quantitation of several hundreds of 
proteins in a single experiment. MS thereby 
contributed considerably to the shift from 
single protein analysis to ‘proteomics’. The 
term ‘proteome’ was coined in 1994 and is 
defined as the complete set of proteins ex-
pressed under a certain condition in a cer-
tain biological system, whether organelle, 
cell, tissue or organism2. 
A major advantage of MS is its unbiased 
nature, which is in stark contrast to tech-
niques like western blotting or Enzyme-
Linked Immuno Sorbent Assay (ELISA), where 
antibodies are raised against known targets. 
Furthermore, mass spectrometry can con-
firm the primary sequence and can thereby 
also distinguish isoforms, genetic variations 
and co- or Post-Translational Modifications 
(PTMs) of proteins that frequently impact 
their function. Last but not least, MS allows 
examining large sets of proteins simultane-
ously and is thereby extremely fast in ana-
lyzing complex mixtures. In short, MS has 
become an indispensible research tool with 
the potential to broadly impact biology and 
laboratory medicine3.
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1.2  MS-based proteomics 
The increasing popularity of MS in protein 
research is reflected in the growing number of 
peer-reviewed publications in this field (red 
and blue line in Figure 1.1). But before MS 
could become ubiquitous, major technological 
improvements were necessary. As depicted 
in Figure 1.1, these advances range from 
the creation of sensitive and high-resolution 
hybrid mass analyzers and the automated 
coupling of Liquid Chromatography (LC) 
systems, to the development of new ‘soft’ 
ionization techniques. The introduction of 
supplementary strategies such as stable 
isotope labeling, as well as the use of 
intelligent acquisition and data analysis 
software complement the hardware 
improvements and yield improved data 
output and quality. 
With all those improvements MS-based 
proteomics is maturing into a robust and 
high-throughput, extremely accurate and 
sensitive platform that can be used with a 
variety of aims. It is for example currently 
possible to catalogue all proteins of an 
organelle or lower organism, to obtain 
information on specific protein-protein 
interactions, or to quantify time- or stimulus-
dependent protein expression or activity 
changes. Many of those aims can be achieved 
using a popular proteomics workflow for 
protein identification and quantitation by 
LC-MS, which is shown in Box A.
In the next paragraphs I will shortly review 
the basics of presently used instrumentation 
and highlight the most important instrumen-
tal improvements that have contributed to 
the high confidence and high accurate plat-
Figure 1.1 Chronological representation of major MS developments since the Second World War. The 
red line indicates the number of papers published and listed in Pubmed per year, using the term ‘mass 
spectrometry’ (retrieved via http://dan.corlan.net/cgi-bin/medline-trend?). The inset shows the number 
of peer-reviewed publications per year related to the search term ‘proteomics and mass spectrometry’.
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form of liquid chromatography tandem mass 
spectrometry (LC-MS/MS). Additionally, I will 
discuss four essential MS parameters and 
examine to what extent current instrument 
configurations fulfill the requirements posed 
by biological experiments. In the last part 
I will highlight a few research areas where 
further advances are required to expand 
MS capabilities. Those areas motivated the 
method developments I carried out during 
my doctoral study and which I will discuss in 
the succeeding chapters.
1.3  MS instrumentation
The basic idea behind mass spectrometry 
is to obtain information about the chemical 
composition of a compound by accurately 
determining the mass-to-charge ratio (m/z) 
of the analyte in ionized form. The charged 
condition is essential for accurate guidance, 
ion separation in electric and magnetic fields 
as well as detection of the ion. A mass spec-
trometer consists of three parts: 1) an ion 
source to transform the compound into gas-
eous ions, 2) a mass analyzer that carries out 
the actual ion separation, and 3) a detector 
that reads out the abundance of each ion and 
converts this signal into a mass spectrum.
Ionization sources
The analysis of biological samples was 
long hampered by the lack of good ionization 
sources.  The chemical ionization methods 
existing since the 1960s were too harsh 
for the molecules involved and induced 
extensive fragmentation. The solution came 
in the 1980s in the form of electrospray 
(ESI) developed by Fenn and coworkers4,5 
and a complementary technique called 
Matrix-Assisted Laser Desorption/Ionization 
(MALDI) published by Hillenkamp and 
Karas6,7. Both ESI and MALDI, schematically 
represented in Figure 1.2, enabled ionization 
Figure 1.2 Schematic representation of ESI and MALDI, adapted from ref. 8.
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of large biomolecules like proteins without 
substantial decomposition. In 2002, both 
inventions were awarded with the Nobel Prize 
in Chemistry, acknowledging their important 
contribution to chemical and biological 
research. 
As shown in Figure 1.2a, ESI produces 
gaseous ions using a needle to spray a mist 
of tiny droplets containing charged analytes 
into a strong electric field. While the neu-
tral solvent evaporates, the droplets undergo 
dispersion by charge repulsion until the ions 
are virtually free of solvent. The nature of 
this process creates mainly multiply charged 
ions for biomolecules larger than 1000 Dal-
ton (Da). In MALDI, analytes are co-crystal-
lized with a chemical matrix before being 
ionized by a laser beam, as is presented in 
Figure 1.2b. The matrix protects the biomol-
ecules from the disruptive laser energy, and 
after ionization it transfers its charges to the 
analytes, resulting in predominantly singly 
charged ions entering the mass spectrom-
eter. 
Mass analyzers
Inside the mass spectrometer the ions 
are guided to a mass analyzer in which they 
are separated based on their m/z. In the 
past fifty years, various types of analyzers 
were developed: the first analyzer was of 
the Time-Of-Flight (TOF) type, followed by 
quadrupole, Ion Trap (IT), Fourier Transform 
Ion Cyclotron Resonance (FT-ICR) and finally 
orbitrap analyzers. Their basic designs are 
depicted in Figure 1.3 and main features are 
briefly explained below. Their differential 
performance in terms of sensitivity, mass 
resolution, mass accuracy and scanning 
speed will be explained and discussed in 
more detail below.
TOF mass analyzers separate ions spatially 
(Figure 1.3a). Inside the instrument, all ions 
are accelerated with a specific kinetic energy, 
inducing them to fly at a velocity proportional 
to their m/z. During the flight through a long 
tube the ions separate and are then scanned 
out by a detector. The m/z of every ion can be 
determined from its traveling time. Reflectors 
correct for differences in kinetic energy and 
longer flight tubes increase the separation 
efficiency and hence the resolution. Modern 
TOF instruments routinely achieve mass 
resolution of 10,000 (at present up to a 
maximum of 60,000) and mass accuracies in 
the low parts per million (ppm) range. 
In quadrupole mass analyzers ions 
travel in between four parallel rods in an 
oscillating electric field (Figure 1.3b). Mass 
spectra are acquired by tuning the electrical 
field such that only ions with a specific m/z 
do not collide with the rods and reach the 
detector on a stable trajectory. Quadrupole 
instruments are very selective and relatively 
fast, but limited in resolution and mass 
accuracy. The maximum resolution, largely 
Many years of development have led to 
a widely used workflow for the identifica-
tion and quantitation of proteins in com-
plex mixtures by MS in a high-throughput 
fashion. Typically the actual MS analysis is 
performed on peptides rather than on intact 
proteins. The reason for this is that pep-
tides behave more homogeneously in LC, are 
easier to solubilize and result in more easily 
interpretable mass spectra than the proteins 
they derive from. Furthermore, sequencing 
a peptide is generally sufficient to identify 
a protein. Therefore, the protein or protein 
mixture is typically digested into peptides 
Box A  Popular proteomics workflow 
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Figure 1.A Schematic workflow of a typical proteomic experiments designed for protein identification 
or quantitation. The basic steps are (1) protein extraction, (2) protein fractionation or enrichment, (3) 
digestion into peptides, (4) peptide fractionation and separation, (5) MS and (6) tandem MS spectra 
acquisition, and (7) data analysis by database searching.
by sequence-specific endoproteases and the 
MS measurement is performed on peptides, 
which are afterwards linked to the originat-
ing proteins. For this reason this MS work-
flow is commonly described as bottom-up or 
shotgun proteomics9,10.
The basic workflow is depicted in Figure 
1.A. Starting from tissue or cell material, the 
proteins need to be extracted by mechanical 
or chemical methods. Solubilization of as 
many proteins as possible and removal (or 
shearing) of DNA are imperative. The second 
step is meant to reduce the sample complexity 
– often at the expense of increasing MS 
measurement time. Fractionation can be done 
by a plethora of biochemical methods like 1D 
(or 2D) gel electrophoresis, cation exchange 
chromatography or gradient centrifugation. 
Depending on the sample complexity and 
the biological question, the fractionation 
can be extensive or can be omitted entirely. 
Subsequently, proteins are digested to 
peptides by site-specific proteases. The most 
commonly used protease is trypsin, cleaving 
C-terminal of arginines and lysines, since 
the resulting peptides are of similar length, 
generally well-ionizable and fragment easily 
in MS. Acidified tryptic digests carry typically 
one charge at the protonated N-terminal 
amine and one at the protonated R or K side 
chain at the C-terminus11. 
The resulting peptide mixture is subse-
quently further separated by C18-Reverse 
Phase Liquid Chromatography (RP-LC) (dis-
cussed in paragraph 1.5).  Eluting peptides 
are ionized (see paragraph 1.3) and guided 
into the mass spectrometer. There, first sur-
vey MS spectra are recorded in which the 
signal intensity is plotted against the mass 
to charge (m/z). To obtain information about 
the peptide sequence, the ions are subse-
quently isolated and fragmented, yielding 
fragmentation spectra, also referred to as 
MS/MS or MS2 spectra. The standard tech-
nique to achieve fragmentation is Collision-
Induced Dissociation (CID). This and other 
types of peptide fragmentation methods will 
be discussed in paragraph 1.3.
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determined by rod length, is typically 100014 
and mass accuracy is in the range of 0.5 Da.
Ion trap (IT) mass analyzers15 function by 
the same physical principles as quadrupole 
instruments but – as the name implies – 
they are capable to confine and thereby 
accumulate ions (Figure 1.3c). Mass spectra 
are acquired by manipulating the potentials 
involved in a manner that successively 
destabilizes ions of specific m/z. Electron 
multiplier detectors, placed on either side 
of the rods, subsequently sense the ions 
ejected from the trap. Since the ion signal is 
multiplied by electron emission this analyzer 
type is extremely sensitive. Its scanning 
speed is another advantage, but also here the 
resolution and accuracy are comparatively 
low. 
 The idea of trapping ions has been 
further optimized in the Fourier transform 
mass analyzers, such as the ion cyclotron 
resonance (FT-ICR)16 and the orbitrap17. 
In both instrument types, ion packets are 
cycling in orbits inside a detector cell, thereby 
generating repeated image currents induced 
by passing close to a pair of detector plates. 
(Figure 1.3d and e). The transient signal - a 
superposition of sine waves - is converted 
into a mass spectrum by application of a 
fast Fourier transformation. Apart from 
their geometic differences, the FT-ICR and 
the orbitrap mass analyzer differ in the way 
the oscillation of ions is induced. In FT-ICR 
instruments a so-called ‘Penning Trap’ cell 
is placed inside a large superconducting 
magnet and ions therefore move in a 
uniform magnetic field. The m/z of every ion 
is then directly proportional to its cyclotron 
frequency (recently reviewed in ref. 18).
In the orbitrap analyzer the magnetic 
field is replaced by an electric field, where 
electrodes guide the ion motions in the 
orbitrap cell. The central electrode attracts 
the ions and thereby counterbalances the 
Figure 1.3 Schematic representation of the different mass analyzers used for proteomic research. 
Modified from ref. 12 and 13.
a      Time of Flight
b    Quadrupole
c         Ion Trap
FT
d      Ion Cyclotron Resonance
FT
e         Orbitrap
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centrifugal force caused by the orbiting 
ions. The outer electrodes register the axial 
oscillations along the central electrode, 
from which the m/z of the ions can be 
determined17. 
In terms of resolution, Fourier 
transformation analyzers perform better 
than any other mass spectrometer. This 
is inherent to their detection principle: 
the resolving power is proportional to the 
number of orbits during data acquisition, 
of which there are many thousands17,19. 
This also explains why FT instruments can 
measure with various resolutions, which 
are selectable through the scan acquisition 
time. Drawbacks of these analyzers are the 
relatively long scanning times (up to 1 s) 
and the relatively low sensitivity: in complex 
mixtures they require millions of ions per 
scan. 
Hybrid mass spectrometers
For accurate readout, the TOF, FT-ICR and 
the orbitrap require pulsed ion injection. Ion 
traps and quadrupoles can be used to select 
and/or accumulate ions of specific m/z and 
subsequently transfer them to a secondary 
analyzer selected from the group above. The 
creation of ‘hybrid’ instruments also allows 
optimal exploitation of the complementary 
features of the different analyzers. Today, 
practically all instruments on the proteom-
ics market are hybrid mass spectrometers. 
Well known types are the triple-quadrupole 
(QQQ), Q-TOF, TOF-TOF, linear ion trap 
(LTQ) FT-ICR or LTQ-FT and the LTQ-Orbi-
trap analyzers. Table 1.1 provides an over-
view of the currently most advanced instru-
ments and their characteristics. 
Table 1.1 Main characteristics of modern (hybrid) mass spectrometers. Adapted from ref. 20. 
1 LOD = Limit Of Detection, 2 MRM = Multiple Reaction Monitoring, 3 IRMPD = InfraRed MultiPhoton 
Dissociation
IT Q-Q-Q Q-Q-TOF TOF-TOF FTICR IT-FTICR IT-Orbitrap
Mass accuracy Low Low Good Good Excellent Excellent Excellent
Resolving power Low Low Good Good Very high Very high Very high
Sensitivity (LOD 1) Good High High High Medium Medium Good
Dynamic range Low Good Medium Medium Medium Medium Medium
ESI Yes Yes Yes No Yes Yes Yes
MALDI (Yes) No (Yes) Yes (Yes) (Yes) (Yes)
MS/MS capabilities Yes Yes (Yes) Yes Yes Yes Yes
Additional 
capabilities MSn
Neutral 
loss, MRM 2
Ion 
mobility -
ECD, 
IRMPD 3
ECD, MSn 
IRMPD, 
ETD, HCD, 
PQD, MSn
Identification + + ++ ++ +++ +++ +++
Quantitation + +++ +++ +++ ++ ++ ++
Speed +++ ++ ++ +++ ++ +++ +++
Detection of PTMs + + ++ ++ ++ +++ +++
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Fragmentation types
Information about the chemical structure 
of an analyte is obtained by gas phase 
fragmentation inside the mass spectrometer. 
Typically, a single ion species is isolated 
and fragmented by collision with neutral 
gas molecules. This technique is named 
Collision-Induced Dissociation (CID)21. CID 
is a relatively slow process in which the 
protons and the energy can reposition prior to 
fragmentation, thus leading to predominant 
breakage of the weakest bonds. In normal 
peptides these are amide bonds, resulting 
in so-called b- and/or y-ions, depending on 
which side retains the proton (see Figure 1.4). 
In case of extremely labile peptide bonds - 
like N-terminal to proline or C-terminal to 
aspartate – the resulting b- or y-ion can take 
up to 80 to 90% of the total ion current. Such 
extremely abundant fragments often hamper 
the peptide identification (see Box B), because 
besides those ions not much else about the 
sequence is revealed. The same problem 
also occurs with peptides containing labile 
Post-Translational Modifications (PTMs) like 
phosphorylation or glycosylation, which 
tend to predominantly lose the phosphate or 
sugar moiety and hence lead to information-
poor spectra. 
To improve identification of peptides with 
labile modifications, two other fragmentation 
techniques were developed that produce MS/
MS spectra complementary to CID (reviewed 
in 22). These methods are based on the inter-
action of multiply charged polypeptides with 
free electrons (Electron Capture Dissociation 
or ECD) or with fluoranthene radical anions 
(Electron Transfer Dissociation or ETD). ECD 
and ETD mainly induce backbone breakage 
between Cα and N, resulting in c- and z-ions. 
These fast reactions involve little energy 
randomization and therefore leave peptide 
modifications untouched23.
As the ionization efficiency is lower, ECD 
and ETD are slightly less sensitive than CID, 
especially for doubly charged ions. But since 
they produce a wider range of peaks of similar 
intensity, the information obtained from the 
spectra can be much higher. Hence, ETD/
ECD fragmentation is very suitable for de 
novo sequencing (see Box B) and for analysis 
of large peptides or intact proteins22.  
Figure 1.4 Roepstorff–Fohlmann–Biemann nomenclature for assigning fragment ions. Assignment is 
based on the cleavage site: (a) N-terminal fragments are named a-, b- or c-ions and C-terminal ions 
are x-, y-, or z-ions. (b) CID fragmentation leads predominantly to b- and y- ions. The location of the 
bond breakage with respect to the precursor backbone is indicated by the amino acid number after which 
fragmentation occurred.
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Figure 1.B Main peptide identification methods: (a) Finding ‘amino acid sequence tags’ in MS/MS spectra 
or (b) correlating match between real and theoretical spectra derived from in silico digested proteins. 
Adapted from ref. 8.
For peptide identification, the total mass 
and a (ideally complete) set of fragment 
masses should be known. The mass of a 
peptide can be calculated by multiplying its 
m/z value with the charge state and sub-
tracting the added proton masses. In rare 
cases, the intact peptide mass is sufficient 
for identification, but - as will be explained 
in paragraph 4.2 - often multiple peptides 
exist with the same nominal mass, therefore 
usually  fragment spectra are needed to elu-
cidate which peptide is detected.
There are two principle approaches for 
peptide identification, shown in Figure 1.B. 
The first approach (Figure 1.B-a) starts from 
fragmentation spectra and uses the know-
ledge that the predominant cleavages occur 
at defined positions along the peptide back-
bone. The difference between fragment ions 
should therefore be equal to the m/z of one 
or more amino acids. ‘Sequence tags’24 can 
be composed by reading out combinations 
of such fragment ion pairs. Together with 
the total peptide mass the sequence tags can 
identify the peptide in protein sequence da-
tabases like the International Protein Index 
(IPI). When the spectrum quality is so high 
that a complete sequence can be ‘read out’, 
it is called ‘de novo sequencing’. 
Less spectrum quality-dependent and 
therefore more commonly applied is the 
second approach (Figure 1.B-b), in which the 
intact and fragment masses are compared 
to a peptide library, composed of peptides 
created by in silico digestion of all known 
proteins. Filtering this library with the de-
tected intact peptide mass results in a list 
of candidates that are subsequently vali-
dated by matching the fragmentation data 
with the hypothetical MS/MS spectra. For 
this approach various complementary search 
engines exist, like Sequest, Mascot, Protein-
prospector, and Xtandem – mainly differing 
in scoring algorithm.
Box B  Peptide identification
a
b
EE ID
re
la
ti
ve
 a
b
u
n
d
an
ce
m/z
b4b2 y3
re
la
ti
ve
 a
b
u
n
d
an
ce
m/z
y2 y4 y5 y7 y8b7
P  E  P  T  I  D  E  I  D
y2y3y4y5y7y8
b7b2 b4
P  E  P  T  I  D  E  I  D
20Chapter 1
1.4  Important MS characteristics 
for proteomics 
When mass spectrometry became avail-
able for protein analysis – with the advent 
of soft ionization techniques, as discussed 
in paragraph 1.3 – it posed new challenges 
to MS instrumentation. Since proteins, even 
when digested to peptides, are much larger 
than most other chemical substances, the 
instruments needed to enlarge their reso-
lution and mass accuracy. Moreover, higher 
sensitivity and faster scanning speed were 
desired for the analysis of complex samples. 
In the following paragraphs I will explain 
these essential MS characteristics and dis-
cuss to what extent they have achieved the 
posed requirements.
Figure 1.5 Definition (a) and impact of mass resolution. (b) An increase of instrumental resolving power 
enlarges the spacing between the peaks and boosts the information content. Depending on the level of 
resolution, charge states, adducts, isotopes or isotopic fine structures can be observed. (c) Typical region 
of a proteomics spectrum, with multiple peaks in the same nominal mass range. Part b adapted from 25.
The power of high resolution
The term ‘resolution’ describes the 
minimal distance between two signals that 
allows their discrimination. In the field of MS, 
mass resolution or mass resolving power is 
therefore defined as 
Resolution =    mass         (1)
         Δmass
As a measure of resolution, typically the 
Full Width at Half Maximum (FWHM) of a 
specific mass-to-charge (m/z) is given, as 
shown in Figure 1.5a. A higher resolving 
power results in sharper peaks and reveals 
more details – from charge states and iso-
tope patterns to relative isotope abundances 
(Figure 1.5b)25. 
 In proteomics, high-resolution mass 
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analyzers are important, because often pep-
tides of the same nominal mass co-elute 
(see Figure 1.5c) and might otherwise go 
unnoticed. Furthermore, a high resolving 
power raises the Signal-to-Noise ratio (S/N) 
and thereby increases sensitivity and quan-
titation accuracy.
What resolution is sufficient depends on 
the biological question as well as the nature 
of the sample and its complexity. In standard 
proteomic experiments where proteins are 
digested to peptides (as explained in Box A), 
peptides typically obtain two to four charges 
with ESI and a resolving power of about 
5000 would suffice to determine the charge 
state and allow calculation of the total mass. 
However, the resolution also influences the 
mass accuracy (see following paragraph) and 
the distinction of co-eluting peptides with 
similar m/z. Hence, the highest possible 
resolving power is typically applied – up to 
50,000 - 100,000 in FT instruments.
Highly accurate mass determination
Mass accuracy is defined as the deviation 
of the instrument reading from a known 
calculated mass. This parameter, which 
becomes better with higher resolution, is 
typically expressed relative to the calculated 
mass in parts per million (ppm) or parts per 
billion (ppb), or in absolute units in Dalton 
(Da).
In proteomics, mass accuracy is a major 
filter criterion for peptide identification. 
In databases containing all proteins of a 
specific organism, many peptides of similar 
mass exist. By applying stringent mass 
accuracy criteria the number of the peptide 
candidates can be appreciably reduced (see 
Figure 1.6) and this lessens the risk of miss-
identification. Accurate mass determination 
is also essential for characterizing PTMs, 
since numerous modifications or amino 
acid substitutions induce similar mass 
shifts. Classical examples of PTMs that are 
difficult to differentiate are trimethylation 
and acetylation differing by only 36 mDa and 
phosphorylation and sulfation differing by 
10 mDa.         
To improve mass accuracy spectra are 
typically recalibrated; either by spiking in 
internal calibrants during acquisition or by 
post-acquisition spectra correction based on 
confidently identified peptides and/or charge 
state information. Current FT instrumentation 
can obtain average deviations in the range 
of 200 to 300 ppb after recalibration, which 
is sufficient to determine the elemental 
composition of most peptides smaller than 
800 Da26. In comparison, TOF analyzers 
reach accuracies in the low ppm range but 
quadrupole and ion trap instruments are 
about two orders of magnitude less precise. 
Although a further 10-fold mass accuracy 
improvement would help to also determine 
the chemical composition of larger peptides 
and ones with lower S/N, much more does not 
seem necessary. For confident identification 
assignment of peptides accurate mass 
alone will remain insufficient, because 
many peptides have counterparts with an 
equal elemental composition but different 
amino acid composition (isomers) or order. 
According to calculations of He et al., there 
is a 50% chance to pick the right peptide 
if all but three residues are known27. Even 
more isomers are to be expected if PTMs are 
considered additionally. 
For peptide identification it is generally 
sufficient to know the precise (intact) peptide 
mass and a set of less exact fragment masses. 
Consequently, fragmentation spectra can be 
acquired in low-resolution mass analyzers 
that have much faster scan speeds and higher 
sensitivity. In some hybrid instruments the 
fragmentation scans are even recorded in 
parallel to the high resolution and accurate 
survey scans. Obtaining more accurate 
fragmentation data is particularly desired, 
if (1) the protease specificity is unknown; 
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(2) the identification is based on de novo 
sequencing or (3) the fragments are large and 
highly charged, as happens when analyzing 
large peptides or intact proteins. In those 
cases the assignment confidence can be 
improved considerably by recording the MS/
MS spectra in high-resolution mass analyzers 
that allow charge state determination of all 
fragments and ppm range mass accuracies. 
High sensitivity and dynamic range
A third essential MS parameter for 
proteomics is sensitivity, typically described 
as Limit Of Detection (LOD) referring to 
the minimal number of ions required for a 
conclusive signal. The importance of this 
parameter is evident: identification is only 
possible if the ion is visible. To analyze low 
abundant ions, the ionization process, the 
transmission and the detection of ions need 
to be highly efficient. 
The ionization process efficiency depends 
on the peptide sequence. Aebersold and 
coworkers found that well-ionizing peptides 
contain on average more histidines, have 
a higher total or average charge and are 
relatively hydrophobic29. Although the 
inherent peptide ionization efficiency can 
not be changed, a reduction of the sample 
complexity may however influence the 
ionization positively. This is thought to be 
due to peptides competing for available 
protons, and this ‘suppression effect’ would 
be smaller in less complex samples3. 
Inside the mass analyzer, two aspects 
of sensitivity are important. The first is the 
total number of ions needed to produce an 
information-rich spectrum. Here ion traps 
are unsurpassed, partly due to their electron 
multiplier detectors. They can produce 
informative spectra from less than 500 ions, 
whereas the FTICR needs at least two orders 
of magnitude more analytes. The second 
essential aspect is the number of different ion 
species that can be observed simultaneously. 
With highly complex samples, as are typical 
for proteomic experiments, low intensity ions 
are likely to be masked by more abundant 
species. Therefore a high ‘dynamic range’ is 
desired, with dynamic range defined as the 
maximum detectable intensity difference 
between the ion species. For most modern 
instruments dynamic range is in the order 
of 103 or 104 per scan, a number typically 
limited in complex ways by the analyzer. 
Measuring larger ion populations in the 
analyzer may improve the dynamic range, 
but simultaneously induces ‘space charging’, 
Figure 1.6 Number of candidate peptides returned from the NCBI-nr protein database upon searching a 
peptide mass (of 1190.7132 Da), demonstrating the filtering function of high mass accuracy. From 28.
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a mutual ion repulsion that negatively affects 
mass accuracy.
Since the dynamic range of complex bio-
logical samples may exceed 1010 to 1012, it is 
evident that without additional adjustments 
proteins of the lowest abundance will not be 
detected, let alone be quantified. Unfortu-
nately, many regulators of disease specific 
cellular processes, that could be interesting 
biomarkers, are expressed in very low copy 
numbers per cell, or trace concentration in 
body fluids, and are therefore difficult to 
identify (Figure 1.7). 
 The most common strategy to improve 
identification of low abundant species is to 
reduce sample complexity by separation 
or specific enrichment. LC is currently 
the standard separation method used 
in combination with MS, but also other 
techniques like gel electrophoresis, iso-
electric focusing or strong cation exchange 
chromatography are applied to achieve 
further fractionation. 
Aside from separation, special methods 
exist to improve the sensitivity or dynamic 
range of mass spectrometers. An interesting 
example is the so-called Multi Reaction 
Monitoring (MRM) technique in triple 
quadrupole (QQQ) instruments. In this 
setup, the first and third quadrupole of the 
instrument are preset to only detect specific 
pairs of precursor peptide and fragment 
ions, while the second quadrupole serves as 
a collision cell for fragmentation. Thus, only 
preselected ions are detected while the rest 
of the peptide signals are ignored. This high 
Figure 1.7 Dynamic range of proteins in blood plasma, demonstrating more than 10 orders of concentration 
difference between the most and least abundant proteins. Many clinically used biomarkers are expressed 
at very low levels. From ref. 30.
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selectivity renders the QQQ a very sensitive 
instrument. In the LTQ-FT and LTQ-Orbitrap 
the dynamic range can be improved by 
so-called ‘selective ion monitoring’ or 
SIM-scanning, where a narrow m/z range 
is monitored. The analyzer is in this case 
only filled with a subpopulation of ions, 
boosting the intensity for and the S/N ratio 
of ions in that mass range. Other options 
are: 1) to selectively destabilize abundant 
ions in the ion trap in order to allow more 
low-intensity ions inside the analyzer; (2) to 
scan alternating with high and low numbers 
of ions (in which the scan with fewer ions is 
used to calculate improved mass accuracy 
of the intense species) as is done in TOF 
instruments; or (3) to improve the mass 
analyzer geometry to enable higher field 
strength. Unfortunately, no option is trivial 
or generally applicable. It is therefore very 
likely that the limiting dynamic range will 
increasingly become a bottleneck in MS 
analysis31 and future efforts should focus on 
improving this MS characteristic. 
Fast scanning instruments
For confident peptide identification, the 
mass spectrometer should attempt to obtain 
sequence data for every detectable ion. To 
do this automatically most instruments 
use a data-dependent precursor selection, 
in which the most intense peptide peaks 
are isolated in turn, based on the previous 
MS scan and sequenced. However, due 
to the co-elution of ions in most LC-MS 
experiments the mass spectrometer can 
currently not scan fast enough to sequence 
all peptides in a single run. This limitation is 
commonly referred to as ‘undersampling’20. 
Undersampling is at present – together with 
the limited dynamic range – one of the main 
issues in MS, because many peaks are not 
targeted for fragmentation and thereby ‘lost’. 
Understandably, many scientists are trying 
to overcome this problem. One method is 
to run the samples multiple times thereby 
increasing the chance that all peptides are at 
least sequenced once by semi-random peak 
selection32. Subsequently the identifications 
from the various measurements are combined. 
Another approach is to use information of 
previous runs and transfer peak identities 
from them, solely based on accurate mass, 
intensity and retention time (without MS/
MS)33. Yet another approach to this problem 
is to employ algorithms targeting specifically 
those ions in a second run that were not 
sequenced in the first run34. 
A completely different way of dealing 
with undersampling is to fragment all ions 
at once and collect alternating full and frag-
mentation scans. With this method many 
data points are generated per second, which 
allows accurate matching of the MS and MS/
MS profile to assign the fragments to the in-
tact peptide ions based on the overlapping 
elution time profile35. 
Which will be the best strategy in the 
long-term remains unclear. MS vendors 
are attempting to build faster scanning in-
struments and researchers are developing 
smarter software to ensure for instance that 
peptide peaks are only selected once, that 
known contaminants are ignored and to 
check that MS/MS spectra contain sufficient 
information to result in identification.
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1.5  Developments in liquid chro-
matography 
Since 1969, Reverse Phase Liquid 
Chromatography (RPLC) has been combined 
with MS36. The chromatographic separation 
is based on hydrophobic interactions with a 
stationary phase, consisting of hydrocarbon 
chains (predominantly octadecyl, C18) 
covalently bound to silica particles. In 
proteomics, peptides (or proteins) are loaded 
onto RP-columns under aqueous, acidic 
buffer conditions and are sequentially eluted 
by an increasing percentage of organic 
solvent like acetonitrile or methanol. Analytes 
elute in order of increasing hydrophobicity in 
linear or segmented gradients37.
LC can readily be coupled to MS, because 
the peptides are already solubilized upon 
separation and need only to be ionized after 
the separation. By adding an ESI emitter to 
the end of the column, the eluting peptides 
are electrosprayed and subjected to direct 
MS analysis. This is often referred to as ‘on-
line LC-MS’. A typical nanoLC-MS setup is 
displayed in Figure 1.8. 
Peak capacity
The chromatography performance is 
defined by the separation power or Peak 
Capacity (PC) and the sample capacity of 
the column. The PC is an estimate of the 
maximum number of peaks that can be 
separated in time on a given column. Under 
the premise that the peak width does not 
change as a function of retention time, PC 
is equal to:
PC = 1+
 Tgrad        (from ref. 38)
  4σ 
with Tgrad being the total gradient time 
and σ the average peak width standard 
deviation38. 4 • σ is generally considered 
adequately separated. The PC is proportional 
to the amount of interaction possibilities 
between the sample and the column 
material and is therefore directly related to 
the column length and the particle size, as 
reviewed in ref. 39. As the flow inside the 
column is predominantly unidirectional, the 
width of the column is theoretically does 
not influence its separation power. This is 
in contrast to the sample capacity, which 
Figure 1.8 Typical nanoLC-MS setup, with a column placed in front of the mass spectrometer orifice. The 
column is packed with small particles that are retained inside by a polymerized frit, or, as shown here, 
with an integrated emitter40. The silica particles within the column are covered with covalently bound 
C18-alkyl chains, with which the peptides interact via hydrophobic interactions.
C18 alkyl chains
coupled to particles
NanoLC column with 
integrated frit
NanoESI in front of MS orifice
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and their avoidance therefore is a major fo-
cus of development. 
Nanocolumns are generally constructed 
by packing a fritted fused silica capillary with 
a slurry of RP-particles The majority of col-
umns are densely packed with small particles 
(of 1.7, 3 or 5 μm) under nitrogen pressure. 
Porous frits can be made by ceramic sinter-
ing, polymerization or by using unions con-
taining stainless steel screens44. To facilitate 
ESI, a needle with small ID is placed behind 
the frit. Columns can also be made from ta-
pered capillaries, where the tip functions as 
an integrated emitter. Ishihama described a 
method to create a frit by building an arch 
of particles in the tip40. The advantage of 
the latter method is that the post-column 
volume is minimized,  thereby preventing 
any post-column mixing effects that could 
negatively affect the separation power. In-
stead of using particles, a column can also 
be produced as a monolith - an in situ po-
is proportional to the Inner Diameter (ID). 
Overloading a column can result in drastic 
peak broadening and the sample amount 
should therefore match the column size.
Increased sensitivity by nanoLC 
LC can also be used for sample concen-
tration purposes. Typically, peptides elute in 
several seconds and the elution volume is 
usually much smaller than the original sam-
ple volume. Given that ESI is a concentration 
dependent process, with the signal intensity 
directly proportional to the analyte concen-
tration, the LC separation results in higher 
peaks compared to direct sample injection.
The concentration dependence of ESI has 
also stimulated the miniaturization of LC to 
nanoLC. In smaller columns peptides elute in 
approximately the same time, but in much 
smaller volumes. The gain in sensitivity 
due to the decrease in column size is pro-
portional to the square of the ID ratio and 
approximately inversely proportional to the 
flow rate41 as can be seen in Table 1.2. Smith 
and coworkers demonstrated this correlation 
experimentally42.
Currently, most laboratories use columns 
of approximately 10 to 30 cm length, 50 to 
100 μm ID and, packed with 3 μm particles, 
which are run at flow rates in the range of 
200 to 300 nL/min. Under those conditions, 
HPLC pumps can deliver a stable and con-
tinuous flow and the samples can be loaded 
relatively fast. To reflect the scale of the 
solvent flow rate used, this separation is re-
ferred to as nanoLC when the column ID is 
between 10 and 100 μm43. Using flow rates 
lower than 500 nL/min in electrospray is also 
noted as nanoESI. 
Further reduction of the column ID and 
flow rate are actively explored to gain fur-
ther sensitivity. However, the detrimental 
effect of difficult to eliminate void volumes 
on chromatographic performance increases 
dramatically with a reduction of the flow rate 
Table 1.2 ESI sensitivity is proportional to 
sample concentration and inversely proportional 
to column ID. Column miniaturization therefore 
leads to significant increases in sensitivity. 
Adapted from ref. 41.
Column ID 
(mm)
Flow rate 
(μL/min)
Relative sensitivity 
increase (fold)
4.6 1000 1
2 200 5.3
1 50 21
0.5 12 84
0.2 2 529
0.1 0.5 2,116
0.075 0.25 3,762
0.05 0.12 8,464
0.025 0.03 33,856
0.01 0.005 211,600
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lymerized, continuous material with pores 
of different sizes. Although these columns 
perform well with higher flow rates, their 
suitability for proteomics is still not clearly 
established43.
Ultrahigh pressure LC 
To improve the separation power, col-
umns can be extended in length or be packed 
with smaller particles, at the expense of in-
creasing the backpressure, as shown in Table 
1.3. Conventional HPLC equipment performs 
best at system pressures below 300 bar and 
thereby constrains column length and parti-
cle size. Recently, special equipment was de-
veloped to employ higher pressures in order 
to obtain increased separation efficiencies. 
So called ‘ultrahigh pressure’ LC (UPLC) sys-
tems can withstand pressures up to 600 bar. 
These instruments are increasingly used for 
fast screening in pharmaceutical companies 
and can separate peptides with reported PCs 
of >700 using short gradients (35 min) and 
relatively high flow rates (1 ml/min)45-46.
Two dimensional LC
Another approach to increase the sepa-
ration power is by applying two orthogo-
nal LC types in sequence. The best-known 
of such approach was developed by Yates 
and co-workers and named Multi Dimen-
sional Protein Identification Technology 
(MuDPIT)47. They placed a short Strong Cat-
ion eXchange (SCX) column in front of the 
column with standard RP-material, loaded 
a complex sample and then used fractions 
of different salt concentrations to transfer a 
subset of peptides from the SCX column to 
the RP-column. The standard organic gradi-
ent only elutes the RP-bound analytes which 
are subsequently analyzed by MS. Although 
this method is theoretically very powerful, 
its deployment in high throughput context 
remains difficult due to practical problems 
such as crystallizing salts.
Further 2D-LC strategies have been pro-
posed, for instance the combination of size 
exclusion chromatography with RP-LC48, 
however, none of these methods has proven 
to be robust or superior to 1D-LC yet. 
Table 1.3 Column backpressure and separation efficiency per cm column length are proportional to 
particle size. As pressure constraints limit the column length, smaller particles do not necessarily result 
in a higher peak capacity. Adapted from ref. 41.
Particle 
size (μm)
Backpressure 
(bar/cm)
Separation 
efficiency 
(plates/cm)
At 400 bar limit
Max. column 
length (cm)
Max. number 
of plates
Max. peak 
capacity
1.7 28 294 14 4116 171
3 9.2 167 43 7181 299
5 3.3 100 121 12100 504
28Chapter 1
1.6  Accompanying technology - 
stable isotope labeling strategies
Until a few years ago, MS was 
predominantly used to identify (semi)
purified proteins. With the advent of online 
nanoLC-MS and automated search engines, 
identification became more straightforward 
and the focus shifted to quantitation49. 
Consequently, researchers have developed 
various methods to compare protein 
abundances, for example, by counting 
the number of identified peptides50, by 
correlating the number of identified peptides 
to theoretically observable peptides51, or by 
comparing the peak intensity or peak area of 
peptide signals52. 
More accurate quantitation is possible 
with stable isotope strategies in MS, since 
the exchange of normal carbon or nitrogen 
atoms by their heavy analog does not affect 
any parameter besides the m/z readout in 
the mass spectrometer49. Peptide mixtures 
with different labels are mixed prior to LC-
MS and the relative intensity of every peptide 
is directly read out as they are visible as 
doublets. Labeling is performed on either 
protein and peptide level, using metabolic 
or chemical strategies. Well-known chemical 
labeling strategies are Isotope-Coded 
Affinity Tag (ICAT), 18H2O, or iTRAQ, and 
they attach a label respectively before, 
during or after digestion53-55. Metabolic 
labeling is performed by feeding cells in 
culture or organisms with a medium in which 
respectively all nitrogen atoms (15N labeling) 
or specifically one or two amino acids 
(termed Stable Isotope Labeling by Amino 
acids in Cell culture or SILAC) are exchanged 
with their heavy isotope variant56. Protein 
quantitation by metabolic labeling strategies 
is more accurate because experimental error 
is minimized by mixing ‘heavy’ and ‘light’ 
cell populations directly after lysis and the 
labeling efficiency can be better controlled. 
Unfortunately, these metabolic methods are 
mainly restricted to systems that grow and 
proliferate, like cells or animals.
For human tissue samples only chemical 
labeling strategies are applicable, but most of 
these are not specific or are difficult to drive 
to completion – factors that can seriously 
complicate quantitation and identification49. 
Probably the best performing approach 
at present is iTRAQ labeling that allows 
comparison of four or eight samples 
simultaneously by use of isobaric reagents. 
The different reagents become visible upon 
fragmentation and can then be read out in 
the fragment mass range from 113 to 121 
m/z. However, iTRAQ quantitation is not as 
accurate as other labeling strategies since 
every peptide is typically only fragmented 
once whereas MS intensity can be averaged 
over multiple survey scans. 
Alternatively, one can refrain from 
labeling and compare the extracted ion 
chromatograms of the same peptides 
measured in consecutive runs. This type of 
quantitation is becoming relatively accurate 
and is applied under the name ‘label-free 
quantitation’. 
In this thesis we applied both SILAC label-
ing and label-free quantitation.
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1.7  In-depth analysis in more 
challenging applications
As discussed above, the rapid develop-
ment of proteomics technology has enabled 
in-depth analysis of many types of biologi-
cal samples. However, for more demanding 
scenarios such as proteins carrying exten-
sive PTMs or proteins available in limited 
amounts only, standard workflows (like the 
one introduced in Box A) provide insufficient 
depth of analysis and alternative strate-
gies need to be explored. Below examples 
of challenging research fields are described, 
in which MS has high potential but currently 
only few applications. 
Intact protein characterization
PTMs often influence the structure of a 
protein and thereby its function. Although 
far from being completely understood, it is 
known that various PTMs are essential in 
signaling pathways, that they are involved 
in practically all cellular processes, and that 
slight disturbances in biological systems 
regulating these modifications can have re-
markable impact. It was shown for example, 
that various diseases are initiated or influ-
enced by altered modification levels57-59. 
In the majority of cases, MS can deter-
mine both the type of PTM and the site of 
modification by the effective mass difference. 
However, the popular protocol involving in 
silico assembly of peptides identified from a 
proteolytic digest (see Box A) is not suited 
to explore the interactions between multiple 
PTMs, since information about combinatorial 
effects is frequently lost. Here intact protein 
characterization can provide invaluable ad-
ditional information. 
Analysis of intact proteins by MS without 
prior digestion is commonly termed ‘top-
down’ mass spectrometry. The difference 
between the earlier introduced bottom-up 
and top-down MS is presented schemati-
cally in Figure 1.9. Under the premise that 
the modified protein form is detectable, top-
down MS enables characterization of all PTM 
combinations as well as determination of the 
modification sites. In addition, it can reveal 
the stoichiometry of the differentially modi-
fied protein species because the ionization 
efficiencies of modified and unmodified pro-
teins are very similar. 
 The detection of distinct protein isoforms 
as a result of differential splicing is in princi-
Figure 1.9 Schematic comparison of top-down and bottom-up mass spectrometry.
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ple also achievable by MS on intact proteins60, 
whereas isoform-identification by bottom-
up approaches depends on the presence of 
unique peptides. The latter generally requires 
high sequence coverage, and sometimes 
there are no unique peptides due to the pro-
tease chosen or as a result of the combina-
tion of splice isoforms present in the sample.
The basic workflow for intact protein 
analysis (see Figure 1.10) is similar to the 
bottom-up approach, but lacks the prote-
olytic step. Protein purification is generally 
more extensive and, in case of pure proteins 
or low-complexity sample mixtures, any RP-
chromatography may be omitted. High reso-
lution and high mass accuracy are essential 
for top-down characterization with ESI, to 
accurately determine the molecular mass of 
the intact protein and of its fragments31. As 
the molecular mass of a protein (Mprotein) is 
defined as:
Mprotein = (m/zmonoisotopic • z) - z • MH+         (3)
the m/z of a monoisotopic peak 
(composed only of 12C atoms) and its charge 
state (z) need to be known. Charge state 
recognition requires only medium resolution 
(see Figure 1.11), but to identify the 
monoisotopic peak, which is typically of low 
intensity for proteins, high S/N and resolving 
power are vital. Ideally this peak is detected 
in the spectrum directly (Figure 1.11c), but 
if it the protein is so large that this isotope 
cannot be seen, its mass can be estimated by 
overlaying the spectrum with a theoretically 
modeled isotope distribution. Additionally, 
high mass accuracy is important, because 
small m/z inaccuracies result in considerable 
protein mass errors upon multiplication with 
the number of protein charges. As described 
in paragraph 1.4, high-resolution MS/MS 
readout is also indispensible for accurate 
and confident fragment ion assignment. 
Without charge state information the risk 
of miss-assignment becomes unacceptably 
high, since the list of theoretical fragments 
used to assign the observed peaks, expands 
with every additional charge the fragments 
are considered to have. 
This demand for high resolution implies 
that top-down characterization with ESI 
can best be performed on FT instruments. 
Although the suitability of FTICR instruments 
has been demonstrated for many years, the 
LTQ-Orbitrap was first used for intact protein 
analysis in our study described in Chapter 2.
Characterization of extremely small sam-
ple amounts
A completely different, but equally 
challenging research area is the field of 
clinical proteomics, in which patient material 
is studied to discover new therapeutic targets 
as well as novel diagnostic or prognostic 
markers. Unfortunately, human samples are 
extremely heterogeneous, usually difficult to 
Figure 1.10 Workflow for intact protein (LC-) MS analysis. Steps are (1) protein extraction and (2) 
separation, (3) MS and (4) MS/MS acquisition and (5) data analysis. Depending on protein purity step 2 
and 3 can be omitted. 
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obtain in vivo and often limited in amount. 
This stands in sharp contrast to fundamental 
biological research where cells of a single 
type are usually grown in culture dishes 
under well controlled and reproducible 
conditions. Such cells can be harvested 
with relative ease in large quantity to study 
fundamental processes like proliferation or 
gene transcription. However, a disadvantage 
of cultured cells is that they may not 
accurately represent molecular events taking 
place in an intact organism. As Pan et al. 
recently demonstrated on the level of the 
proteome, long-term selection for fast cell 
proliferation induced significant metabolic 
changes compared to primary cells61.
Although animals can be used to model 
humans in health and disease – address-
ing some limitations of cell culture systems 
– animal studies are also often restricted 
in terms of clinical use due to differences 
in longevity, exposure to different external 
influences, and different genetic predisposi-
tions. As a result the transfer of results from 
animal models to the actual human disor-
ders often remains challenging. 
Thus, many studies of medical relevance 
have no alternatives to the use of human 
samples. However, this comes with great het-
erogeneity, introduced by individual genetic 
variability (in addition to gender, ethnicity, 
etc.) and environmental factors like diet, 
climate, and health. To deduce convincing 
functional trends large cohorts of patients 
need to be screened. Furthermore the data 
need to be of sufficient depth to detect more 
than typical housekeeping proteins. 
When analyzing body fluids (blood, saliva, 
cerebrospinal fluid, or urine) it is generally 
possible to collect sufficient material. 
However, when tissue samples are taken 
as biopsies, the protein amounts are often 
extremely low, preventing an in-depth 
analysis using standard protocols. Sample 
scarcity is predominantly a problem for 
protein analysis, since signal from RNA or DNA 
molecules can effectively be amplified by the 
well-established polymerase-chain reaction 
(PCR) technique and in principle 100 - 1000 
cells are sufficient62. Proteome analyses 
currently need at least 30,000 – 100,000 
cells, which correspond to approximately 
3-10 microgram of proteins. Only recently 
attempts with lower amounts of cells (3,000) 
were published63, in which 1003 proteins 
were identified by matching their retention 
time and mass to previously acquired samples. 
To improve the analysis of those clini-
cally relevant samples, sample losses during 
preparation steps need to be minimized and 
the LC-MS sensitivity needs to be increased. 
If in-depth proteomes could be recorded 
with small sample amounts and little or no 
fractionation, virtually unlimited possibilities 
emerge in the combination of histology and 
pathology and proteomics. 
Figure 1.11 Importance of high resolution for identification of intact proteins. (a) A resolving power of 
2000 FWHM is insufficient to distinguish individual peaks of the isotope cluster; (b) 10,000 FWHM enables 
charge state recognition; and (c) 100,000 FWHM additionally results in accurate mass determination.
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Outline of this thesis
The aim of this thesis was to develop and optimize LC-MS strategies to accurately characterize samples to more depth than possible hitherto 
and thereby expand the field of MS-based proteomics to novel applications. 
We chose three categories of proteins or proteomes that were challenging            
for different reasons: 
 1. Intact proteins characterization and quantitation
2. High speed characterization of low-complexity protein mixtures
3. Quantitative proteomic analysis from extremely small sample amounts
We start by investigating the capabilities 
of the (in 2005) novel LTQ-Orbitrap for 
top-down protein analysis. As described 
in Chapter 2, we observed that this type of 
mass spectrometer is extremely accurate, 
highly sensitive and well suited for direct 
characterization of small proteins and for 
localizing their modifications. In Chapter 
3 we continued this analysis by evaluating 
whether SILAC labeling can be applied in top-
down MS experiments to provide quantitation 
to this approach. Modeling demonstrated 
that isotope clusters of differentially labeled 
proteins would not overlap in survey spectra 
and we proved this experimentally by 
measuring a protein named Grb2 in heavy 
and light labeled states using online LC-MS. 
Averaged over 20 spectra, we determined the 
ratio of heavy versus light with a precision of 
6%.
In Chapter 4 we switch to bottom-up 
MS and present a novel method intended to 
analyze simple protein (or peptide) mixtures 
with faster throughput (sample type 2). We 
revived the direct nanoESI by use of the Tri-
versa Nanomate robot and developed a fast 
and in-depth characterization method with 
extreme sensitivity and mass precision. By 
use of selective ion monitoring (SIM) scans, 
higher m/z regions with typically low ion 
signals were boosted in intensity and hence 
resulted in more peptide identifications. 
To increase analysis depth also in more 
complex proteomic studies, we attempted to 
collect fractions while running LC-MS. After 
a few iterations, we developed a system that 
we named RePlay. As described in Chapter 5, 
the RePlay is composed of a splitting valve 
and a long capture capillary in which a part 
of the LC-column effluent is stored. Fully 
automated control allows direct reanalysis 
of the stored effluent and thereby enables a 
second analysis in which information from 
the first run may be used. 
In Chapter 6, we subsequently applied the 
novel chromatographic system and proved 
its usefulness for the analysis of minute 
amounts of tissue material (sample type 3). 
Using four hour gradients at a reduced flow 
rate we analyzed single islets of Langerhans. 
From these mini-organs composed of less 
than 4000 cells, we identified 2013 proteins. 
Additionally we quantified the protein 
expression levels after one day of glucose 
stimulation. Up- or downregulated proteins 
confirmed published reports on specific 
transcriptional or translational effects upon 
hyperglycemia, and in addition we found a 
novel proteins involved in islet response as a 
result of high glucose exposure.
Finally, Chapter 7 and 8 encompass the 
summary and recommendations regarding 
future work.
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Introduction
Major goals in every mass-spectrometry-
based proteomics experiment are protein 
identification and characterization. Almost 
invariably, proteins are enzymatically 
degraded to peptides, which are much 
more amenable to mass spectrometric 
investigation1. Further advantages of this 
‘bottom-up proteomics’ approach are 
that one protein generates many peptides, 
providing many opportunities to identify 
or quantify it. However, identified peptides 
rarely cover the whole sequence of a given 
protein often leading to difficulties in protein 
characterization, particularly in determination 
of posttranslational modifications (PTMs). In 
the alternative approach, termed ‘top-down 
proteomics’, intact proteins are ionized, 
physically fragmented and analyzed in the 
mass spectrometer (reviewed in 2-4). Since 
this approach starts from MS-detection of 
the intact, fully modified protein, it has the 
potential for full protein characterization. 
Although analysis of intact proteins has 
been reported for almost all mass analyzers, 
to date only one, the Fourier-transform ion 
cyclotron resonance (FT-ICR) analyzer, has 
sufficient resolving power and mass accuracy 
to efficiently analyze large protein ions. In 
addition, several methods especially useful 
for fragmentation of whole proteins have 
Top-down proteomics, the analysis of intact proteins (instead of first digesting them to peptides) has the potential to become a powerful tool 
for mass spectrometric protein characterization. Requirements for extremely 
high mass resolution, accuracy and ability to efficiently fragment large ions have 
often limited top-down analyses to custom built FT-ICR mass analyzers. 
Here we explore the hybrid linear ion trap (LTQ) – orbitrap, a novel, high performance and compact mass spectrometric analyzer, for top-down 
proteomics. Protein standards from 10 to 25 kDa were electrosprayed into 
the instrument using a nanoelectrospray chip. Resolving power of 60,000 was 
ample for isotope resolution of all protein charge states. We achieved absolute 
mass accuracies for intact proteins between 0.92 and 2.8 ppm employing the 
“lock mass” mode of operation. Fifty femtomole of cytochrome c applied to 
the chip resulted in spectra with excellent S/N and only low attomole sample 
consumption. Different protein charge states were dissociated in the LTQ 
and the sensitivity of the orbitrap allowed routine, high resolution and high 
mass accuracy fragment detection. This resulted in unambiguous charge state 
determination of fragment ions and identification of unmodified and modified 
proteins by database searching. 
Protein fragments were further isolated and fragmented in the LTQ, followed by analysis of MS3 fragments in the orbitrap, localizing modifications 
to part of the sequence and helping to identify the protein with these small 
peptide-like fragments. Given the ready availability and ease of operation of the 
LTQ-Orbitrap, it may have significant impact on top-down proteomics.
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been developed for the FT-ICR analyzers, 
such as infrared multiphoton dissociation 
(IRMPD), sustained off-resonance irradiation 
(SORI) and, in particular, electron-capture 
dissociation (ECD), which is nonergodic in 
nature and in some cases can cleave almost 
any peptide bond in proteins of up to 50 kDa5. 
A similar fragmentation method, electron 
transfer dissociation (ETD), was recently 
introduced for ion traps and, in combination 
with charge state reduction, shows great 
promise for top-down proteomics on these 
mass analyzers6. 
Collision-induced dissociation (CID) 
fragments proteins efficiently in ion traps, 
but these mass spectrometers lack sufficient 
resolution to resolve large protein fragment 
ions and their charge states. With the hybrid 
ion trap-FTICR mass spectrometer (LTQ-FT, 
Thermo Electron) it is possible to fragment 
large peptides or even protein ions in the ion 
trap and detect them with high resolution 
and accuracy in the FT-ICR7,8. However, in 
our experience, and as showed here, the 
LTQ-FT is less suitable for detection of 
fragments produced in the LTQ due to lower 
sensitivity and time-of-flight effects. On the 
other hand, the ions can be fragmented in the 
ICR cell using methods like ECD and IRMPD. 
Furthermore, even though the LTQ-FT is 
a commercial and robust instrument, the 
necessity for a high magnetic field detector 
and relatively high maintenance costs tend 
to limit its use to specialized laboratories.
In 2005 a new hybrid mass spectrometer, 
the LTQ-Orbitrap (Thermo Fisher Scientific), 
was introduced9. It consists of a linear 
quadrupole ion trap (LTQ) coupled to a novel 
mass analyzer, the orbitrap,  invented by 
Makarov10-12. In the orbitrap, ion packages 
circle between two concentric electrodes 
and their axial motion is detected, as in the 
FT-ICR, by recording their image currents 
followed by Fourier Transformation of the 
time-domain signal to obtain the mass 
spectrum. Importantly, the orbitrap is very 
compact and requires no magnetic field or 
special maintenance. LTQ and orbitrap are 
coupled via the C-trap, an intermediate RF-
only storage device, which can also be used to 
store background ions of known composition. 
When analyte ions are added and analyzed 
together with this ‘lock mass’, sub-ppm 
mass accuracy for peptides is achievable13. 
No systematic study dealing with intact 
proteins and their fragments in the LTQ-
Orbitrap has been reported so far. In this 
study, we have explored the utility of the 
LTQ-Orbitrap mass spectrometer for top-
down analysis of proteins ranging in mass 
from 10 to 25 kDa. Our results show that the 
instrument is capable of routinely achieving 
high sensitivity (attomole to femtomole 
range), high mass accuracy (low ppm) and 
isotope resolution of small proteins. In 
addition, selected multiply charged protein 
ions can be successfully fragmented in two 
stages, MS/MS and MS3, in the linear ion 
trap and their fragments transferred and 
measured in the orbitrap. We demonstrate 
ready identification of modified and 
unmodified proteins by MS/MS and MS3 data. 
Materials and methods  
All protein standards were obtained from 
Sigma. The following proteins were analyzed: 
bovine cytochrome c, bovine α-crystallin A 
and B chain, bovine β-lactoglobulin, bovine 
β-casein, and recombinant human ubiquitin. 
Proteins were dissolved in methanol/water 
with 0.5% formic acid immediately before 
analysis. Sample concentration ranged from 
100 fmol/μL (acquisition of whole protein 
spectra), to 1 pmol/μL (acquisition of MSn 
spectra). A sample volume of 0.5 μL was 
delivered to the mass spectrometer using a 
Nanomate 100 system (Advion Biosciences). 
A Nanomate low-flow 2.5 µm ESI chip was 
used as static nanoelectrospray emitter, 
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providing a stable flow of 20-30 nL/min. 
Voltages of 1.3-1.6 kV were applied to the 
chip through the Nanomate power supply, 
while the mass spectrometer source voltage 
was set to zero. Samples were infused using 
nitrogen gas at a pressures of 0.7-1.0 psi.
LTQ-Orbitrap Mass Spectrometry 
Measurements were performed on a LTQ-
Orbitrap mass spectrometer (Thermo Fisher 
Scientific), in the positive ion mode. Electron 
multiplier gain, FT and storage transmission, 
as well as mass accuracy (FT) were calibrated 
immediately before measurements according 
to manufacturer’s instructions. Collision-
induced dissociation (CID) of selected protein 
charge states was performed in the LTQ and 
fragments were subsequently transferred 
and measured in the orbitrap. Selected 
protein charge states (typically the most 
abundant ones) were isolated with a width 
of m/z = 6 to 10 and activated for 30 ms 
using 30% normalized collision energy and 
an activation q of 0.25.  The instrument was 
controlled using TunePlus 2.0 (beta 3) and 
the acquired spectra were evaluated using 
Xcalibur 2.0 software. 
The orbitrap automated gain control (AGC) 
targets were set to 2x106 charges for full 
scan, and 2x105 for MSn scan. Protein mass 
spectra were acquired at a resolving power 
of 60,000 and MSn spectra were acquired at 
60,000, 30,000 or 15,000. Lock-mass op-
tion was enabled in all measurements un-
less otherwise stated and polydimethylcy-
closiloxane (PCM) background ions (at m/z 
445.120025 and 429.088735) were used for 
real-time internal calibration as described 
previously13. Unless otherwise stated, all or-
bitrap scans consisted of 10 microscans (see 
below).
Data analysis
Protein masses were determined either 
by deconvolution using the integrated Xcali-
bur Extract software (Thermo Fisher Scien-
tific) or by direct calculation from the peak 
positions and charge states. Expected pro-
tein fragment masses were calculated using 
PILGrinder software (developed in-house by 
Peter Mortensen), Protein Prospector soft-
ware (http://prospector.ucsf.edu/)14 or GP-
MAW (Lighthouse data)15. MS/MS spectra 
were searched with the web-based ProSight 
PTM (https://prosightptm.scs.uiuc.edu/)16 
against either the human Uniprot or a custom 
bovine database in ‘Absolute Mass’ mode. A 
wide tolerance of up to 2000 Da was used 
for the protein mass, to allow for differences 
between measured and theoretical masses 
due to protein modification. Fragment ion 
mass tolerance was in all cases set to 5 ppm 
and at least 5 matched fragments were re-
quired for protein identification. 
MS3 spectra were searched against NCBInr 
protein database (date 2005/04/15; 2440425 
sequences) using the Mascot search engine 
(Matrix Science)17. Search criteria were: no 
enzyme specificity, precursor mass tolerance 
5 ppm, and fragment mass tolerance 0.01 
Da. Since Mascot cannot handle MS3 data, we 
manually added the mass of H2O (18.0106 
Da) to all precursor ions that gave good 
quality MSn spectra but did not result in pro-
tein identification. This formally turns b-type 
ions or internal fragments into peptide pre-
cursors. To match MS3 fragments by Mas-
cot when the precursor was a b-ion, y-ions 
were allowed to match only with H2O loss. 
Results and discussion
The utility of the LTQ-Orbitrap mass spec-
trometer for top-down analysis of proteins 
was assessed at three levels: (a) high-accu-
racy MS measurement of the whole protein in 
the orbitrap; (b) MS/MS (CID) fragmentation 
of a single charge state of the protein of in-
terest in the LTQ, with subsequent detection 
of resulting fragments in the orbitrap; and 
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(c) MS3 of selected CID fragment(s) in the 
LTQ and their detection in the orbitrap.
First we wanted to establish optimal 
conditions for protein measurement on 
the LTQ-Orbitrap. Nanoelectrospray18,19 
is commonly used in top-down proteomics 
because it allows detailed investigation of 
complex samples for extended periods of 
time and because it is very sensitive. Here we 
employed a newly developed very low flow 
nanoelectrospray chip (Nanomate, 2.5 μm 
nozzle inner diameter, Advion Biosciences), 
which supports stable flow rates in the true 
nanoelectrospray range of 20 to 30 nl/min. 
This allowed us to routinely use a volume of 
0.5 μl and still acquire data for more than 
15 minutes, more than sufficient time for all 
measurement sequences. 
We investigated optimal parameters for 
acquisition of whole protein spectra in the 
orbitrap mass analyzer. The best sensitivity, 
S/N and accuracy were obtained when 
each scan consisted of 10 microscans. In 
this regime, transients of 10 consecutive 
microscans are added to form a final transient 
on which Fourier transform is performed. 
Data acquisition time was between 10 and 
30 s at the resolution chosen (see below), 
so it was still very short compared to total 
available spray time. At the concentrations 
used, fill times for the 106 target value 
chosen was between 0.2 to 4 s, comparable 
to the transient time of 750 ms.
In non-mass resolved mode, target values 
of up to 107 are possible in the LTQ part of 
the instrument, much higher than the limit 
of about 106 of the C-trap. However, in mass 
resolved mode, for example when storing a 
charge state for subsequent dissociation, 
only about 105 ions can be accumulated. 
In this mode, the ability to sequentially fill 
the C-trap would be useful as pointed out 
previously13. 
Measurement of Intact Proteins 
Sensitivity
At the intact protein level, well-defined 
“envelopes” arising from detection of mul-
tiple charge states were routinely obtained 
in the orbitrap for all investigated proteins 
at concentrations of 100-500 fmol/μL and 
total protein amounts of less than 250 fmol 
(Table 2.1). The lowest amount analyzed in 
this study was 50 fmol of cytochrome c (Fig-
ure 2.1). Note that this was the total pro-
tein amount used for measurement, and that 
high S/N protein mass spectra were obtained 
even after one MS scan (10 microscans), on 
a population of  about 2x107 ions (low atto-
mole range) and acquisition time of 30 s. The 
same amount of cytochrome c was detected 
on the LTQ-FT instrument under the same 
measurement conditions, albeit with lower 
intensity and S/N ratio (data not shown). 
High sensitivity measurements at the 
whole protein level have been reported 
before on FT-ICR instrumentation. For 
example, McLafferty and co-workers have 
reported sub-attomole detection of 8-30 
kDa proteins using capillary electrophoresis 
separation coupled with FT-ICR mass 
detection20, and Smith’s group has reported 
low zeptomole detection of proteins in the 
same mass range21. However, these high 
sensitivities were not achieved routinely and 
required either up-front analyte separation 
and concentration, or extensive instrument 
optimization. The static nanoelectrospray 
measurements in this study show that the 
orbitrap sensitivity for proteins compares 
favorably with other instrumentation 
routinely used in top-down proteomics. 
Resolution
All orbitrap protein spectra presented 
here were recorded at 60,000 resolution 
at m/z 400, which is the specified resolv-
ing power of the orbitrap mass analyzer. 
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This resolution requires ‘one second’ mea-
surements (750 ms transients), whereas the 
maximum possible measurement time of 1.8 
s leads to a resolution of 100,000. Although 
this value is less than the maximum possible 
with high magnetic field FT-ICR analyzers, 
it was sufficient for isotope resolution of all 
investigated proteins (Figure 2.1 and 2.2) 
and provided a good duty cycle. Further-
more, resolution in the orbitrap is inversely 
proportional to the square root of the m/z 
value, rather than to the m/z value directly 
as it is in the FT-ICR10, resulting in slower 
decrease of observed resolution across the 
mass range. In practice this means that at 
m/z values above 1111.1 resolution power 
of 60,000 (m/z 400, 750 ms transient) of 
the orbitrap analyzer exceeds resolution 
power of 100,000 of the 7 Tesla LTQ-FTICR 
instrument. This unique feature is useful 
in analysis of intact protein mass spectra, 
where protein charge states are often ob-
served above m/z 1000. It has to be noted, 
however, that longer transient acquisition 
in the LTQ-FT instrument leads to signifi-
cantly higher resolution (specified to up to 
500,000), whereas in the orbitrap mass ana-
lyzer the transient acquisition time is limited 
to 1.8 s and consequently its resolving power 
to about 100,000. Isotope resolution directly 
enables the detection of modifications such 
as disulfide bridges (Δm=2 Da) or deamida-
tion (Δm=1 Da) of small proteins, whereas 
the ability to resolve isotopic clusters of dif-
ferent protein charge states across the mass 
range is important for proper charge state 
assignment in complex spectra caused by 
overlapping protein charge distributions. 
Figure 2.1 Single-scan mass spectrum of cytochrome c (0.5 µL of a 100 fmol/µL solution) acquired in the 
orbitrap mass analyzer at AGC target of 2x106 charges, and resolution 60,000. The scan consisted of 10 
microscans and took a total time of 29 s to acquire. Inserts show isotope resolution of protein charge 
states across the mass range. ‘x’ marks breakdown products or impurities in the sample.
700 750 800 850 900 950 1000
m/z
0
10
20
30
40
50
60
70
80
90
100
R
el
at
iv
e 
A
b
u
n
d
an
ce
941.0 942.0 943.0 944.0
m/z
x
x x
x
z = 13
z = 14
z = 15
z = 16
z = 12
z = 17
z =18
679.5 680.5 681.5 682.5
m/z
44Chapter 2
Mass accuracy
For high mass accuracy, orbitrap spec-
tra in this study were acquired in the ‘lock-
mass’ mode of operation using background 
polydimethylcyclosiloxane (PCM) ions from 
the ambient air as internal calibrants, as de-
scribed recently13. In the lock-mass mode, 
each orbitrap scan is preceded by a short LTQ 
scan in which a defined number of calibrant 
ions is injected into the C-trap. Analyte ions 
are then added into the C-trap and injected 
together with the calibrant ion into the or-
bitrap. The calibrant ion is recognized on-
the-fly and masses of all ions are corrected 
in real time. For the intact protein measure-
ments, the PCM ion at m/z 445.120025 was 
used as the reference, whereas for the MSn 
measurements the corresponding neutral 
loss (-CH4) PCM ion at m/z 429.088738 was 
used instead, due to its higher abundance in 
the MSn spectra. This improved mass accu-
racy up to three fold (see Table 2.1). 
Masses and standard deviations for each 
protein standard were calculated from up to 
10 members of each isotopic distribution in 
at least two different charge states and two 
different scans. For larger proteins, where 
the monoisotopic peak could not readily be 
determined, the isotope state was calculat-
ed using the top-fitting method described 
by Zubarev et al.22, with the cutoff level of 
h=50%. Alternatively, the protein mass was 
determined from the protein spectra decon-
voluted by Xcalibur software. As expected, 
all protein standards were measured with 
very high mass accuracy, between 0.92 ppm 
(standard deviation, s.d. 0.79 ppm) to 2.80 
ppm (s.d. 1.02 ppm) (Table 2.1). The overall 
(combined) absolute mass accuracy was 2.25 
ppm with average s.d. 1.46 ppm. 
Although FT-ICR MS is capable of achiev-
ing extremely high mass accuracies, there 
are only a few reports where accuracy was 
better than 10 ppm at the protein level. The 
main reason for this is the space-charging 
effect, which depends on the ion popula-
tion in the ICR cell. Although several strate-
gies have been proposed to overcome this 
effect23,24, the best results were obtained 
when ion population was well controlled or 
when internal calibration was performed. For 
example, Smith and coworkers have used a 
dual ESI source to infuse γ-endorphin as in-
ternal calibrant and enabled “mass locking” 
to its doubly charged ion. In a high-through-
put LC-FT-ICR analysis of intact proteins of 
the yeast large ribosomal subunit they have 
identified about a hundred proteins with av-
erage absolute accuracy of about 2.5 and s.d. 
of 2.0 ppm, in cases when protein monoiso-
Table 2.1 Masses and accuracies of intact proteins measured in the LTQ-Orbitrap (with and without 
lock mass (LM)), and amounts of proteins used for analysis. Two charge states, about 10 isotopes and 
two different scans were used for mass determination. Standard deviation was calculated from these 40 
values.
MWtheoretical
(Da)
MWexperimental 
(Da)
Mass accuracy (ppm) Amount 
measured
(fmol)- LM + LM
Cytochrome c 12224.209 12224.175 1.96 ± 1.33 2.16 ± 1.79 150 
α-Crystallin (A) 19820.867 19820.838 6.63 ± 1.86 2.44 ± 1.50 250 
α-Crystallin (B) 20067.393 20067.404 7.25 ± 1.69 2.78 ± 1.80 250 
β-Lactoglobulin 18266.394 18266.396 4.72 ± 1.32 0.92 ± 0.79 150
β-Casein 23969.226 23969.198 6.50 ± 2.14 2.41 ± 1.84 150 
Ubiquitin 10026.329 10026.484 4.15 ± 0.77 2.80 ± 1.02 150 
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topic mass could be measured25. 
While a detailed study of space-charging 
effects in the orbitrap mass analyzer has 
not yet been published, we have not ob-
served systematic mass shifts as a func-
tion of ion number up to the limit imposed 
by the C-trap, of about 106 charges. Thus 
in our experiments mass accuracies for all 
six standard proteins were never worse than 
7.5 ppm, even without lock mass option. 
In addition, protein masses were measured 
with extremely high precision, almost always 
better than two ppm (Table 2.1). Together, 
these data demonstrate that the LTQ-Or-
bitrap can routinely achieve extremely high 
mass accuracy at the protein level, without 
any software or hardware modification.    
Analysis of posttranslational modifica-
tions (PTMs) at the protein level
One of the strengths of the top-down 
approach in MS-based proteomics is poten-
tially comprehensive characterization of 
PTMs. Three of the proteins analyzed in this 
study, namely β-casein, and α-crystallin A 
and B chains are known to be phosphorylated. 
In case of β-casein, five phosphorylation sites 
have been reported, and the mass measured 
in the orbitrap corresponded to the mass of 
the protein form containing all five phosphate 
groups. In contrast, both A and B chains of 
α-crystallin were detected in several forms; 
A-chain was detected as unmodified, and 
modified with one phosphate group; B-chain 
was detected as unmodified, and modified 
with one, two and three phosphate groups 
(Figure 2.2). Stoichiometries of these 
modifications were in agreement with those 
observed in a previous MS study26. Note that 
mass differences arising from modifications 
were measured with high precision (10 mDa, 
or two significant decimal places), potentially 
enabling discrimination of modifications with 
the same nominal mass, such as acetylation 
and trimethylation (Δm = 35 mDa), at the 
intact protein level. In addition, it is clear 
from Figure 2.2 that sensitivity for detection 
of phosphoproteins was excellent in this 
case, since 250 fmole total protein mixture 
had been loaded, and the singly and doubly 
phosphorylated crystallin B chain make up 
less than 15 percent of this amount. 
Measurement of Protein MS/MS Fragments 
in the orbitrap
Accurate protein mass alone would be of 
little use in the analysis of unknown proteins 
or protein mixtures. As discussed before, 
various fragmentation methods have there-
fore been applied to intact proteins (or their 
isolated charge states) in order to obtain at 
least partial information on protein primary 
structure. In the LTQ-Orbitrap fragmentation 
must be performed outside of the orbitrap 
mass analyzer, therefore two fragmentation 
types are currently possible. Proteins can be 
fragmented by nozzle-skimmer (in-source) 
dissociation, or collision-induced dissocia-
tion (CID) in the linear quadrupole ion trap 
(LTQ) with subsequent detection of fragment 
ions either in the ion trap or in the orbitrap. 
Our initial studies using nozzle-skimmer 
fragmentation resulted in very little fragmen-
tation, without useful sequence information 
(data not shown), therefore all fragmentation 
was performed by CID in the LTQ. 
As already reported in experiments on the 
LTQ-FTICR, intact proteins readily fragment 
in the LTQ under the same conditions 
normally used for peptide sequencing7,8. 
Various charge states of all analyzed proteins 
produced multiply charged fragment ions 
which were isotopically resolved and showed 
excellent S/N (Figures 2.3 and 2.4). As in the 
case of intact protein measurements, spectra 
were acquired as the sum of 10 microscans. 
Efficient transfer from the LTQ to the C-trap 
and orbitrap and absence of time-of-flight 
effects insured that fragments could be 
acquired in a single mass range. MS/MS 
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fragments were calculated by ProSight (Single 
Protein Mode)16. Since ProSight calculates 
only b- and y-ions, internal fragments were 
calculated using Protein Prospector14 or 
GPMAW software15. As demonstrated for 
β-lactoglobulin and β-casein, fragments 
were measured with average absolute 
accuracy better than two ppm in the orbitrap. 
CID of intact proteins has been performed 
in ion trap instruments before, producing 
multiply charged fragment ions (reviewed in 
2). Unfortunately, this had little application so 
far, due to the inability of ion traps to resolve 
charge states of fragment ions and necessity 
to perform charge state reduction by intro-
duction of anions into the mass analyzer. The 
combination of a linear ion trap and the high 
resolution orbitrap analyzer now enables 
straightforward interpretation of protein 
fragment spectra without ion-ion reactions.
Figure 2.2 Mass spectrum of modified and unmodified α-crystallin A and B chains acquired in the orbitrap. 
(a) Appearance of the protein envelope at a total protein concentration of 500 fmol/µL; (b) Zoom-in 
of the [M+23H]23+ charge state reveals presence of several phosphorylated forms of α-crystallin A 
and B chains; (c) Deconvoluted and de-iosotoped spectrum of α-crystallin. The experimental values 
of the mass differences between modified forms are consistent with phosphorylation as the protein 
modification (theoretical mass difference 79.966).
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Fragmentation patterns
Figure 2.3a shows an MS/MS spectrum 
of β-lactoglobulin upon isolation and CID 
fragmentation of its [M+15H]15+ charge 
state in the LTQ, and subsequent detection 
of fragment ions in the orbitrap. The 
fragmentation patterns of proteins in our 
study were in agreement with the ones 
previously reported for ion trap CID of 
intact proteins7,8,27. Cleavages C-terminal 
to charged residues, in particular Asp, 
Glu and Lys, as well as N-terminal to Pro, 
were the major fragmentation channels, 
although other cleavages were observed 
as well (Figures 3b and 4b). In MS/
MS spectra of cytochrome c, ubiquitin, 
and  β-lactoglobulin, complementary 
b/y fragments were observed. However, 
β-casein fragmented to approximately 
70 residues from the N-terminus and 25 
residues from the C-terminus, leaving the 
central portion of the molecule uncovered 
(Figure 2.4). Importantly, all detected b-ions 
formed by CID of its [M+22H]22+ charge 
state that encompassed the five predicted 
phosphorylation sites indeed had all five 
Figure 2.3 Collision-induced dissociation of β-lactoglobulin. (a) Single-scan fragmentation spectrum 
of the [M+15H]15+ charge state of  β-lactoglobulin acquired in the orbitrap at 30,000 resolution shows 
extensive fragmentation in the N-terminal region with a sequence tag easily detectable (insert); the scan 
consisted of ten microscans and took 12 s to acquire; (b) Sequence of the molecule with fragmentation 
pattern observed upon CID. The part of the molecule protected by the disulfide bonds is also indicated. 
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phosphate groups attached. Together with 
low mass, unmodified b-ions, this locates 
all phosphosphorylation sites to between 
residues 9 and 57 of the sequence. Since 
the loss of phosphoric acid from the peptide 
backbone, commonly observed in ‘bottom-
up’ approach, was not observed after CID of 
intact proteins, modified fragments could be 
fragmented further to give insight into the 
exact locations of protein modifications.
It is well known that CID fragmentation 
of whole proteins depends largely on the 
protein structure (such as the positions of 
disulfide bonds) and size and that larger 
proteins (>20 kDa) tend to fragment mostly 
in terminal regions. It is both an advantage 
and a disadvantage of CID that it concentrates 
fragmentation products into a few preferred 
Figure 2.4 Collision-induced dissociation of β-casein. (a) Single-scan fragmentation spectrum of the 
[M+22H]22+ charge state of β-casein analyzed in the orbitrap shows fragmentation at both termini. 
Note that all five phosphate groups remained attached to MS/MS fragments - neutral loss of phosphate 
upon CID was not observed. The insets show typical isotope patterns of small and large fragments as 
well as the obtained mass accuracy; the scan consisted of one microscan and took 1.12 s to acquire (at 
R=60,000); (b) Sequence of β-casein, with phosphorylation sites indicated by circles and fragmentation 
pattern observed upon CID. 
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channels. This increases the sensitivity for 
detecting these fragments but will often 
preclude complete characterization with 
single residue resolution. ECD can potentially 
cleave almost all peptide bonds in a protein28, 
however it suffers from relatively low 
efficiency, which results in lower sensitivity 
and increased acquisition times. Therefore, 
these methods are complementary, rather 
than competing. ETD, a recently developed 
fragmentation technique for ion traps, 
would be very suitable for the LTQ-Orbitrap, 
since it would combine the advantages of 
nonergodic fragmentation (high sequence 
coverage, preservation of labile bonds, 
etc.), with the high resolution, sensitivity 
and accuracy of the orbitrap mass analyzer 
demonstrated here.   
Protein identification using MS/MS data
High accuracy measurement – typically 
better than two ppm – and straightforward 
assignment of the charge states of frag-
ment ions, together with the accurately 
determined protein mass were used for 
protein identification. Monoisotopic masses 
of the MS/MS fragments were submitted 
to ProSight PTM (Absolute Mass mode), 
currently the only publicly available search 
engine for top-down proteomics. MS/MS 
spectra of recombinant human ubiquitin 
were searched against the human Uniprot 
database, whereas all other proteins were 
searched against both custom-made bovine 
database and human Uniprot database. The 
protein mass tolerance was set to 2000 Da 
to allow for potential modifications, and 
a minimum of 5 matched fragments with 
accuracy of 5 ppm or better were required 
for a hit. These stringent criteria led to 
unambiguous identification of all analyzed 
proteins. Human ubiquitin was identified 
with 10 fragment ions (average absolute 
mass accuracy 2.45 ppm, s.d. 0.92 ppm), and 
probability score of 7.4x10-19. As expected, 
its mass was 1597.42 Da higher than 
theoretical, corresponding to the difference 
of the Flag-tag (DYKDDDDKKLMV) plus Met 
at its N-terminus (Δm = 0.030 Da). In the 
case of cytochrome c, the measured mass 
differed from the theoretical by 616.172, 
which corresponds to the mass of the heme 
group (Δm = 0.006 Da). This not only shows 
the potential of the top-down approach to 
conclusively identify proteins, but to point to 
modifications not considered in the database, 
as well. α-Crystallin A and B chain, β-casein, 
and  β-lactoglobulin were also identified as 
unique, high probability hits; however, their 
scores were not representative since the 
custom-made bovine database contained 
only eight entries. When searched against 
the human database MS/MS spectra of these 
proteins did not lead to any hits. 
This demonstrates that high accuracy MS/
MS spectra of whole proteins acquired in the 
orbitrap can routinely be used for high strin-
gency database search in top-down pro-
teomics, leading to high confidence identifi-
cation and greatly constraining the nature of 
a possible modification. 
Top-down Proteomics Using MS3 on the 
orbitrap
We have recently shown that an additional 
level of peptide fragmentation (MS3) is 
feasible on the LTQ-FT-ICR at high sensitivity 
and chromatographic time scale29. Together 
with a new scoring algorithm, this data 
significantly improved confidence of peptide 
identifications. With this background and the 
excellent quality of the MS/MS spectra, we 
decided to explore the feasibility of the LTQ-
Orbitrap for top-down, MS3 experiments.  
Figure 2.5a shows the MS/MS spectrum 
of ubiquitin. The predominant ion is y587+ 
caused by proline directed cleavage. This ion 
was isolated and dissociated in the LTQ and 
resulting fragments analyzed in the orbitrap 
(Figure 2.5b). Even a single microscan acqui-
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sition (0.6 s) led to a good S/N spectrum, 
which was further improved by summing 21 
spectra (Figure 2.5b). The spectrum contains 
many informative ^b and y ions (^b refers 
to the MS3 fragment ion generated from the 
end of the sequence truncated by the MS/
MS cleavage, see29). To generate MS3 spec-
tra similar in quality to Figure 2.5b typically 
required selecting one of the dominant ions 
of the MS/MS spectrum and a total acquisi-
tion time less than one minute. Thus, several 
different MS3 spectra can be acquired of a 
single protein loaded a few hundred femto-
moles into the Nanomate. We also explored 
higher stages of MSn. Figure 2.5c shows an 
MS4 spectrum analyzed in the LTQ and dem-
onstrates that interpretable spectra can still 
be obtained after four rounds of isolation 
and fragmentation.  
Recently, Zabrouskov et al.8, working on 
an LTQ-FT-ICR, used MS3 of proteins for in-
creased confidence of protein identification. 
Fragment and protein masses alone may not 
be sufficient to identify a protein in cases 
where overlapping protein envelopes lead to 
simultaneous fragmentation of two or more 
different proteins (such as in complex mix-
tures), or where CID of proteins results in 
low number of detected fragments, leading 
to multiple hits and/or low probability scores 
in database search. In these cases, unam-
biguous protein identification may require 
an additional level of structural information. 
Additionally, as mentioned above, MS3 could 
help to pinpoint or restrict sites of modifica-
tion in proteins. 
Finally, we decided to investigate if small, 
peptide-like MS/MS fragments of proteins 
could be fragmented and used for protein 
identification in a manner similar to protein 
identification in the ‘bottom-up’ approach. 
The advantage of such a strategy would be 
that small fragments are less likely to be 
modified and that there are relatively few 
possible fragmentation channels. We chose 
a small fragment of β-casein which was eas-
ily determined to be doubly charged based 
on its isotope spacing (see Figure 2.4a).  This 
fragment was accumulated in the LTQ, frag-
mented and analyzed in the orbitrap. Figure 
2.6 shows a relatively simple MS3 spectrum 
similar to the MS/MS spectrum of a small 
peptide. Several changes were made to the 
normal Mascot modus to be able to search 
this data. Since the MS3 precursor could be 
a b or y ion of the protein, both possibili-
ties were checked. Assuming a y-ion did not 
lead to any matches, therefore the mass of 
water was added to the precursor mass to 
formally convert it from b-ion to a peptide 
precursor. Mascot was directed to match 
only b or y-H2O ions (these are the ^y MS3 
fragments generated from b-ion precur-
sors29). Despite the short peptide length, a 
‘non-enzyme’ specificity search by Mascot 
in the non-redundant database (NCBInr) 
yielded only two significant matches. The 
top match was located in the N-terminal re-
gion of the beta-casein precursor. A check 
of the database confirmed that Mascot had 
identified the eight N-terminal residues of 
the mature protein. The second significant 
hit had a related peptide sequence account-
ing for matched fragments despite the high 
mass accuracy, but was located close to 
the center of the protein sequence and was 
therefore discarded. Since the protein was 
modified with five phosphogroups, this ex-
ample shows an interesting additional way of 
identifying modified proteins. 
Conclusions
We here investigated whether a compact 
linear ion trap – orbitrap hybrid mass spec-
trometer (LTQ-Orbitrap) was suitable for 
top-down proteomics of small proteins. We 
interfaced the LTQ-Orbitrap to a low flow 
Nanomate static nanoelectrospray source 
providing more than 20 minutes measure-
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Figure 2.5 Multistage MS of the FLAG-tagged ubiquitin [M+11H]11+ charge state in the LTQ-Orbitrap. 
(a) MS/MS fragmentation spectrum analyzed in the orbitrap; (b) MS3 spectrum of the abundant, proline 
directed y587+ fragment ion analyzed in the orbitrap; (c) MS4 spectrum (LTQ) of the proline directed 
y404+ fragment shown in panel b.
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ment time for half a microliter of solution. 
Sub-picomole amounts of intact proteins 
proved sufficient to obtain high quality MS, 
MS/MS and MS3 spectra, with mass accura-
cies in the few ppm range. Intriguingly, da-
tabase searches with the MS/MS data allow 
straightforward identification not only of 
unmodified but also of modified proteins. 
Since the molecular weight of proteins sel-
dom corresponds to that calculated from the 
database sequence, this should be very valu-
able for top-down proteomics. In particular 
we show that small peptide-like fragments 
generated by protein MS/MS can be frag-
mented similar to peptides in the bottom-up 
approach, potentially combining advantages 
of both strategies. In the future, it will be in-
teresting to employ this instrument with on-
line protein separation as well as to develop 
new algorithms tailored to the strength of the 
data that it generates. This technology may 
then allow routine, high accuracy and high 
confidence analysis of the ‘peptidome’ and 
small protein component of the proteome.
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Introduction
The use of mass spectrometry to 
analyze biological samples has evolved 
tremendously over the last decade, and 
mass spectrometry-based proteomics, in 
particular, has become an indispensable 
part of modern life sciences1. In recent 
years, the need for quantitative as opposed 
to qualitative proteomics experiments has 
become apparent and a large number of 
different approaches have been developed, 
mainly based on incorporation of a ‘light’ 
and ‘heavy’ stable isotope tag2. In chemical 
approaches, such as in the original ICAT and 
in the iTRAQ method, the label is reacted 
with a functional group of an amino acid. In 
metabolic approaches, the label is instead 
incorporated by living cells through protein 
turnover. Our laboratory has previously 
described a metabolic labeling method called 
Stable Isotope Labeling by Amino acids in 
Cell culture (SILAC,3). In SILAC, an essential 
amino acid has been substituted by its stable 
isotope counterpart in the medium in which 
the cells grow, and this ‘heavy’ amino acid 
is hence incorporated into all expressed 
proteins. SILAC allows very accurate peptide 
quantitation in an automated, high through-
put experimental setup.
In contrast to this ‘bottom-up’ approach, 
‘top-down’ proteomics seeks to characterize 
intact proteins. Although not widely used in 
biological research yet, top-down proteomics 
has unique potential because it can charac-
terize the complete primary structure of the 
proteins, including modifications that may 
be missed in the bottom-up approach. Until 
now, most top-down studies have focused 
on mass measurement of the protein, its 
Stable Isotope Labeling by Amino acids in Cell culture (SILAC) has become a popular labeling strategy for peptide quantitation in proteomics experi-
ments. If the SILAC technology could be extended to intact proteins this would 
enable direct quantitation of their relative expression levels and of the degree 
of modification between different samples. 
Here we show through modeling and experiments that SILAC is suitable for intact protein quantitation and top-down characterization. When SILAC-
labeling lysine and/or arginine, peaks of light and heavy SILAC-doublets do not 
interfere with peaks of different charge states at least between 10 and 200 kDa. 
Unlike chemical methods, SILAC ensures complete incorporation - all amino ac-
ids are labeled. The isotopic enrichment of commercially available SILAC amino 
acids of nominally 95-98% shifts the mass difference between light and heavy 
state, but does not lead to appreciably broadened peaks. 
We expressed labeled and unlabeled Grb2, a 28 kDa signaling protein, and show that the two forms can be quantified with an average standard 
deviation of 6%. We performed on-line top-down sequencing of both forms in a 
hybrid linear ion trap orbitrap instrument. The quantized mass offset between 
fragments provided information about the number of labeled residues in the 
fragments, thereby simplifying protein identification and characterization. 
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identification in databases using MS or MS/
MS data or on measuring protein modifica-
tions. Hardware and software developments, 
such as improved resolution and sensitivity, 
better fragmentation techniques and more 
automated software, have recently made 
top-down identification and characterization 
much faster4-7. These developments should 
make quantitative rather than qualitative 
top-down proteomics more feasible. So far, 
however, very few studies have combined 
the top-down approach with protein quanti-
tation. Gordon et al. demonstrated that rela-
tive molecular ion intensities can be used for 
intact protein quantitation8. Kelleher and co-
workers investigated the use of 15N labeling 
of yeast proteins for intact protein quanti-
tation and determined 50 protein ratios9. In 
the same paper, the authors also chemically 
labeled yeast proteins with acrylamide and 
iodoacetamide. They concluded that the 
use of stable isotopes is preferred, since it 
prevents chromatographic shifts during LC-
MS separation and make quantitation easier 
and more accurate. Furthermore, a general 
problem of chemical labeling strategies is 
the fact that it is not 100% complete in terms 
of incorporation. Due to steric hindrance in 
the intact proteins, not all amino acids react 
evenly well with the isotope labeled reagent, 
and therefore the degree of labeling is dif-
ficult to control.
Although quantitative approaches are 
rare in the top-down proteomics field, stable 
isotopes have been used for intact protein 
analysis for a number of years. In 2000, 
Smith and co-workers used deuteriated 
leucine to improve the identification of E. coli 
proteins as the mass offset in the full scan 
indicated the number of leucines present in 
the protein10. They also substituted other 
essential amino acids like Ile, Phe, Arg, His 
and Lys to determine their number in the 
protein11. ‘Heavy’ and ‘light’ labeled proteins 
were well separated as long as the labeled 
amino acid was present at least three times 
per protein. 
We have recently investigated the LTQ-
Orbitrap, a hybrid linear ion trap orbitrap mass 
spectrometer, for top-down proteomics12. 
We found that the good sensitivity and 
excellent mass accuracy and resolution 
are sufficient for fast and reliable protein 
identification and characterization. We now 
extend this work by investigating whether the 
SILAC technology is also applicable to intact 
protein quantitation and characterization. 
We show feasibility by modeling SILAC-
labeling for proteins up to 220 kDa, and by 
quantifying a 28 kDa signaling protein that 
was expressed in medium with normal and 
with heavy arginine and lysine residues. 
Materials and methods
Modeling
The theoretical applicability of SILAC for 
protein quantitation was tested by modeling 
the isotopic and charge state clusters of 
proteins of different molecular weight. Based 
on the amino acid frequencies as determined 
by McCaldon and Argos13, we calculated the 
mass of a hypothetical sequence with 100 
residues (~11 kDa) and extrapolated this to 
55 and 220 kDa. For the modeling we used 
the Isotopica web application, developed 
by the groups of Fernandez-de-Cossio and 
Takao14. We first simulated SILAC-labeling 
with 13C615N4-arginine and 13C615N2-lysine, 
inducing a mass increment of 10.008 and 
8.014 Da respectively, assuming that 100% 
of the substituted carbon and nitrogen 
atoms were ‘heavy’. 
The influence of incomplete labeling and 
isotope enrichment were tested by calcula-
ting the frequency of different protein forms 
in an arginine-labeled 55 kDa protein with 
approximately average amino acid distribu-
tion. To test the effects of imperfect isotope 
enrichment of the SILAC amino acids, we 
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varied the relative abundance of the substi-
tuted 13C and 15N in the labeled amino acid 
from 100 percent to a lower value such as 
98 or 95%.  
In order to simulate incomplete amino 
acid incorporation, we calculated the rela-
tive abundance of protein forms when the 
chance of incorporation of light labels was 
p=0.02 or p=0.05, assuming a binominal 
distribution. For every protein form, the iso-
tope distribution of the 34th charge state was 
predicted with Isotopica (resolution 60,000) 
and protein forms were weighted according 
to their probabilistic frequencies. 
In vitro expression & purification of Grb2
The gene for growth factor receptor-
bound protein 2 (Grb2) was purchased from 
RZPD (clone RZPDo834A0934D). It was trans-
ferred into pDEST17 via Gateway-cloning 
for T7 RNA polymerase dependent expres-
sion as an N-terminally His6-tagged protein. 
All chemicals and enzymes were purchased 
from Sigma or Roche Applied Science at the 
highest purity.
 Recombinant N-terminally His6-tagged 
Grb2 was expressed using a cell-free system 
prepared as described in ref. 15 with slight 
modifications. E. coli S30 lysate was prepared 
from BL21(DE3)RIL cells (Novagen). T7 RNA 
polymerase was also expressed in BL21(DE3)
RIL containing the vector pAR1219 described 
in ref. 16, but without enzyme purification. 
Instead, we prepared another lysate from 
this IPTG-induced culture and added 60 µL of 
this lysate with 400 µL the standard lysate to 
1 mL of reaction volume. The concentration 
of the reaction components were adjusted 
to 57 mM HEPES-KOH buffer (pH 8.2), 2 mM 
DTT, 1.2 mM ATP, 0.85 mM each of CTP, GTP 
and UTP, 100 mM creatine phosphate, 130 
μg/mL creatine kinase, 2.0% PEG 8000, 0.64 
mM 3’,5’-cyclic AMP, 34 μM L(-)-5-formyl-
5,6,7,8-tetrahydrofolic acid, 175 μg/mL E. 
coli total tRNA, 90 mM potassium glutamate, 
80 mM ammonium acetate, 12 mM mag-
nesium acetate, 2.0 mM of each of the 20 
amino acids and 6.7 μg/mL of plasmid DNA. 
The reaction mixture was incubated for 2 h 
while shaking at 600 rpm at 30 °C.
For the heavy SILAC labeled Grb2, the 
normal arginine and lysine were replaced 
with their heavy-isotope counterparts 
13C615N4-arginine and 13C615N2-lysine, also 
at a concentration of 2 mM. The reaction 
mixture contained the target protein 
mostly as insoluble precipitate which was 
solubilized with 6 M guanidinium chloride 
and subsequently purified employing Ni2+-
affinity chromatography according to the 
manufacturer’s protocol for purification of 
denatured protein using Ni-NTA sepharose 
(Qiagen) and spin columns (MoBiTec). The 
purified protein was dialyzed against distilled 
water to remove imidazole and guanidinium 
which again lead to precipitation of the 
protein.
Sample preparation & mass spectrometry
Heavy and light labeled forms of Grb2 
were aliquoted separately and stored at 
-80 prior to use. Before mass spectromet-
ric analysis, the proteins were washed on 
RP-C18 StageTips17, eluted and mixed in 
the desired ratio. 
All experiments were done on a LTQ-
Orbitrap (Thermo Fisher Scientific), coupled 
to a nanoLC system (Agilent). Online protein 
separation was performed by use of 75 µm x 
150 mm IntegraFrit columns (New Objective) 
packed in-house with 5 µm RP-C18 beads 
(Reprosil-Pur Aq, 200Å pore size, Dr. 
Maisch). The column was connected to a 
short nanospray needle and spraying voltage 
was kept low (<2 kV) to prevent oxidation18. 
During loading and washing the flow was set 
to 500 nL/min; whereas during the actual 
gradient the flow rate was 250 nL/min. 
Buffers compositions were 0.5% acetic acid in 
mQ distilled water (buffer A) and 0.5% acetic 
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acid in acetonitrile (buffer B). The proteins 
eluted in a thirty-minute gradient from 40% 
to 90% of buffer B. CID fragmentation was 
performed in the LTQ, but MS/MS ions were 
detected in the orbitrap mass analyzer.
Data analysis
The MS scans were deconvoluted with 
Xtract-software (Thermo Fisher Scientific) 
and matched with the expected sequence. 
The light form of Grb2 was used to deter-
mine the sequence of the linker between the 
His-tag and the protein (see Table 1). CID 
fragments observed in light or in both light 
and heavy MS/MS spectra were searched 
in ProSight PTM, but without success. We 
therefore suspected they were internal frag-
ments and searched them in Mascot (Ma-
trix Science) after increasing light fragment 
masses by one water molecule (18.0152 
Da). A peptide mass fingerprint search was 
performed against the human IPI database 
(version 3.19) and a small database with the 
predicted His-tagged Grb2 sequence with 10 
ppm maximum mass deviation and without 
enzyme specificity. 
Results and discussion
Simulation of SILAC quantitation
We first wanted to investigate whether 
SILAC would be applicable for proteins of 
all sizes and whether any overlap between 
charge states and labeled states could occur. 
To this end, we used Isotopica, a software 
package freely available on the internet 
and developed by Fernandez-de-Cossio 
and Takao14, to model the effect of SILAC 
labeling. Isotopica can predict the isotopic 
cluster of specific charge states and can also 
calculate the mono-isotopic and average 
mass of all charge states (up to 50) for both 
heavy and light labeled proteins. As shown 
in Figure 3.1, panels a-c, SILAC labeling 
with heavy arginine and lysines results in 
mass offsets that are clearly distinguishable 
in a spectrum. The thickness of the lines 
is a proxy for the full width of the isotopic 
cluster. Even for a 220 kDa protein (Figure 
3.1c) the two lines are separate, indicating 
that at least theoretically the isotopic clusters 
of the light and heavy protein forms do not 
overlap with consecutive charge states. 
Because the mass offset induced by SILAC 
is in the range of a few hundred Dalton - 
when both arginine and lysine are labeled - 
post-translational modifications with a mass 
less than this would not overlap with either 
the heavy or the light form of the protein. For 
example, several phosphorylation sites on a 
50 kDa protein would not overlap with the 
heavy version, which is approximately 500 
Da higher in mass. 
The simulation also allowed us to visualize 
the effect of incomplete isotope enrichment. 
In principle, SILAC amino acids should be 
labeled with 13C or 15N to 100 percent at the 
substituted sites but in practice commercial 
sources guarantee isotope enrichment 
between 95 and 98 percent. As described in 
the Experimental Section we modeled this 
by varying isotope abundances in the heavy 
form of an average 55 kDa arginine-labeled 
protein. Interestingly, incomplete isotope 
enrichment does not broaden the peaks but 
it does shift the mass of the heavy form to 
a lower value (Figure 3.1d). It follows from 
this that accurate mass measurement to 
determine the molecular weight of the intact 
protein should be performed on the light and 
not on the heavy form of the SILAC protein 
pair. 
Next, we modeled the effect of incomplete 
labeling, that is, we modeled the case that 
not every light amino acid was replaced by its 
heavy counterpart. This could happen during 
SILAC cell adaptation, while light amino acids 
are still present. As Figure 3.1e shows, even 
incomplete labeling at the two percent level 
(on average no more than one amino acid per 
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Figure 3.1 Simulation of heavy and light SILAC labeled proteins of various molecular weights with an 
average amino acid distribution. (a-c) SILAC-labeling with 13C615N4-Arg and 137615N2-Lys increases the 
protein mass by approximately one percent, resulting in well separable isotope clusters, independent of 
protein size. The isotopic clusters of light and heavy labeled proteins of 11, 55 and 200 kDa in the m/z 
range 1500 to 1650 are depicted in panels a-c, respectively.  The thickness of the lines indicates the full 
width of the isotope cluster, which for all size proteins remains below 1 Thomson. (d-f) The effects of 
incomplete isotope enrichment and incomplete mass labeling are modeled, based on the 34+ peak of 
a theoretical protein of 55 kDa with average amino acid composition, labeled with heavy arginine and 
measured with 60,000 resolving power. (d) A 98 percent isotope enrichment of 13C and 15N in the heavy 
amino acids results in a shift of the total heavy isotopic cluster from 100% enrichment. The width and the 
intensity of the isotopic cluster remain unchanged. (e) In contrast, if only 98% of the arginines and lysines 
are labeled with heavy amino acids, the result is a significant spread of the signal. (f) With 95% labeling 
the signal is even more spread and the total intensity is reduced to 33% of the original signal.  
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Figure 3.2 (right page) Experimental spectra of mixed Grb2 forms, showing the experimental feasibility of 
SILAC. (a) Single spectrum of mixed light and heavy Grb2 forms, showing multiple charge states of both 
forms with isotopic clusters that do not overlap. (b) An experimentally obtained spectrum was overlaid 
with the Isotopica prediction (red), calculated using 99% heavy isotope enrichment. (c) The inserts show 
that the simulation is accurate down to the isotopic resolution, indicating higher isotope enrichment 
of Arg and Lys than specified by manufacturers. (d) Contour plot of the eluting SILAC labeled protein 
pair. The graph is color coded with light green corresponding to low and dark green to high intensity. 
The ratio between heavy and light Grb2 is constant over the different charge states and allows accurate 
quantitation based on relative intensities. (e) Averaging of spectra leads to significant noise reduction 
and improves quantitation accuracy.  (f) Intensity ratios between light and heavy labeled Grb2, based on 
the eight most intense charge states of single or averaged spectra (20 scans) for 5 different LC-MS-runs 
were determined with their 95% confidence interval error bars. 
protein in our example), causes the signal 
to split into at least three states and this 
reduces the overall intensity and signal to 
noise (S/N) dramatically. At the five percent 
level, severe splitting into at least four states 
occurs, and the heavy peak is broadened at 
least three fold. Therefore, complete labeling 
is a precondition for successful quantitative 
top-down analysis. Fortunately, it is not 
difficult in SILAC experiments to achieve 
complete labeling; the only requirement is to 
grow the cells for a sufficient number of cell 
doublings.
Note, however, that this broadening is very 
likely to occur in chemical labeling strategies 
because it is very difficult to achieve close 
to 100% labeling on the desired amino acids 
while preventing any labeling of untargeted 
sites. 
Expression & MS of SILAC-labeled Grb2
In order to experimentally test the 
feasibility and accuracy of quantitation by 
SILAC for an intact protein we expressed 
HIS-tagged Grb2, a signaling protein with a 
calculated monoisotopic mass of 27789.758 
Da in vitro in normal media and in media with 
heavy arginine and lysine. Light and heavy 
protein forms were measured separately and 
mixed in approximately 1:1 or 2:1 ratio. The 
mixture was analyzed by online HPLC MS on 
the LTQ-Orbitrap (See Figure 3.2).
The resolving power of the orbitrap was 
sufficient to observe the isotopic clusters. By 
measuring the heavy labeled protein only, we 
obtained a single population and conclude 
that we achieved 100% label incorporation 
(data not shown).
Influence of isotope enrichment 
Above, we modeled the influence of 
incomplete isotope enrichment of the SILAC 
amino acid. The SILAC amino acids used in 
our experiment were specified at 98% for 
13C. For 15N they were specified as 95% for 
Lys and 98% for Arg. Thus about 2% of the 
labeled carbon and nitrogen atoms in their 
stable isotope labeled amino acids should be 
light (12C and 14N). However, when we used 
this value to predict the mass offset between 
the heavy and light labeled Grb2 protein 
forms, we could not explain an additional 
mass difference of 3 Da for the heavy labeled 
Grb2 form in comparison to the calculated 
one of 264.3 Dalton. Since the sequence of 
the protein is known and confirmed by the 
light labeled protein, this mass difference 
had to be caused by the heavy amino acids. 
When overlaying the experimentally 
obtained spectra with the prediction made 
by Isotopica (Figure 3.2c), we discovered 
that the matching became very accurate 
when isotope enrichment was 99%. Thus, 
in this case, the isotope enrichment of the 
SILAC amino acids was almost complete 
and significantly higher than specified. 
Furthermore, our measurements confirmed 
the simulation in Figure 3.1d. The rare 
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presence of 12C and 14N instead of 13C and 
15N in the heavy amino acids did not cause 
problems for the analysis or quantitation, 
since the signal intensity and the width of 
the isotopic distribution remained the same. 
Note that the percentage of light atoms in 
the heavy label needs to be determined only 
once as it will be the same for all proteins 
that are labeled with that specific batch of 
heavy amino acids.  
Protein quantitation using SILAC
A contour plot of the SILAC labeled Grb2 
forms showed that they eluted as a one minute 
peak with no discernable retention time 
shift between them (Figure 3.2a). Complete 
isotopic separation and co-elution should 
allow for very accurate quantitation. The 
spreading of the protein signal into multiple 
charge states reduces the S/N but improves 
quantitation, since all charge states should 
show the same ratio between heavy and light 
labeled forms. To determine the quantitation 
precision, the ratio between Grb2-light and 
Grb2-heavy was calculated for a single scan 
and for an averaged scan, composed of 20 
separate scans over the elution profile. In 
both cases the eight most intense charge 
states were used for the calculation. We then 
repeated this measurement in five separate 
HPLC runs to demonstrate the reproducibility 
of the measurement. In the insert of Figure 
3.2, the average ratio is displayed with 
95% confidence interval error bars. When 
averaging 20 scans, the mean standard 
deviation was 6%, whereas ratios determined 
from single scans had a standard deviation 
of typically 18%. 
The ratio calculation can be further 
improved by using the complete elution 
profile of the proteins (see Figure 3.2b). 
Furthermore, as Ong et al.19 and Du et al.9 
have noted, results become more accurate 
if they are corrected for noise, especially in 
case of  low S/N peaks.
Improved assignment of top-down 
fragments by SILAC
Besides the accurate quantitation, SILAC 
can also be used for identification and 
characterization purposes. The information 
in fragmentation spectra is valuable in 
assigning modifications and in improving 
the reliability of protein identification. 
Modifications and truncations are more 
easily detected and more likely correctly 
assigned. Due to the speed and sensitivity of 
the orbitrap, such MS/MS spectra are readily 
obtainable on small proteins12. 
To demonstrate this in a SILAC experi-
ment, we performed data-dependent CID 
fragmentation in the online format, collecting 
MS and MS/MS scans in the orbitrap - 
without microscanning to keep the duty 
cycle as fast as possible. The MS/MS scans 
were of relatively low intensity (Figure 3.3), 
but the resolution and mass accuracy of the 
fragments was sufficiently high that even low 
abundant ions could be clearly distinguished 
from the noise.
When comparing the MS/MS scans of 
heavy and light labeled Grb2, we observed 
very similar fragmentation that appeared 
very useful for assigning the fragments. 
The mass offset between the heavy and 
light fragments should exactly represent 
the number of lysines and arginines of every 
fragment. Table 1 lists the fragments and 
their mass deviations from the calculated 
values. Most of the fragments were internal 
and likely observed because the disulphide 
bridge was still present in the protein.
The absolute mass deviation of the 
fragments was very low, on average 3.2 
ppm, and the number of lysines and 
arginines determined by the mass increment 
of the heavy labeled fragments matched 
exactly with the proposed identification. 
One potential false positive hit could be 
eliminated both because of its mass deviation 
of 14 ppm and also because of the fact that 
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its counterpart in the spectrum of the heavy 
form of Grb2 did not indicate the correct 
number of lysines. In total the single scan 
CID fragmentation depicted in the Figure 3.3 
resulted in fragments covering 40% of the 
protein sequence. It is clear that the SILAC 
information at the fragment level would have 
been very valuable to assign any protein 
modification, had it been present. 
Conclusions and perspectives
Here we have investigated the applicability 
of the SILAC technology to top-down 
proteomics. Through theoretical modeling, 
we found that heavy and light SILAC-doublets 
do not interfere with each other even for 
very large proteins. The incomplete isotope 
enrichment of commercial SILAC amino acids 
Figure 3.3 Identification of Grb2 is supported by direct comparison of the heavy and light CID fragmentation 
spectra. Mass differences between corresponding fragments observed in MS/MS spectra of the (a) light 
and (b) heavy Grb2 protein indicate the number of lysines and arginines per peptide and thereby simplify 
and confirm the peptide and protein identification. Assigned fragments have an average absolute mass 
accuracy of 3.1 +/- 2.3 ppm. N-terminal fragments are shown in blue and internal fragments in red. 
Asterisk indicates that 13C peaks were used for mass accuracy determination. (c) In total the fragments 
covered 40% of the total protein sequence. 
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Table 3.1 Fragments of Grb2 identified by Mascot.
does not cause peak broadening but does 
shift the mass to lower values. This effect 
can be modeled very precisely. Incomplete 
labeling, on the other hand, would lead 
to distribution of the signal into several 
peaks, substantially broadening them and 
decreasing the signal to noise. Fortunately, 
incomplete labeling can easily be avoided in 
metabolic labeling experiments. 
We have shown that a 28 kDa signaling 
protein, Grb2, can be readily quantified 
in the labeled versus the unlabeled form. 
The quantitation in a one to one mixture 
had a typical standard deviation of six 
percent and is mainly limited by the lower 
signal to noise in protein measurements 
compared to peptide measurements. Grb2 
was fragmented and analyzed in an LTQ-
Orbitrap instrument using single scan data 
from online experiments. The high mass 
accuracy combined with the quantized mass 
offsets significantly improves fragment 
identification when comparing tandem mass 
spectra of light and heavy SILAC labeled 
protein. The unambiguous information about 
the number of labeled residues per fragment 
or protein is a clear advantage of the SILAC 
technology over 15N labeling.
In our experiment we chose to use two 
amino acids, arginine and lysine that were 
isotopically labeled, leading to a one percent 
mass offset between light and heavy form. 
Often, it may be more convenient to label 
with a single amino acid, for example, 
lysine. This would allow direct ‘counting’ 
of the number of lysines in the protein and 
1  13C peaks were used for mass accuracy determination
Precursor mass 
(m/z) Charge Δmass
Nr of 
heavy 
residues
Mass 
Accuracy 
(ppm)
Sequence
Light Heavy
954.7748 3 5.49 MSYYHHHHHHLESTSLYKKAGGME
978.7882 3 3.90 MSYYHHHHHHLESTSLYKKAGGMEA
1039.831 1045.504 3 16.03 2 Lys  (1.88) 1 MSYYHHHHHHLESTSLYKKAGGMEAIA
881.6691 887.6808 4 24.04 3 Lys 4.79 MSYYHHHHHHLESTSLYKKAGGMEAIAKYD
705.5377 5  (0.50) 1 MSYYHHHHHHLESTSLYKKAGGMEAIAKYD
1175.223 3 4.81 MSYYHHHHHHLESTSLYKKAGGMEAIAKYD
1015.456 1015.455 2 0.01 0 2.00 SYYHHHHHHLESTSLY
1079.503 1083.511 2 8.02 1 Lys 1.10 SYYHHHHHHLESTSLYK
1577.204 2 1.67 LFDFDPQEDGELGFRRGDFIHVMDNSD
1520.661 1530.668 2 20.02 2 Arg 1.20 FDFDPQEDGELGFRRGDFIHVMDNSD
1447.125 2 -0.57 DFDPQEDGELGFRRGDFIHVMDNSD
1100.515 1110.52 2 20.04 2 Arg 1.59 PQEDGELGFRRGDFIHVMD
1258.566 1268.573 2 20.03 2 Arg 1.07 QEDGELGFRRGDFIHVMDNSDP
1023.975 1033.983 2 20.03 2 Arg 1.18 GELGFRRGDFIHVMDNS
1747.536 1757.54 3 30.01 3 Arg  (0.42) 1 FNSLNELVDYHRSTSVSRNQQIFLRDIE-QVPQQPTYVQALFDFD
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spectrometry of integral membrane proteins. 
Expert Rev Proteomics 3, 585-596
7 Zandborg, L., et al. (2007) ProSight PTM 2.0: 
improved protein identification and charac-
terization for top down mass spectrometry. 
Nucleic Acids Res 35(2), W701-W706
8 Gordon, E. F., et al. (1999) Hydropathic in-
fluences on the quantification of equine heart 
cytochrome c using relative ion abundance 
measurements by electrospray ionization 
fourier transform ion cyclotron resonance 
mass spectrometry. J Mass Spectrom 34, 
1055-1062
9 Du, Y., et al. (2006) Top-down approaches for 
measuring expression ratios of intact yeast 
proteins using Fourier transform mass spec-
trometry. Anal Chem 78, 686-694
10 Veenstra, T. D., et al. (2000) Proteome analysis 
using selective incorporation of isotopically 
labeled amino acids. J Am Soc Mass Spectrom 
11, 78-82
11 Martinovic, S., et al. (2002) Selective incor-
poration of isotopically labeled amino ac-
ids for identification of intact proteins on a 
proteome-wide level. J Mass Spectrom 37, 
99-107
12 Macek, B., Waanders, L. F., et al. (2006) Top-
down Protein Sequencing and MS3 on a Hy-
brid Linear Quadrupole Ion Trap-Orbitrap 
Mass Spectrometer. Mol Cell Proteomics 5, 
949-958
13 McCaldon, P. and Argos, P. (1988) Oligopep-
tide biases in protein sequences and their use 
in predicting protein coding regions in nucle-
otide sequences. Proteins 4, 99-122
14 Fernandez-de-Cossio, J., et al. (2004) Auto-
mated interpretation of mass spectra of com-
plex mixtures by matching of isotope peak 
distributions. Rapid Commun Mass Spectrom 
18, 2465-2472
15 Kigawa, T., et al. (2004) Preparation of 
Escherichia coli cell extract for highly 
productive cell-free protein expression. J 
Struct Funct Genomics 5, 63-68
16 Davanloo, P., et al. (1984) Cloning and ex-
between fragments in the ‘heavy’ and ‘light’ 
tandem spectrum. Double amino acids may 
be valuable when analyzing proteins with 
potentially a high number of modifications. 
Extension of the SILAC technology to 
intact protein analysis should allow direct 
quantitation of endogenous and unprocessed 
proteins. However, the most interesting 
application could be in the direct quantitation 
of multiple and combinatorial modifications 
of regulatory proteins as a function of cellular 
state. This goal will require SILAC quantitation 
of fragments isolating these modifications. It 
may also require non-ergodic fragmentation 
techniques such as ECD or ETD as well as 
several stages of fragmentation. 
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Nanoelectrospray peptide 
mapping revisited: 
Composite survey spectra allowing 
high dynamic range protein 
characterization without LC-MS on 
an orbitrap mass spectrometer
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Introduction 
During the last few years, efforts in mass 
spectrometry-based proteomics have con-
centrated on the qualitative and quantitative 
analysis of complex protein mixtures1. How-
ever, most biological mechanisms involve 
protein modifications, which are not easily or 
comprehensively picked up in these large-
scale experiments2,3. In contrast to the few 
peptides required for identification by MS, 
the analysis of Post-Translational Modifica-
tions (PTMs) in principle requires peptides 
covering every part of the protein (100% se-
quence coverage). Furthermore, some modi-
fications may be sub-stoichiometric, even 
in the purified protein of interest, requiring 
the analysis of several peptides covering the 
same sequence stretch.  
MALDI Time-Of-Flight (TOF) or MALDI-
TOF/TOF is a popular method to identify 
gel-separated proteins. MALDI sample 
preparation has been optimized and is rapid 
and convenient4. MALDI-TOF/TOF has been 
increasingly automated and now allows large 
number of gel spots to be identified, i.e. in 
combination with 2D gel electrophoresis. 
Nevertheless, the trend towards mixture 
Fast and in-depth mass spectrometric (MS) determination of the primary structure of proteins, including posttranslational modifications, remains a 
challenging task. Proteins are usually digested to tryptic peptides that are mea-
sured either by MALDI peptide mapping or by liquid chromatography on-line 
coupled to tandem MS (LC-MS/MS). 
Here we instead analyze peptides by a chip implementation of nano-electrospray (TriVersa Nanomate) coupled to a linear ion trap-orbitrap 
hybrid instrument. The C-trap connecting the linear ion trap and orbitrap is 
filled repeatedly in different m/z ranges with up to a million charges. Each range 
is analyzed in the orbitrap repeatedly and separately, creating a survey spectrum 
composed of hundreds of single spectra. The composite spectrum is inherently 
normalized for different m/z ranges due to their different fill times and retains 
information on the variability of mass measurement and intensity. 
Nanoelectrospray offers analysis durations of more than 30 minutes per microliter of peptide mixture, sufficient for in-depth peptide characteri-
zation by high resolution C-trap fragmentation in addition to high sensitivity 
ion trap fragment analysis. We obtain over thousand fold dynamic range and 
subfemtomole sensitivity. Automated analysis of digested BSA resulted in 
sequence coverage above 80% in low femtomole amounts. We also demonstrate 
identification of seven modified peptides for a histone H3 sample. Static spray 
allows relative quantitation of the same peptide with different modifications. 
Chip-based nanoelectrospray on an orbitrap instrument thus allows very high confidence protein identification and modification mapping and is an 
alternative to MALDI peptide mapping and LC-MS/MS. 
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analysis and quantitative proteomics 
have made LC-MS/MS ‘shotgun’ methods 
increasingly popular5-7. In particular, the 
quality of MS/MS data in LC-MS/MS often 
makes protein identifications much more 
specific than with the MALDI method8. 
Further advantages of LC-MS/MS are its 
high sensitivity as peptides are concentrated 
into very small peak volumes and the extra 
information contained in the chromatographic 
retention time of each peptide. Disadvantages 
are the dynamic nature of LC-MS/MS, which 
makes it difficult to do repeat measurements 
of the same peak as well as to apply several 
fragmentation techniques during the elution 
time of typically less than 30 seconds.  
In theory, nanoelectrospray9,10 which is 
static and allows directed measurements, 
offers a compromise allowing both ready 
identification of proteins without LC 
separation while still offering extremely high 
accuracy protein identification and mapping 
of post-translational modifications. The 
original ‘manual’ nanoelectrospray has now 
largely fallen out of favor, mainly because 
of its low throughput. However, recently 
nanoelectrospray has been revived in a 
chip based form, commercially in the form 
of the Advion TriVersa Nanomate. Here 
we investigate the combination of this 
automated nanoelectrospray with a powerful 
new mass spectrometer, the hybrid linear 
ion trap – orbitrap11. 
Materials and methods 
Sample preparation of protein standards 
Unless otherwise specified, chemicals were 
from Sigma Aldrich. Bovine serum albumin 
(BSA, 2 mg/mL, Bio-Rad) was diluted to a 
concentration of 4 pmol/µL with 6 M urea/2 
M thiourea, incubated in 1 mM dithiothreitol 
(final concentration) for 45 min at 56°C for 
protein reduction and subsequently in 5.5 
mM iodoacetamide (final concentration) at 
room temperature in the dark for 30 min for 
alkylation. The solution was digested with 
1:50 w/w protein amount of endoproteinase 
Lys-C (Wako) for 4 h at room temperature, 
then diluted 4x with 50 mM NH4CO3 and 
digested further with 1:50 w/w protein 
amount of trypsin (Promega) overnight at 
37°C. The digestion was stopped by adding 
1 percent (v/v) of absolute trifluoric acid. 
BSA peptides were desalted and stored on 
RP-C18 StageTip columns12 and eluted right 
before mass spectrometric analysis with 50% 
methanol/0.5% formic acid. 
Sample preparation of Histone H3 
Complete™ proteases inhibitors (tablet, 
Roche) were added to all buffers below and 
the solutions were cooled to 4°C before use. 
Semi-confluent HeLa cells were collected and 
resuspended in Buffer-N (15 mM Hepes-KOH 
pH 7.6, 60 mM KCl, 15 mM NaCl, 0.5 mM 
EGTA, 10% Sucrose). Lysis was performed 
by adding 0.2% NP40 and rotating the cell 
suspension for 10 min at 4 °C. Cell lysates 
were carefully poured on 20 ml sucrose 
cushions (20% sucrose in Buffer-N). Nuclear 
pellets were fractionated upon centrifugation 
(4000 rpm, 15 min, 4 °C) and washed in 
PBS. Core histones, together with linker 
histones and high mobility group (HMG) 
proteins were then extracted by adding a 
half volume of ice-cold HCl (0.8 M) overnight 
with continuous rotation at 4 °C. The sample 
was centrifuged for 10 min at 12,000 g, and 
histones and the other acid-soluble proteins 
remained in the supernatant. Residual 
histones were re-extracted for 3-4 hours in 
0.4 M ice cold HCl, the supernatants derived 
from the two extractions were pooled and 
dialyzed against 100 mM ice cold acetic 
acid. The dialyzed sample was aliquoted, 
lyophilized, and evaluated for purity and 
concentration by resuspension in H2O and 
by performing SDS-PAGE (18%). About 100 
µg histone sample was resuspended in 100 
NanoESI peptide mapping revisited 73
µL 0.1% TFA, 2% acetonitrile and directly 
loaded onto a reverse phase HPLC column 
(Jupiter C18, 4.60 mm x 250 mm, 5 µm, 
300 Å) (Phenomenex) connected to an Aekta 
LC-system (Amersham). Individual histones 
were separated by applying a gradient from 
20% to 80% acetonitrile in 0.1% TFA.  
 The total amount of histone H3 was 
estimated by SDS-PAGE. A fraction containing 
1.5 µg of histone H3 was dried down and 
redissolved in a buffer composed of  100 mM 
Tris-HCl, 10 mM CaCl2, pH 7.6 for overnight 
Arg-C (1:50, w/w) digestion at 37 °C. One 
half of the peptide solution was desalted 
and stored using RP-C18 StageTip columns, 
while the other half was desalted and stored 
using Strong Cation Exchange (SCX) StageTip 
columns. Peptides on the RP-C18 column 
were eluted by 50 µL 80% acetonitrile/0.5% 
acetic acid, and the peptides on the SCX 
column were eluted by 50 µL 5% ammonium 
hydroxide/30% methanol. Both eluates were 
combined, dried down, and redissolved in 
50% methanol/0.5% formic acid (1 pmol/µL 
or 15 ng/µL) for nanoelectrospray. 
Mass spectrometric analysis 
All experiments were performed using a 
linear ion trap - orbitrap hybrid mass spec-
trometer (LTQ-Orbitrap, Thermo Fisher Sci-
entific) with a TriVersa Nanomate (Advion 
Biosciences) as ion source. A positive volt-
age (1.5 kV) is applied on the chip while the 
mass spectrometer sample orifice remains at 
0 kV. The electrostatic field between the chip 
and the orifice drives the positive ions to-
wards the mass spectrometer. The flow rate 
is dependent on the chip diameter. When not 
mentioned otherwise, all results were ac-
quired with the low flow rate chip (ID 2.5µm) 
from Advion, providing a flow rate of 20 nL/
min. At this flow rate, one microliter of sam-
ple provided stable static electrospray longer 
than 30 min, just like in ‘classical’ nanoelec-
trospray. 
Every sample, consisting of 1 µL of 
solution was sprayed twice and MS spectra 
were acquired either by full range acquisition 
(full scan) or multiple overlapping segmented 
range acquisition (Selected Ion Monitoring, 
or SIM scans). For the BSA sample, four 
segmented SIM mass ranges (300-500, 
450-650, 600-800, 750-1350) were 
recorded. For the histone H3 sample, the 
four SIM segments were chosen as 300-550, 
500-650, 600-750, and 700-900 m/z. 
MS/MS fragmentation was performed by 
data-dependent selection of the five most 
intense peaks in the segmented mass range. 
Dynamic exclusion was set to 150 seconds, 
longer than the acquisition time per two 
overlapping segments.  
Data analysis 
The Mascot engine was used for mass 
spectrometry data identification (Matrix 
Science). BSA peaks were searched in IPI_
Human_v3.13 to which the BSA sequence 
had been added, using 5 ppm precursor 
mass tolerance, 0.5 Da fragment mass 
tolerance (maximum mass deviation  or 
MMD13), carbamidomethylation (C) as fixed 
modification, and oxidation (M), N-acetylation, 
deamidation (NQ), pyro-glutamate (N-term 
QC) as variable modifications. Up to three 
missed cleavages were allowed and every 
fully tryptic, unique peptide (‘bold red’ in 
the Mascot report) without a second protein 
match was accepted as a hit.  
 Histone H3 peaks were searched in a his-
tone database (276 non-redundant sequenc-
es, including different histone proteins/
variants, keratins and the proteases used), 
using 5 ppm MMD for precursor ions, 0.5 Da 
MMD for ion-trap fragmentation, and 0.01 
Da mass tolerance for C-trap fragmentation 
(minimum possible in Mascot), and seven 
variable modifications, including methionine 
oxidation, N-terminal acetylation, mono-, 
and dimethylation of lysines and arginines 
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and lysine trimethylation and acetylation. Up 
to two missed cleavages were allowed and 
peptides with a score higher than that cor-
responding to a significance value of p=0.05 
were accepted. 
Results and discussion 
Automated nanoelectrospray coupled to 
the LTQ-Orbitrap 
‘Classical’ nanoelectrospray requires 
handling of fragile pulled needles, which is 
both time consuming and a skill demanding 
considerable dexterity. In contrast, the Tri-
Versa achieves the same low flow rates and 
thereby sensitivity using a micro-machined 
chip that is operated completely automati-
cally. Here we describe operation of the au-
tomated nanoelectrospray combined with a 
high accuracy mass spectrometer, the LTQ-
Orbitrap. The TriVersa automatically takes 
a tip, aspirates the sample, and transfers it 
to the nozzle of the chip, located in front of 
the mass spectrometer (Figure 4.1). As can 
be seen in the Figure 4.1, the LTQ-Orbitrap 
contains a C-trap, which functions as a con-
tainer for ions transferred from the ion trap 
and waiting to be ejected into the high reso-
lution analyzer – the orbitrap. Importantly, 
the instrument allows any ion populations 
isolated in the ion trap to be accumulated in 
the C-trap for final high resolution analysis 
in the orbitrap. This high resolution scan in 
the orbitrap takes 0.5 to 1 s, depending on 
the resolution chosen. 
While the instrument is extremely sensi-
tive, its duty cycle is limited by the fact that 
the C-trap only accommodates 106 ions, 
which is often achieved with ion accumulation 
for just a few milliseconds. Secondly, the 
dynamic range is also limited by dominant 
ions (typically in the low to middle m/z 
range), which can make up a large fraction 
of the total ion population. We reasoned that 
Figure 4.1 Schematics of the TriVersa Nanomate coupled to the LTQ Orbitrap. Samples were applied by 
coated tips to the nozzle of the electrospray chip in front of the TriVersa instrument. The low flow rate 
chip (ID 2.5 µm) provided a stable flow rate of 20 nL/min, which is in the ‘true’ nanoelectrospray range. 
TriVersa Nanomate
ESI-chip Linear ion trap C - trap
Orbitrap
MS 
sample
orifice
ESI-chip
a b
c
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the combination of nanoelectrospray and 
LTQ-Orbitrap should allow us to ameliorate 
both problems. Instead of acquiring a single 
full scan spectrum, we decided to acquire 
a large number of spectra by filling up the 
C-trap to capacity for each of a number of 
segmented mass ranges. This should lead 
to a ‘normalized’ mass spectrum consisting 
of a ‘matrix’ of individual spectra for several 
mass segments and averaged over many 
scans. This ‘composite’ spectrum should 
have a much larger dynamic range and 
peptide mass measurement accuracy than 
a single full scan spectrum or averaged full 
scan spectra. Furthermore, the long spray 
time allows directed and iterative peptide 
fragmentation experiments. Peptides can 
be identified by peptide mass fingerprinting 
(PMF), ion trap fragmentation with read out in 
the ion trap or in the orbitrap, fragmentation 
in the C-trap or any combination of these. 
We therefore sought to devise efficient MS/
MS schemes to characterize the maximum 
number of peptide peaks. 
Acquisition methods for the composite 
spectrum and MS/MS acquisition 
We found that a three step procedure, en-
compassing peptide mapping, data depen-
dent sequencing and directed sequencing 
of ‘missing’ peaks, was optimal for protein 
characterization (Figure 4.2). In the first step 
the full mass range is divided by SIM scans 
into multiple overlapping segments (several 
hundred m/z units wide), which were ac-
quired in the orbitrap. The segmented mass 
ranges, shown in the Figure 4.2a, were cho-
sen so that the accumulation time for every 
segment would be similar. Each mass seg-
ment window was measured many times 
to gain sensitivity and precision. If several 
minutes are allocated to acquisition of the 
composite survey spectrum, then each mass 
segment is typically acquired more than 
hundred times.  
First identification is based on PMF analy-
sis. Because of the high mass accuracy of the 
orbitrap, particularly when including an in-
ternal mass standard in each spectrum (see 
below), dominant proteins in the sample are 
readily identified at this stage. In the sec-
ond step data dependent fragmentation is 
performed in each segmented range. Again 
SIM survey scans are recorded for each m/z 
range but now they are followed by ion-
trap MS/MS spectra of the five most intense 
peaks. For each m/z range, the SIM-MS/MS 
cycle is repeated for a time adapted to the 
number of MS/MS candidates (Figure 4.2b). 
Peptide identification is performed in the 
MS/MS ion search mode and peaks identi-
fied by PMF are confirmed by the MS/MS ion 
search. Since MS/MS spectra contain more 
information than the peptide mass alone, 
many peaks that cannot be identified only 
by the precursor mass are identified at this 
stage. This analysis still leaves some peptide 
peaks unfragmented – mainly because of 
their low signal, which may mean that they 
do not appear in every scan. These peaks are 
then targeted by a so-called ‘inclusion list’ in 
the third part of the measurement sequence. 
Figure 4.2c presents an overview of the three 
step sequence.   
Since the acquisition methods for com-
posite full spectra and SIM-MS/MS take only 
four and five minutes respectively, one mi-
croliter of sample sprays long enough to re-
cord both steps three times. A second mi-
croliter is used for step three in which we 
specifically target peaks not fragmented yet. 
Several microscans are applied for both MS 
(SIM) and MS/MS acquisition to boost sensi-
tivity and data quality.  
Subfemtomole sensitivity 
Having established an efficient protocol 
for comprehensive protein characterization, 
we wanted to assess its sensitivity on a model 
protein. Using the strategy as described in 
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Figure 4.2 Schematic description of the acquisition strategy as performed for protein characterization of 
tryptic digested BSA. (a) Selected Ion Monitoring (SIM) scans of multiple mass segments were repeatedly 
analyzed in the orbitrap mass spectrometer and these multiple SIM acquisitions were combined in 
one ‘composite’ spectrum. (b) After each SIM scan, the five most intense ions were data-dependently 
selected for MS/MS fragmentation in either ion-trap or orbitrap. (c) Overview of the complete protein 
characterization method, including the acquisition of the composite spectrum and the data- dependent 
SIM-MS/MS mode. These two methods are followed by a third strategy that aims to identify peptides 
that were not sequenced yet. In this directed SIM-MS/MS mode all precursor masses that were not 
fragmented so far are placed on an inclusion list. The entire experiment can be carried out with only two 
microliters of very diluted sample solution.
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Figure 4.2c, we obtained a sequence coverage 
of more than 80% for BSA. The missing 
peptides were generally very short and some 
of them did appear under different digestion 
conditions as ‘missed cleavage’ peptides. 
We found that the BSA concentration could 
be diluted to 25 fmol/µL without losing 
protein sequence coverage (data not shown). 
Illustrating the excellent sensitivity of the 
set up described in this paper, more than 
60% of the BSA sequence was still identified 
when the protein was diluted to 500 amol/
µL (see Table 4.1). As shown in the table, 
the inclusion list SIM-MS/MS method turned 
out to be particularly advantageous for lower 
protein concentrations.  
Extremely high mass precision in the 
composite full spectra 
The orbitrap detection is based on inher-
ently very precise frequency measurement 
and is, in our experience, much less affected 
by space charge than a Fourier-transform 
ion cyclotron resonance (FT-ICR) instrument. 
When combined with ‘lock mass’ injection in 
every spectrum, the orbitrap is capable of 
achieving low to sub-ppm mass accuracy14. 
We reasoned that, by measuring each SIM 
mass range multiple times, the mass values 
of peaks extracted from the composite full 
spectra should become even more precise, 
since the standard deviation of a population 
is inversely dependent on the square root of 
the number of measurements. In our case, 
Table 4.1 BSA sequence as identified by the three-step method introduced in this paper. In total 2 µL of 
trypsin digested BSA sample was used for every concentration. One microliter BSA was used to generate 
the composite SIM spectra and to carry out the data-dependent SIM–MS/MS method. Both methods were 
performed three times to assess their reproducibility. The second microliter was used specifically to 
characterize the peptides only identified by PMF but not sequenced yet. When all identification methods 
were combined, a sequence coverage of 66% was reached even for 500 attomole/µL.
BSA concentration Acquisition methods Sequence identified
25 fmol/µL
Composite SIM
87%
88
88%
79%
81%
SIM- MS/MS
63%
75% 77%73%72%
Inclusion list MS/MS 1.4%
5 fmol/µL
Composite SIM
73%
82%
83%
77%
78%
SIM- MS/MS
54%
65% 75%51%60%
Inclusion list MS/MS 10.1%
500 amol/µL
Composite SIM
45%
60%
66%
42%
49%
SIM- MS/MS
24%
35% 46%20%24%
Inclusion list MS/MS 10.5%
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by repeated measurement of the same spec-
trum for one hundred times, the standard 
deviation of the mass value should be de-
creased by a factor of ten. 
In Figure 4.3, the peak intensity is plotted 
versus peak precision on a double logarithmic 
scale, and the data show that more intense 
ions yield better precision within the same 
measuring time. As can be seen in the Figure 
4.3, a large percentage of the peptides have 
a precision well below one ppm, with some 
peptides even reaching 100 ppb or less. Thus 
we conclude that the TriVersa–LTQ-Orbitrap 
combination is capable of extremely high 
mass accuracy, comparable or superior to any 
other platform currently used in proteomics. 
More than 6000 fold dynamic range in the 
composite full spectra 
Summing up multiple spectra filters out 
noise but boosts low intense ions that can 
not be distinguished from background peaks 
in single spectra. We demonstrate further 
improvement of the dynamic range by col-
lecting segmented m/z ranges instead of 
one full spectrum. Often a few, very intense 
ions comprise 90% of the total ion number of 
a spectrum, whereas in the segmented mass 
range strategy, ranges with low intense sig-
nals are accumulated for a longer time in 
order to reach the same specified injection 
target value.  
As depicted in Figure 4.4a, the composite 
spectrum is much more feature rich in 
the higher mass range compared to the 
spectrum consisting of averaged full mass 
range spectra with the same total acquisition 
time. Both the composite spectra and the 
summed-up full spectra were acquired in 
the same experiment. As is apparent from 
the Figure 4.4, the S/N was much better (see 
arrows). With the 25 fmol/µL tryptic digested 
BSA sample, we assigned BSA peaks with a 
signal intensity difference of up to 6700 
(Figure 4.4b). While the dynamic range of 
the orbitrap is specified at 104, this value 
applies only to a simple two component 
mixture. In our experience, dynamic range in 
complex peptide mixture analysis is around 
103 in LC-MS experiments, so the composite 
spectra exhibit a comparable or superior 
dynamic range for complex samples to 
online experiments. 
Sequence coverage comparable to LC-MS 
We compared the sequence coverage 
obtained after 5 min of SIM-MS/MS acqui-
sition with a conventional LC-MS run, both 
times using 50 fmol of BSA and the same 
parameter settings on the LTQ-Orbitrap. 
For this experiment, a higher flow rate chip 
(ID 5 µm) was used for nanoelectrospray, 
resulting in a flow rate of 200 nL/min. 
The LC-MS run took in total 53 minutes, 
of which the actual gradient lasted for 28 
minutes. Both methods were performed 
twice. The sequence coverage obtained by 
these two methods was very comparable, 
83.7% for nanoelectrospray SIM-MS/MS and 
78.5% for LC-MS/MS. Detailed identification 
information for each tryptic peptide in the 
BSA sequence is shown in Figure 4.5. Most of 
the peaks were identified by both methods, 
Figure 4.3 Mass precision correlated to ion 
intensity. Plot of the intensity of different ions 
extracted from the composite spectrum versus 
their precision, from thousands of scans depicted 
on a double logarithmic scale. Note that for most 
peaks we achieve sub ppm mass precision. 
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Figure 4.4  Advantages of composite spectra.  (a) In the composite spectrum ions of low intensity were 
boosted in comparison to full spectra summed-up for the same time span. 500 attomole/µL BSA sample 
was sprayed, and the composite spectra and the summed-up full spectra were acquired directly after 
one another. Whereas for intense ions there is no large visible difference, the S/N ratio for low intense 
ions increases dramatically. (b) A dynamic range of over six thousand fold was obtained in the composite 
spectrum. 25 fmol/µL BSA resulted in a composite spectrum, in which the most intense peptide with 
m/z of 487.73 (2+, DLGEEHFK) had an intensity of 8.85 • 104, while the peptide at m/z 962.12 3+, 
LVTDLTKVHKECCHGDLLECADDR) was observed with an intensity of 13.2 (inset), resulting in a dynamic 
range of 6700.
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but some low intensity peaks were only 
sequenced in LC-MS. This may be due to 
the concentration effect of chromatography, 
where each ion elutes in a very short time span 
in contrast to the long but ‘diluted’ duration 
in nanoelectrospray. On the other hand, 
there were a few peptides that co-eluted 
with others and disappeared before having a 
chance to be fragmented in LC-MS but those 
were sequenced in the SIM-MS/MS run.
Characterization of Histone H3 post-
translational modifications  
Histones are the protein constituents of 
nucleosomes around which DNA is wound 
in eukaryotic cells. Histone tails on the nu-
cleosome are subject to enzyme-mediated 
posttranslational modifications (PTMs) of 
selected amino acids, such as lysine acetyla-
tion, lysine and arginine methylation, serine 
phosphorylation and attachment of small 
ubiquitin peptides15,16. These modifica-
tions, singly or in combination, are thought 
to generate an epigenetic code that specifies 
different patterns of gene expression and si-
lencing17. 
Characterization of post-translational 
modifications on bulk histones by employ-
ment of mass spectrometry approaches has 
proven to be very successful as recently 
reviewed by Hunt and co-workers18. 
Here we investigate the suitability of the 
nanoelectrospray–orbitrap combination to 
characterize modifications on histone H3 
purified from human HeLa cells, separated 
from other histone molecules by RP-
chromatography and in-solution digested 
with Arg-C protease. In order to distinguish 
between several modifications present on 
such molecules, many of them only differing 
in single methyl or acetyl groups, we also 
employed high resolution read out of MS/
MS spectra in the orbitrap. Fragmentation 
by higher energy injection into the C-trap19 
leads to triple-quadrupole like behavior and 
preservation of the full mass range in the 
MS/MS spectra. Fragmentation spectra were 
acquired at a resolution of 30,000 and the 
mass accuracy was in the low ppm range for 
these fragmentation spectra. 
More than 500 peaks were extracted from 
the composite full spectra. Spectra recorded 
in SIM-MS/MS mode were searched in a 
histone database and 46% of the sequence of 
Figure 4.5 Comparison of the BSA sequence coverage obtained in SIM–MS/MS versus LC–MS/MS mode. 
In both experiments 50 fmol of BSA solution were used and both measurements were performed with 
the same instrument settings. Peptides in blue are identified in both methods (421 residues, 72.2%), red 
peptides only in SIM–MS/MS (67 residues, 11.5%) and green peptides only in LC–MS mode (37 residues, 
6.3%). Black peptides were not identified (59 residues, 9.9%).
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histone H3 was identified (based on peptides 
with a score higher than p<0.05). The 
heavily modified N-terminal sequence was 
completely covered and seven differently 
modified peptides were detected (Table 4.2). 
In six of them the modified residues were 
unambiguously determined. In particular, the 
high mass accuracy of the orbitrap allowed 
easy distinction between trimethylation and 
acetylation, both of which are important 
histone modifications that have the same 
nominal mass. In the seventh peptide,  which 
was the both trimethylated and acetylated 
peptide KSTGGKAPR, the modified sites 
could not unambiguously be assigned to the 
sequence by the MS/MS spectrum acquired 
in the LTQ, as the mass difference between 
these modifications (0.0364 Da) is far less 
than what the LTQ can distinguish. Therefore, 
a second microliter of the sample was sprayed 
and C-trap fragmentation was performed 
combined with recording of the MS/MS 
spectra in the orbitrap. With the resulting 
high mass accuracy in the fragmentation 
spectra, both types of modifications were 
confirmed and trimethylation was assigned 
to K9 and acetylation to K14.  
The reported seven modified peptides 
are relatively abundant in the bulk prepara-
tion histone sample, and have already been 
reported by either top-down20 or LC based 
bottom-up18 mass spectrometric method. 
Our approach provides an alternative way 
to characterize histone by bottom up mass 
spectrometric analysis without online LC 
separation. Preliminary work furthermore 
indicates that modifications on short pep-
tides that escape detection by LC-MS/MS 
can be detected by automated nanoelectro-
spray (data not shown).   
Relative quantitation by deconvoluted 
peak intensity 
As mentioned above, quantification of 
peptides and proteins is becoming more 
and more important. An advantage of the 
acquisition of a large number of spectra 
is the increasing precision, not only of the 
mass value but also of the intensity ratio 
between ions. This is illustrated by the ratio 
determination between two BSA peptides 
as well as between a methylated and non-
methylated histone peptide. Figure 4.6 
illustrates the relative quantitation of the 
BSA peptides with the m/z 395.239 (2+) 
and 379.715 (2+). As shown in Figure 4.6a, 
both peaks are present in the spectra of m/z 
segment 300 to 500. Figure 4.6b reveals that 
the ratio of the relative intensities varied per 
spectrum between 1.7 and 3.5. However, 
with increasing number of accumulated 
spectra quantitation becomes more and 
more precise.  As shown in Figure 4.6c, the 
99% confidence interval for quantitation 
decreases from 13% after accumulating 10 
scans to 0.9% after accumulation of 1500 
scans (15 minutes acquisition).  
In the case of histone H3 we investi-
gated quantitation of the normal peptide 
against a slightly modified form. The advan-
tage of quantitation by nanoelectrospray is 
that both peptides are present in the same 
scan, whereas in LC-MS/MS experiments the 
Table 4.2 Histone H3 modifications (combinations) 
identified by the SIM–MS/MS method.
Modified amino acids Sequence
K4 Monomethylation TKQTAR
K9 Dimethylation + 
K14 Acetylation
KSTGGKAPR
K9 Trimethylation + 
K14 Acetylation
K23 Acetylation
KQLATKAARK18 Acetylation + 
K23 Acetylation
K79 Monomethylation
EIAQDFKTDLR
K79 Dimethylation
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Figure 4.6 Highly accurate relative quantitation by the ratio of ion intensities within one segmented 
spectrum. Segmented SIM scans from m/z 300 to 500 were acquired for 15 min with 25 fmol/µL tryptic 
BSA. (a) A single SIM scan including the ions with m/z 395.239 (2+) and 379.715 (2+) of which the ratios 
of intensities were quantified. (b) Per single scan the ratio varies from 1.5 to 3.5. (c). With an increasing 
number of accumulated spectra, the precision of the quantitation ratio increases.
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methylated peptide elutes typically slightly 
later. In order to avoid inaccuracy due to 
transmission ‘edge effects’ in the SIM win-
dows, we chose to quantify based on the full 
spectrum. The ratio of the identified histone 
H3 peptide pairs are listed in Table 4.3. As 
is apparent from the table, every (additional) 
modification was subjected to a small frac-
tion (7-12%) of the peptides molecules. Note 
that this value gives a general idea of the ab-
solute stoichiometry of this methylation site 
but that it needs to be corrected for the dif-
ferent ionization efficiencies of the modified 
vs. the unmodified peptides21. 
Conclusions
In this paper, we have endeavored to 
revive nanoelectrospray, an ‘old’ protein 
mapping method using no chromatographic 
peptide separation, as an alternative to MALDI 
peptide mapping. Using the advantages 
of a stable spray in combination with the 
LTQ-Orbitrap mass spectrometer, we have 
introduced the concept of ‘composite 
spectra’, which are spectra composed of 
a high number of segmented SIM scans. 
These composite spectra allow very high 
sensitivity, accuracy and dynamic range 
due to optimized C-trap fill times for each 
mass segment. In the automated format of 
the TriVersa Nanomate, nano-electrospray 
measurements are robust, user-friendly and 
easily amenable for different protein samples 
while using very low amounts of spraying 
solution. Since the instrument can readily 
switch between MS and MS/MS, and between 
fragmentation in the linear ion trap and 
the C-trap, it allows for a large number of 
complementary methods and is very flexible 
and user-friendly.  
The LTQ-Orbitrap mass spectrometer 
is a dual instrument with two independent 
detection systems (LTQ and orbitrap), 
which can be operated simultaneously, 
thus the ideal combination would be to 
fragment high intense ions in the orbitrap 
while simultaneously performing ion-trap 
fragmentation of low intensity ions. This 
would increase the duty cycle and analysis 
speed. However, this requires direct access 
to the LTQ-Orbitrap acquisition software, 
which we are currently lacking. At the other 
extreme of acquisition sophistication is the 
so called ‘ion-mapping’ technique. In this 
method, the whole mass range is scanned 
step by step by SIM-scans of for example 6 
Dalton windows with and without applying 
collision energy to fragment the ions in 
this small window. Especially for complex 
mixtures this method could in principle be 
very valuable in a nanoelectrospray setup 
since the dynamic range is expected to be 
further increased by these small segments. 
However, when we tried this method we 
found that it allocates too much time to 
‘empty’ regions and is thus overall less 
efficient than the method described here.  
In order to further improve protein 
characterization, we plan to access to the 
LTQ-Orbitrap acquisition software directly 
and perform genuine ‘real time’ data 
acquisition. Fragmentation (MS/MS or MS3) 
Table 4.3 Ratio of peptide pairs with identical 
sequence but different modification state.
Identified Peptide Pairs
Ratio with 99% 
confidence 
interval 
TKQTAR / 
TK(Monomethyl)QTARK
11.791 ± 0.916
K(Dimethyl)STGGK(Acetyl)APR / 
K(Trimethyl)STGGK(Acetyl)APR
9.849 ± 0.826
KQLATK(Acetyl)AAR / 
KQLATK(Diacetyl)AAR
14.651 ± 1.307
EIAQDFKTDLR / 
EIAQDFK(Monomethyl)TDLR
11.391 ± 0.868
EIAQDFK(Monomethyl)TDLR / 
EIAQDFK(Dimethyl)TDLR
8.206 ± 0.990
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will focus on the peaks recognized in the 
survey scan but not identified in the search 
with expected variable modifications. This 
will allow identification of new peptide 
sequences, variant alleles or unexpected 
modifications. Of course, digestion with 
multiple enzymes is also an obvious next 
step for even more for more in-depth 
characterization of modified peptides. 
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Introduction
The development of electrospray mass 
spectrometry has allowed analysis directly 
from the liquid phase1. This feature of 
electrospray makes it eminently suitable 
for the online coupling of separation and 
ionization before MS analysis. In nanoscale 
liquid chromatography-mass spectrometry 
(LC-MS) analyte species are concentrated into 
very small volumes, increasing sensitivity. 
Furthermore the excellent separation capacity 
of high performance chromatographic sys-
tems is multiplied with the high resolution 
of modern mass spectrometers, resulting in 
exceptional combined separation power2. 
Both small molecules and peptides and 
proteins are routinely analyzed by this 
powerful technology. However, compared to 
offline methods such as nanoelectrospray3 
or MALDI4, online coupling also has some 
inherent drawbacks. The short time during 
elution of a peak requires a fast and automatic 
decision on which peak to sequence. In 
complex mixtures, many peptides co-elute 
and some may not be sequenced at all5. 
Peptides of special interest, for example, 
those with regulatory post-translational 
modifications, should be characterized in 
depth, but the fact that they are important 
may only become evident after the analysis. 
Some of these drawbacks can in principle 
be addressed by slowing down the flow (‘peak 
parking’, 6), fraction collection or by repeat 
injection. However, none of these methods 
is ideal from an analytical standpoint. Peak 
parking is of limited utility for complex 
mixtures as the flow may have to be stopped 
every few seconds and the run would be 
extended to impractical lengths. Fraction 
collection is useful in many instances but 
at very low flow rates it is less practical 
because of the low volume of fractions. In 
nanoflow LC peptides typically elute in about 
Liquid chromatography combined with electrospray ionization is widely used for direct analysis of polar and labile molecules by mass spectrometry 
(LC-MS). The online coupling in LC-MS is a major strength but also causes a 
principal limitation – that each eluting analyte has to be analyzed immediately 
and is not available for detailed interrogation after the LC-MS run. 
Here we develop a new chromatographic strategy, which removes this limitation. After column separation the flow is split, one portion is 
analyzed directly and the other is diverted to a capture capillary. After the 
direct LC-MS run, the flow is switched and the portion stored in the capillary is 
analyzed (‘replay run’). We describe a set up consisting of an analytical column, 
a splitting valve and a focusing column, which performs at full sensitivity and 
undiminished chromatographic resolution. 
We demonstrate three principal advantages of this system; nearly continuous MS utilization, duplicate analysis without requirement for 
additional sample and targeting of important but undersampled features in the 
replay run.
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50 nL (based on an elution time of 15 s 
using 200 nL/min flow rate). To handle these 
fractions one would need approximately 1 
μL of sample, but adding buffer reduces the 
concentration 20-fold causing a dramatic 
loss of signal intensity. Repeat injections 
multiply total required analysis time and may 
not be optimal if sample is limited, since re-
injection consumes twice as much sample.
We wished to develop a novel concept 
in LC-MS that would allow targeted 
measurement of analyte mixtures without 
compromising sensitivity or chromatographic 
performance while requiring little or no 
additional time. Since electrospray is a 
concentration dependent process and 
therefore maintains full signal at decreased 
flow rates, we and others previously 
developed splitting systems in which the 
column effluent was directed to MS analysis 
as well as to a fraction collector to enable the 
reanalysis of chromatographic fractions7,8. 
However, at very low flow rates, fraction 
collection became increasingly difficult which 
prompted us to explore alternative ways of 
storing the chromatographically separated 
sample. 
Here we describe a novel setup in which 
we collect part of a column effluent in a long 
capture capillary, which we reanalyze after 
the direct run. In this paper we describe 
the new concept and evaluate the system 
in terms of chromatographic and mass 
spectrometric performance. Furthermore 
we show the applicability for a complex 
proteomics sample and demonstrate a useful 
application: targeting important peptides 
that were not characterized in sufficient 
detail in the direct run. A ‘head to head’ and 
exhaustive comparison with other possible 
LC-MS setups or MALDI methods is not the 
subject of this paper. 
Material and methods
RePlay Setup
We constructed the ‘RePlay system’ con-
sisting of a 6-port splitting valve, a flow sen-
sor, a long capillary serving as a capture cap-
illary and short capillaries to adjust the split 
ratio (see Figure 5.1). The splitting valve was 
specially constructed for accurate flow ratios 
and extremely low dead volumes at nL/min 
flow rates (Advion Biosystems). LC was per-
formed on a nano-HPLC 1200 (Agilent) with 
a 10 cm long 75 µm ID IntegraFrit™ Proteo-
PepII analytical column (5 µm RP-C18 resin, 
New Objective), coupled to the RePlay valve in 
which the flow was split. The gradients were 
essentially as described previously12, with 
peptides eluting from 13% to 60% of solvent 
B (0.5% acetic acid in 80% acetonitrile). One 
part of the effluent was directed to a 7 cm 
in-house pulled 75 µm ID fused silica emit-
ter packed with ReproSil-Pur C18-AQ 3 µm 
resin (Dr. Maisch GmbH), termed ‘focusing 
column’ for direct online LC-MS analysis on 
a LTQ-Orbitrap mass spectrometer (Thermo 
Fisher Scientific). Meanwhile, the second part 
of the effluent was collected in the fused sil-
ica capture capillary of typically 13 m length 
and 30 µm inner diameter (ID). The capture 
line (Composite Metal Services Ltd) was ca-
pable of storing around 10 μL, appropriate 
for a 100 min gradient at an effective flow 
rate of 100 nL/min. For the 30 min gradient 
a 3 m capillary was used. This stored gra-
dient was then directed to the same 7 cm 
pulled column by valve-switching triggered 
from the MS acquisition software. 
Split adjusters, 10 μm ID capillaries 
(Composite Metal Services Ltd), were cut to 
the length resulting in the desired split ra-
tio. These split adjusters needed to be fine-
tuned whenever the focusing column was 
replaced. We recommend to carefully tighten 
– not to overtighten – these capillaries since 
we found that small glass particles easily 
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clog the capillaries with a small ID (used as 
split adjusters). For calculation of the theo-
retical peak broadening we used the ‘capil-
lary flow calculator’ option of the ‘Molecular 
Weight Calculator’, software freely available 
Figure 5.1 Schematics of the conventional LC-MS and the RePlay setup. (a) Conventional LC-MS setup 
using a column with integrated emitter placed in front of the mass spectrometer. The light grey arrow 
indicates the direction of the flow. (b) In the ‘direct run’ of the RePlay setup the six-port splitting valve 
is positioned such that part of the effluent of the first nanoLC column (‘analytical column’) flows to the 
mass spectrometer via a short second column (‘focusing column’). The other part is stored in a long 
capture capillary, which has the volume appropriate to hold the complete gradient. (c) When the valve is 
switched the stored gradient is directed to the mass spectrometer (‘replay run’). Capture capillaries of 
different lengths serve as split adjusters – at port 3 in the direct run and port 4 in the replay run – and 
control the split ratio, which is read out by the flow sensor. The split adjuster at port 4 can be replaced 
by a plug, but a split allows higher flow rates and reduces the time used for washing and loading of the 
analytical column.
on the internet (http://www.alchemistmatt.
com). This program calculates the width of 
the peak as a consequence of diffusion when 
inserting the initial peak width, the length 
and ID of the capillary and the flow rate. 
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Liver proteome analysis
Frozen mouse liver tissue was homog-
enized and in-solution digested by trypsin 
as previously described9, desalted and con-
centrated on in-house prepared StageTips10 
and eluted for LC-MS analysis. With a split 
ratio of 1:1, we ran a 100 min gradient (100 
nL/min to MS) and reanalyzed the sample in 
another 100 minutes (100 nL/min). We also 
split 3:1 (direct:replay), used a 100 min di-
rect gradient (200 nL/min to MS) and reana-
lyzed the sample in 35 min (200 nL/min). 
During the replay run the LC loaded the next 
sample on the analytical column. The run was 
analyzed by in-house developed MaxQuant 
software (version 1.07.5) essentially as de-
scribed in ref. 11. The data was searched 
using Mascot (version 2.1.04, Matrix Sci-
ence Ltd) against the mouse IPI database 
(version 3.37) supplemented with frequently 
observed contaminants and concatenated 
with reversed copies of all sequences (2 x 
51,467 entries). Enzyme specificity was set 
to trypsin, allowing for cleavage N-terminal 
to proline and between aspartic acid and 
proline12. Carbamidomethylcysteine was set 
as fixed and N- acetylation and methionine 
oxidation were set as variable modifica-
tions. The maximum allowed mass deviation 
(MMD, 13) was set to 5 ppm for monoisotopic 
precursor ions and 0.5 Da for MS/MS peaks. 
Maximally three missed cleavages were al-
lowed. The false positive rate at the peptide 
level and false discovery rate at the protein 
level were set to 1 % and the required mini-
mum peptide length was 6 amino acids. If 
the identified peptide sequence set of one 
protein was equal to or contained another 
protein’s peptide set, these two proteins 
were grouped together by MaxQuant and 
they were not counted as independent pro-
tein hits. Proteins were considered identified 
when at least two peptides were identified 
(of which one uniquely assignable to the re-
spective sequence).
Determination of SUMO-2 interaction 
partners
HIS6-SUMO-2 conjugates were purified 
as described previously14. The samples 
were subsequently digested by trypsin and 
concentrated on in-house made StageTips10. 
After measuring the direct run with a ‘top 10’ 
method employing fragmentation of the 10 
most abundant ions in the ion trap, a peak 
list was created with MaxQuant software 
(version 1.07.5) using default parameters. 
This list was screened for precursors, that 
– when fragmented – showed ions with m/z 
corresponding to SUMO-2 b-ions in the 
range of b5 to b18. Of the precursors that 
had more than three fragment matches, and 
with a total mass larger than a free SUMO-2 
peptide, the highest expected isotope peak 
was added to an inclusion list. In the replay 
run only these ions were sequenced by 
use of higher collision dissociation (HCD) 
fragmentation15. We deselected charge 
state, precursor mass screening and dynamic 
exclusion, and fragmented all ions matching 
an inclusion list item with a 30 ppm tolerance 
and with a minimum intensity of 30,000. 
These high-resolution fragmentation spectra 
were validated manually.
Results and discussion
RePlay setup
In a first iteration of our systems we 
used a storage capillary instead of the 
fraction collector and we reversed the flow 
for reanalysis of the stored gradient. This 
arrangement inverted the order of the elution 
and resulted in good resolution of late 
eluting peaks (those stored in the capillary 
for a short time) but not of early eluting 
peaks (data not shown). To enable First In 
First Out analysis, we combined the functions 
of flow splitting and redirection of the flow 
into a single device, a low-flow, low dead 
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volume splitting valve (Figure 5.1). Finally, 
in order to prevent possible deterioration 
of chromatographic performance in the 
second run due to diffusion in the capture 
capillary, we introduced a second ‘focusing’ 
column prior to the electrospray emitter. We 
termed this system ‘RePlay’. The effluent 
from the analytical column was split in the 
appropriate, fixed ratio for direct analysis 
in the mass spectrometer and for storage 
in a capture capillary (Figure 5.1a). At the 
end of the gradient, the valve was switched 
and the stored gradient separation was 
eluted through the same focusing column 
as in direct mode (Figure 5.1b). We tested 
the performance of the RePlay system 
(Advion BioSystems) with a bovine serum 
albumin (BSA) standard (Sigma-Aldrich). 
As shown in Figure 5.2, peak intensity and 
chromatographic resolution was very similar 
between direct and RePlay analysis with 
no deterioration over the gradient (Figure 
5.2c). The fact that the signal in electrospray 
is concentration dependent rather than 
dependent on total analyte amount, readily 
explains this feature of the RePlay setup.
Figure 5.2 Schematics of a conventional LC-MS and RePlay setup and base peak chromatograms of 
four consecutively acquired replay runs with 30 minute gradients. (a) In the conventional LC-MS setup 
the mass spectrometer sequences effectively only 50% of the time when using short gradients. (b) In 
the RePlay setup the second analysis can be carried out while the LC system is washing and loading 
the analytical column. In this way no extra time is needed. (c) BSA chromatograms of four replay runs 
measured in a sequence. Chromatographic performance of direct and RePlay were very similar. 
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Chromatographic performance
We tested different split ratios of the total 
flow (typically 200 nL/min) between direct 
and replay run from 1:4 to 3:1 and found 
that the chromatographic performance 
was excellent with splits in this range. For 
the experiments reported in this paper, 
we chose a split ratio of 1:1 or 3:1 to keep 
the volume of the capture capillary small 
and RePlay analysis time short. To test for 
potential detrimental effects of diffusion, 
we varied the inner diameter (ID) of the 
capillary between 20 and 40 μm and stored 
the gradient in the capture capillary for up to 
30 minutes. Theoretically, using a flow rate 
of 100 nL/min, a peak of 20 s measured at 
the base would diffuse into 33 seconds in a 
20 μm ID capillary, whereas the same peak 
would broaden to 45 s in a 30 μm ID tubing 
and to 57 s in a capillary of 40 μm ID. All 
data presented in this paper were acquired 
using a 30 μm ID capture capillary, and for 
this capillary no significant influence on 
chromatographic performance was observed. 
This indicates that the diffusion can still 
be reversed by the focusing column under 
these conditions. However, when we did 
not employ the focusing column we indeed 
observed appreciable peak broadening.
Figure 5.2a, b and Figure 5.3a illustrate 
one of the advantages of the RePlay system 
compared to the routine workflow in our lab-
oratory. During the replay run, the analytical 
column is re-equilibrated and loaded with a 
new sample. Thus, the mass spectrometer is 
continuously sequencing peptides and the 
loading and washing steps do not subtract 
from the duty cycle of MS utilization. As 
shown in Figure 5.2c, four runs were ana-
lyzed in 8 x 30 minutes with essentially 100% 
duty cycle, whereas without RePlay, the duty 
cycle is about 50%. For 100 minute gradients 
we accomplished a duty cycle of 90% by di-
recting one-quarter of the flow to the cap-
ture capillary and pushing the gradient out 
three times faster (see Figure 5.3). However, 
to ensure continued high chromatographic 
resolution we found it advantageous to in-
clude a few minutes’ wash and equilibration 
of the focusing column in all protocols. 
RePlay analysis of a complex proteomic 
samples
Next, we characterized the performance 
of the RePlay system for complex peptide 
mixtures typical of proteomics experiments. 
We loaded slightly less than 1 μg of mouse 
liver tryptic digest, corresponding to less 
than 20,000 hepatocyte cells, onto the Re-
Play system. Analysis was performed with a 
100 minute gradient by a standard ‘top 5’ 
method on the LTQ-Orbitrap, as routinely 
used in our laboratory16. The base peak 
chromatogram in Figure 5.4 shows that the 
peptide pattern is largely indistinguishable 
between direct and replay run. Peaks eluted 
on average within 15 s in the direct and 16 
s in the replay run, (with standard devia-
tions of 5 s and 7 s, respectively; see Figure 
5.4b). This is as good or better performance 
than our standard one-column setup for 
proteomics experiments. At a false discov-
ery rate of one percent, 6,535 fully tryptic 
peptides were identified in the direct run, 
and 5,936 in the replay run, documenting 
the high reproducibility between the runs. A 
total of 8,383 unique peptides were identi-
fied in the combined analysis. Even though 
this experiment was meant to investigate 
reproducibility, the replay run nevertheless 
added 1,848 peptides (28 %) not identified 
in the direct run. On the protein level, the 
RePlay system identified 1,093 proteins with 
two unique peptides and at a false discovery 
rate of one percent, demonstrating that it is 
well suited to complex proteomic samples. 
This performance will likely further improve 
if the mass spectrometer is programmed to 
sequence only peptides in the replay run that 
have not been sequenced in the direct run. 
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To demonstrate the ability of reanalyzing 
a complex mixture without adding to total 
analysis time, we split one quarter of the 
flow into the capture capillary (Figure 5.3). 
The total flow was 270 nL/min during direct 
analysis (200 nL/min to the focusing column) 
that lasted for 100 min. During the replay 
run the flow to the focusing column was also 
200 nL/min, ‘squeezing’ the reanalysis into 
35 min. Figure 5.3b and c show that this re-
gime preserved peak intensities and slightly 
sharpened chromatographic peaks. Note 
that total analysis time was 150 min, very 
close to the 140 min standard cycle used in 
our laboratory - in which peptides elute for 
about 100 min.  
Figure 5.3 Timing schedule and base peak chromatogram of a setup using a 3:1 split and a fast replay 
run demonstrating excellent chromatographic performance in both runs without using additional time. 
(a) Timing schedule of two automated replay runs with the nanoLC and MS operating asynchronously. 
After sample loading and before starting the gradient the LC system starts the mass spectrometer. After 
finishing the gradient, the MS measures the replay run while the LC system loads the next sample. (b) 
Liver digests were run with a direct gradient of effectively 100 min and 33 minutes duration for the 
replay run. In nearly 90% of the measurement time, the mass spectrometer sequenced peptide ions. As 
shown in (c), the elution pattern and intensity of direct and replay run are very similar. 
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Figure 5.4 Chromatographic performance in complex proteome analysis with the RePlay system. (a)
Typical base peak chromatogram of a RePlay analysis consisting of 100 minute direct (black) and 100 
minute replay run (red) indicating the similarity of the chromatography performance. One µg of tryptic 
digest of liver homogenate was measured with the RePlay system using a 1:1 split (100 nL/min direct: 
100 nL/min RePlay). (b) Selected ion chromatograms (0.01 m/z units wide) of four peptide peaks selected 
over the length of the gradient showing essentially identical signal intensities and peak widths at half 
height in direct and replay runs. 
Targeting of SUMO-2 substrates in the 
replay run
Online reanalysis also allows targeting 
important peptides that were missed or un-
identified in the direct analysis. We demon-
strate this principle by targeted re-analysis 
of peptides that are extremely difficult to 
identify by tandem mass spectrometry. In 
our work investigating the conjugation of 
substrates with ubiquitin family proteins, we 
looked for specific proteins that are in-vivo 
sumoylated by SUMO-214. Unlike ubiquitin, 
SUMO-2 leaves a large 32 or 34 amino acid 
peptide on the substrate peptide after tryptic 
digest, which makes it highly charged. The 
complex fragmentation spectra of the cross-
linked peptides are notoriously difficult to 
identify with low resolution data17. For con-
fident identification of the sumoylated pep-
tide sequence, confirmation of high resolu-
tion and high accuracy data is required. To 
identify these conjugated SUMO-2 peptides 
in a streamlined fashion we purified HIS6-
SUMO-2 conjugates from HeLa lysate and 
measured them in the standard way in the 
direct run. Low resolution fragmentation 
spectra from the linear ion trap which indi-
cated possible SUMO-2 conjugated peptides 
were then targeted in the replay run. In this 
run we only targeted these potential sub-
strate peptides, fragmented them by Higher 
energy Collision Dissociation (HCD, ref. 15) 
and analyzed them with high resolution and 
mass accuracy in the orbitrap instead of in 
the ion trap. Note that this analysis is slower 
and less sensitive and therefore could not 
have been performed efficiently in the di-
rect run. Figure 5.5 shows the setup of the 
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Figure 5.5 Targeted experiment to identify SUMO-2 substrates with high confidence. (a) After a 100 
minute gradient with an MS method sequencing the 10 most abundant peaks in the ion trap by CID, 
a peak list of MS2 fragments was generated. This peak list was checked for peptides that contained 
multiple b-ions of the SUMO-2 C-terminal peptide and the corresponding peptide precursor masses 
were inserted in an inclusion list. These peptides were then specifically targeted by HCD and detected 
in the orbitrap in order to obtain high resolution and high mass accuracy data. (b) Annotated ion trap 
fragmentation spectrum of a SUMO-2 SUMO-2 conjugate, the orbitrap precursor of which is shown as an 
inset. Due to low resolution, charge states cannot be assigned and masses are inaccurate. (c) Sequence 
of SUMO-2 SUMO-2 peptide, indicating fragments observed in the ion trap (black and half-height) and 
in the orbitrap (green and at full height). (d) HCD-fragmentation spectrum of the same ion, with orbitrap 
resolution set to 7,500. Charge state can easily be assigned and the average absolute mass accuracy 
was in the low ppm range. Inset shows excellent quality of the fragmentation spectrum. Given the 
identification from spectrum (d), the quintuply-charged precursor ion in (b) matches within 1.35 ppm.
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experiment as well as results for a SUMO-2 
conjugated peptide. In the replay run, but 
not in the direct run, charge states and frag-
ment masses are determined with very high 
accuracy (see inset of Figure 5.5d). Interes-
tingly, the ion trap CID did not fragment the 
crucial substrate part of the cross-linked 
peptide (Figure 5.5b), therefore re-analysis 
with a different fragmentation method (HCD) 
was especially beneficial in this case (Figure 
5.5d). The RePlay analysis produced an es-
sentially complete run of y-ions of the sub-
strate peptide.  
This experiment was performed with 
a 3:1 split ratio where the RePlay analysis 
was kept entirely within the time usually 
needed for washing and loading, but that 
would suffice for characterizing a handful of 
interesting peptides. In this way, the mass 
spectrometer could – instead of standing 
idle – acquire targeted and very high quality 
data ‘for free’.
Conclusions
In summary, we have demonstrated that 
the RePlay system enables very efficient use 
of the mass spectrometer, which is an im-
portant advantage given the high demand on 
sequencing time in large-scale proteomics 
laboratories and the costs of high resolution 
mass spectrometers. We also demonstrated 
a ‘targeted analysis’ in which the replay run 
enabled the collection of crucial, comple-
mentary data, thereby dramatically enhan-
cing the information obtained in the direct 
run. 
The great value of the RePlay system lies 
within the combination of several conceptual 
features that are otherwise only available 
individually; in separate set ups. Table 5.1 
illustrates the features of RePlay compared 
to several other possible formats for LC-MS/
MS experiments. Compared to a standard 
LC-MS setup, RePlay allows a second 
analysis using no or little extra analysis time. 
A duplicate injection in a standard set up 
would also allow investigating a sample to 
greater depth, but in that case it comes at the 
expense of more sample usage and doubled 
analysis time. Compared to a setup with two 
parallel columns and LC systems, RePlay 
achieves nearly the same time utilization of 
the mass spectrometer, without requiring an 
additional pump or LC system. Similarly, in 
the case of performing dual injections with 
dual pre-column setup one would require 
twice the sample amount and an extra (or 
Conventional
LC-MS/MS
Duplicate 
injection 
(conv. setup)
RePlay
Pre-
column
setup
Setup with 2
parallel 
columns
Sample utilization + - ++ + +
Depth of analysis + ++ ++ + +
MS utilization - - ++ + ++
LCMS analysis time + - ++ ++ ++
Setup simplicity + + +/- +/- +/-
LC requirement + + + + -
Table 5.1 Comparison of conceptual parameters for different LCMS setups. 
N.B. The conventional nanoflow LC-MS/MS setup is taken as a reference. The most favourable settings 
are highlighted in grey.
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more complex) LC system. Not included in 
the table are ‘fraction collection’ and ‘peak 
parking’, which are impractical for high 
throughput proteomics for reasons described 
in the introduction of this chapter. 
The only analytical cost of the RePlay 
system is a higher complexity of the setup. 
The split needs to be fine tuned whenever 
pressure changes after the split occur. 
However, we found the system to be robust, 
it did not lead to any loss of signal, and the 
chromatographic performance was better 
than or equivalent to our standard setup.
Most of the measurement time in 
standard LC-MS/MS is currently spent on 
obtaining information that later on turns out 
to be uninteresting. For example, one may 
be interested in only the peak pairs with 
unequal ratios in isotope based quantitative 
proteomics or one may only be interested 
in modified peptides. We envision that the 
RePlay system will be mainly used to analyze 
such interesting features in a focused 
way. This was demonstrated here with the 
example of the SUMO cross-linked peptides. 
However, dedicated acquisition software 
should enable a multitude of interesting 
features accessible to detailed proteomic 
analysis. For this purpose, the system will 
probably be configured to perform the replay 
analysis in a short time, during washing and 
loading of the analytical column.
However, beyond these applications, the 
system opens up a number of attractive 
possibilities, including ultrasensitive nano-
scale proteomics. In this application, the 
flow would be split asymmetrically, allow-
ing a very long analysis time in the replay 
run. Importantly, the LC system would still 
work at normal nanoflow rates (~200-500 
nL/min), but the effective flow to the MS can 
be reduced a factor 5-10, without wasting 
any sample. This enables two analyses with 
ultrahigh sensitivity of a single injection and 
may be very beneficial for samples where the 
amount is limiting, for example in studies 
where cells or tissue samples are obtained 
by laser capture microdissection. In conclu-
sion, we predict that the RePlay system will 
become a powerful and universal addition to 
the LC-MS tool chest. 
Proteome data
Tables with lists of identified proteins and 
peptides are deposited at MCP online. 
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Introduction
Mass spectrometry is inherently an ex-
tremely sensitive analysis technique: single 
proteins have been analyzed at the attomole 
level many years ago1,2. Similarly, it is now 
possible to identify thousands of proteins in 
single experiments and a first comprehensive 
proteome identification and quantitation has 
been reported3. However, the complexity of 
the proteomic mixtures typically necessitates 
micrograms or milligrams of starting mate-
rial – protein amounts that can readily be ex-
tracted from cell or tissue homogenates4,5. 
The analysis of small tissue substructures 
with specialized functions is medically im-
portant but has remained much more dif-
ficult. Ideally these structures are separated 
from the surrounding tissue to enrich pro-
teins specific to these areas. Although such 
selection is possible by laser-capture mi-
crodissection (LCM), successful use of this 
technology has so far overwhelmingly been 
in the areas of RNA and DNA assays. In the 
few cases where LCM was combined with MS 
analysis, many thousands cells were collect-
ed (taking presumably several hours or days 
of selection), to obtain the protein amounts 
typical for MS6. Only a few investigators have 
attempted to measure smaller cell numbers. 
Luider et al. reported 1000 identified pro-
teins from 3000 cells and a similar number 
from LCM-selected breast cancer tissues, 
but they did not sequence peptides by mass 
spectrometry, relying instead on mass mea-
surements only7,8.
Main obstacles in analyzing small protein 
amounts are the considerable sample losses 
Technological developments make mass spectrometry (MS)-based proteomics a central pillar of biochemical research.  MS has been very 
successful in cell culture systems, where sample amounts are not limiting. To 
extend its capabilities to extremely small, physiologically distinct cell types 
isolated from tissue, we developed a high sensitivity chromatographic system 
that measures nanogram protein mixtures for eigth hours with very high 
resolution. This technology is based on splitting gradient effluents into a capture 
capillary and provides an inherent technical replicate. 
In a single analysis this allowed us to characterize kidney glomeruli isolated by laser capture microdissection to a depth of more than 2400 proteins. 
From pooled pancreatic islets of Langerhans, another type of ‘mini-organ’, we 
obtained an in-depth proteome of 6873 proteins, many of them involved in 
diabetes. We quantitatively compared the proteome of single islets, containing 
2000-4000 cells, treated with high or low glucose levels, covering most of the 
characteristic functions of beta-cells. 
Our ultrasensitive analysis recapitulated known hyperglycemic changes but we also find novel components upregulated such as the mitochondrial 
stress regulator Park7. Direct proteomic analysis of functionally distinct cellular 
structures opens up new perspectives in physiology and pathology. 
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during preparation and the limited ‘dynamic 
range’ of liquid chromatography – tandem 
mass spectrometry (LC-MS/MS) setups used 
in proteomics. Sample preparation efficiency 
has improved by the advent of polished sam-
ple tubes (e.g. Eppendorf Protein LoBind) and 
MS-friendly detergents9,10, thereby allowing 
shorter extraction and digestion protocols 
and reduced unspecific surface binding. 
The second important obstacle, the 
dynamic range, refers to the number of 
different ion species that can be observed 
simultaneously. With highly complex samples, 
as are typical for proteomic experiments, 
low intensity ions are likely to be masked 
by more abundant species. In order to 
also detect these low abundance proteins, 
extensive fractionation is commonly applied. 
But this is not possible with very low starting 
amounts as sample losses are too high.
Recently, we described the ‘RePlay 
chromatography system’ to allow direct 
reanalysis of every sample without losing 
signal intensity11. In RePlay, post-column 
effluent is split with one part directed to 
online LC-MS/MS analysis and the other one 
stored for another round of analysis after the 
first one is finished. We envisioned that this 
setup should also be extremely valuable for 
analysis of probes where starting amount is 
limiting, and therefore optimized the system 
for high sensitivity ‘single shot’ analysis. We 
used optimized sample preparation methods 
and the RePlay system in combination 
with the sensitive LTQ-Orbitrap mass 
spectrometer. Due to the split flow of the 
RePlay system flow rates could be reduced 
five-fold compared to normal operation while 
maintaining normal backpressures and a 
continuous stable flow and spray. In addition 
we doubled the gradient time to increase the 
sequencing events per sample and applied 
the unique RePlay ability to re-measure the 
sample without losing signal intensity. Thus 
we inherently obtain a technical replicate, 
increasing quantitation accuracy, even from 
the smallest proteomic samples. 
Here we demonstrate that our novel 
high-sensitivity RePlay workflow enables 
the analysis of small ‘mini-organs’: we 
examined mouse glomeruli selected by LCM 
and single islets of Langerhans, handpicked 
after purification. In both cases the starting 
material was less than 400 ng of proteins – 
and still resulted in more than 2000 protein 
identifications. Besides high confident iden-
tifications, we demonstrate quantitation of 
protein expression levels in single islets of 
Langerhans. These islets were stimulated 
in high or low glucose prior to LC-MS/MS 
and we identified many known and some 
novel responders, like antioxidants, proteins 
involved in glucose catabolism or vesicle 
secretion processes. 
Materials and methods
LCM workflow 
Cryosections of mouse kidney were cut 
(12-16 μm thick), placed on glass sec-
tions and stained with methylene blue. Per 
sample, about 50 glomeruli were selected 
(tissue areas of approx. 500,000 μm2) and 
dissected by a MicroBeam laser (Carl Zeiss 
MicroImaging). 
Pooled islets & total pancreas homogenate
Pancreatic islets were isolated from 
12-16 weeks old C57Bl6/J male mice. Islet 
preparation was done as described in ref. 12. 
Prior to removal of the pancreas, Liberase I 
solution was injected into the pancreatic duct 
(~2 ml/mouse). The pancreas was incubated 
at 37°C for 23 min after which the digestion 
was stopped by adding media supplemented 
with 10% foetal bovine serum, followed by 3 
min centrifugation at 1000 g. Low glucose 
DMEM was added to the pellet, mixed 
vigorously, and filtered though a 400 μm 
diameter wire mesh. Remaining islets were 
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washed once. The islets were spun down and 
resuspended in histopaque 1077 (Sigma). 
Low glucose DMEM was added carefully, 
prior to centrifugation for 50 min at 1100 g 
at 10°C without acceleration or braking. The 
islet layer was collected and washed twice 
with DMEM to remove histopague. Total 
pancreas tissue was obtained by dissecting 
directly after pancreas excision. 
Single Islet preparation
Pancreatic islets were isolated from 
C57Bl6/J male mice, 8-10 weeks old 
as described above. Purified islets were 
recovered overnight in 11 mM glucose CMRL 
medium containing 15% heat inactivated 
foetal bovine serum, 100 units/mL penicillin, 
100 μg/mL streptomycin, 1 mM sodium 
bicarbonate, 0.15% sodium bicarbonate and 
0.001% beta-mercaptoethanol. Subsequently, 
the cells were incubated for 24h with either 
16.7 mM (high) or 5.6 mM (low) glucose in 
Krebs-Ringer-Hepes buffer (25mM HEPES 
pH7.4, 115 mM NaCl, 24 mM NaHCO3, 5 mM 
KCl, 2.5 mM CaCl2, 1 mM MgCl2, 0.1% BSA). 
Single islets were handpicked.
Sample digestion
LCM and single islet samples were 
dissolved in 0.1 % PPS Silent Surfactant 
(Protein Discovery) in 50 mM ammonium 
bicarbonate with 1 mM dithiothreitol, heated 
to 95°C for 3 min and sonicated for 2 min. 
Subsequently proteins were alkylated in 
1 mM chloroace-tamide in ammonium 
bicarbonate for 30 min and digested 
overnight with porcine trypsin (Promega) in 
an enzyme-to-protein ratio of 1:50. After 
acidification by trifluoroacetic acid, peptide 
mixtures were concentrated and desalted on 
StageTips13 and eluted directly before LC-
MS measurement. To prevent protein losses 
during sample preparation LoBind Eppendorf 
Tubes and Axygen Maxymum Recovery tips 
were used and sample contact was minimized. 
For pooled islet and pancreas proteome the 
peptide samples were additionally separated 
into 12 fractions by peptide isoelectric 
focusing as described14. 
RePlay Setup
The RePlay system was based on the 
one described in9, but developed for high 
sensitivity: the capture capillary was 19 m 
x 30 μm inner diameter (ID); the focusing 
column, a pulled capillary of 22 cm x 40 
um ID was packed with 3 µm ReproSil-Pur 
C18-AQ resin (Dr. Maisch GmbH)15. For the 
LCM and single islet measurements we used 
a split ratio of 1:1 (MS : capture capillary), an 
effective flow rate of 50 nL to the MS in both 
direct and replay run, and 240 min gradients. 
For the pooled islet and pancreas proteome 
gradients of 2h were used with 150 nL/min 
effective flow rates. The flow sensor was 
placed in the waste line to prevent potential 
dilution effects.
The gradient generated by a Proxeon 
easyLC (Proxeon) was coupled, via the RePlay 
system and an electrospray interface, to an 
LTQ-Orbitrap mass spectrometer (Thermo 
Fisher Scientific). MS and MS/MS were 
acquired data-dependently of the ten most 
intense ions per survey spectrum, using MS/
MS target values of 5000, with a minimal 
intensity of 1000 ions and a maximum fill 
time of 150 ms. For survey spectra one million 
ions were accumulated with maximum fill 
times of 500 ms. 
Data analysis
MS/MS data were analyzed by in-house 
developed MaxQuant software (version 
1.0.12.27), essentially as described10. The 
data was searched using Mascot (version 
2.1.04, Matrix Science Ltd) against the mouse 
IPI database (version 3.37) supplemented 
with frequently observed contaminants 
and concatenated with reversed copies of 
all sequences (2 x 51,467 entries). Enzyme 
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specificity was set to trypsin, allowing 
for cleavage N-terminal to proline and 
between aspartic acid and proline and 
a maximum of two missed cleavages. 
Carbamidomethylcysteine was set as fixed 
and N-acetylation and methionine oxidation 
were set as variable modifications. The initial 
maximum allowed mass deviation was set 
to 7 ppm for monoisotopic precursor ions 
and 0.5 Da for MS/MS peaks. The required 
minimum peptide length was six amino 
acids. If the identified peptide sequence set 
of one protein was equal to or contained 
another protein’s peptide set, these two 
proteins were grouped together and the 
proteins were not counted as independent 
hits. Proteins were considered identified 
when at least two peptides were identified 
of which at least one uniquely assignable to 
the respective sequence. The false discovery 
rate (FDR) at the peptide level and protein 
level were set to 1% for the glomeruli, pooled 
islet and pancreas proteome. Based on the 
additional identification confidence provided 
by the pooled islet dataset, we accepted 
single unique peptide identifications with 5% 
FDR on peptide and 2.5% on protein level. 
For quantitation proteins were additionally 
filtered, and were required to be detected 
in 4 out of 8 most intense LC-MS/MS runs 
with at least 2 unique peptides. Parametric 
ANOVA analysis was performed with p<0.01 
significance cut-off.
Results and discussion
There are two challenges in the 
measurement of very small in vivo cell 
populations by liquid chromatography – 
tandem mass spectrometry (LC-MS/MS): 
efficient recovery of the proteins and high 
analytical sensitivity. To meet the first 
challenge, we implemented a workflow with 
a minimal number of handling steps starting 
from LCM (Figure 6.1a) or mini-organ 
purification (Figure 6.1b) and resulting 
in a trypsin digested proteome. LC-MS/
MS sensitivity was improved in three ways 
(Figure 6.1c): (1) By reducing the effective 
flow rate to 50 nL/min and employing 
smaller diameter columns; (2) By separating 
the peptide mixture with very long gradients 
(4h) to increase peptide sequencing events 
by the high-resolution LTQ-Orbitrap mass 
spectrometer; (3) By splitting the flow 
after chromatographic peptide separation, 
thereby providing a technical replicate from 
a single sample loading without loss of signal 
(RePlay11). 
Glomeruli
First, we tested this high-sensitivity 
workflow on mouse glomeruli, about 50 of 
which we isolated by LCM from histological 
slices. Glomeruli are the filtering units 
in the kidney and consist of only a few 
hundred cells in mice. Automated analysis 
proved robust and the chromatographic 
setup retained excellent average peak width 
(<22s) in direct and replay runs (Figure 
6.1d). Overall signal was the same in both 
runs and individual peptide intensities, 
which ranged over more than four orders of 
magnitude, correlated highly between them 
(R=0.92; Supplementary Figure 6.1a). Data 
processing with MaxQuant16 resulted in 
the identification of 2406 distinct proteins 
from a single injection.  Virtually all known 
glomeruli proteins are contained in this 
data set. Repeat measurements resulted 
in 2402 and 2377 proteins identified and 
the three data sets shared 86% of protein 
identifications (Supplementary Figure 6.1b). 
For comparison, our recent proteomic 
analysis of 20 fractions of mouse liver tissues 
using thousand-fold more material resulted 
in a similar number of identifications17. 
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In-depth proteome of pancreatic islets
Islets of Langerhans are another type of 
mini-organ essential for human health. In 
mice, 2000 islets are dispersed throughout 
the pancreas of which the insulin producing 
β-cell is the most predominant18. To obtain 
an in-depth islet proteome we pooled puri-
fied islets and analyzed them after peptide 
fractionation. Triplicate analysis employing 
RePlay and material from six mice resulted 
in the identification of 7014 proteins with at 
least two peptides and a FDR of 1%. The larg-
est previous islet proteome is less than half 
the size and almost completely contained in 
our proteome (94%)19. This list consists of 
(i) islet specific proteins, (ii) proteins shared 
between islets and the rest of the pancreas, 
and (iii) proteins from the rest of the pan-
creas that contaminate the islet preparation. 
To distinguish these classes we measured 
Figure 6.1 Schematic workflow for high-sensitive LC-MS analysis with direct replicate measurement. (a) 
Workflow for laser capture microdissection of mouse kidney glomeruli followed by protein extraction 
and digestion. (b) Purification of islets of Langerhans from mouse pancreas by Liberase I treatment 
and gradient centrifugation. Islets were stimulated with high or low glucose, individually collected, and 
proteins solubilized and digested by trypsin. (c) High sensitivity nanoLC-MS setup with the RePlay to 
obtain two measurements per injection. (d) Total ion chromatogram in direct and replay analysis are 
very similar. Insets show identical resolution and intensity for three typical peptide peaks.
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an in-depth proteome of complete pancreas 
homogenate, of which the islets constitute 
less than 2%, and quantified proteins against 
the islet proteome by label-free quantifica-
tion in MaxQuant20. Elastase, trypsin, and 
other digestive enzymes produced by the 
exocrine pancreas were more than 30-fold 
more abundant in the total pancreas pro-
teome compared to purified islets. After fil-
tering out proteins with a similar behavior, 
we retain a high quality islet proteome of 
6873 proteins. Our data indicate that islets, 
which are highly specialized tissue struc-
tures, use of at least a third of the genes in 
the genome. Moreover, several proteins were 
identified as the pancreas specific isoform of 
the gene and our data provides isoform spe-
cific tissue expression information for many 
more.
The known endocrine hormones produced 
by this mini-organ, such as insulin 1 and 2, 
glucagon and secretogranins are among the 
most highly expressed proteins in the pro-
teome judged by added peptide intensity3. 
To contrast islet specific expression to ex-
pression in whole pancreas we categorized 
islet proteins by their enrichment factors 
(Figure 6.2a). More than half of the islet pro-
teome is within a four-fold abundance range 
compared to whole pancreas, and these 
proteins are predominantly associated with 
house-hold functions. The pancreatic islet 
is an intricately assembled structure con-
necting the endocrine cells to the circulation 
and neural control. Concordantly, proteins 
connected to cell communication and cell 
adhesion make up much of the specific is-
let proteome. In the 1133 proteins enriched 
more than four-fold in islets, membrane and 
extracellular proteins comprise a large part 
(Figure 6.2b). This class of proteins contains 
various G-protein coupled receptors, cAMP 
regulators, receptor tyrosine kinases and ion 
channels - potential and established targets 
for diabetes drugs, as well as autoantigens in 
type I diabetes (Figure 6.2b-c, Supplemen-
tary Figure 6.1c). Interestingly, 86 of 396 
identified kinases are highly enriched in the 
islets. Our dataset also contains many un-
annotated proteins, especially among those 
that were close to the limit of detection and 
therefore not quantified and categorized 
(Figure 6.2a). 
Single islet analysis
High fat and high glucose conditions are 
reported to negatively affect β-cell function, 
a process that is central to the development 
of type 2 diabetes21. Dynamics of β-cells are 
frequently studied in cell culture; however, 
it is physiologically more relevant to investi-
gate these cells in their native cellular con-
text22. We wondered if our high sensitivity 
workflow was capable of analyzing single 
pancreatic islets. To this end, we determined 
single, isolated islet proteomes after 24h at 
16.7 mM and 5.6 mM glucose, representing 
hyperglycemic and basal conditions, respec-
tively. One day of elevated glucose concen-
tration significantly affects metabolic func-
tions at the mRNA level23, but does not yet 
evoke irreversible changes24. 
First we assessed the proteome coverage 
in single islet experiments. Similar to the 
case of glomeruli we achieved very good 
correlation on the peptide level between 
direct and replay runs (Figure 6.3a). 
Protein quantitation integrates several 
peptide measurements and therefore the 
quantitative reproducibility is even higher 
on the protein level (R=0.98; Figure 6.3b). 
We sequenced 15,193 different peptides 
originating from 2013 unique proteins (2.5% 
FDR). Per biological replicate we identified on 
average 84% of the total number of proteins. 
97% of the single islet proteins (1949) were 
also present in the large islet proteome 
determined above (Supplementary Figure 
6.1d). The single islet proteome contained all 
the islet specific hormones as well as known 
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Figure 6.2 The proteome of pooled islets of Langerhans. (a) Classification of purified islet proteome 
versus pancreatic proteome, based on protein ratios between the two samples. After subtracting 
pancreas contaminants (141), a high confidence list of 6873 islet proteins was obtained. Note that 
for proteins with less than 3 peptides and close to the limit of detection, accurate ratios and hence 
classification were not assigned (‘not classified’). Proteins enriched more than four-fold (total 1133) 
were categorized by (b) GO cellular compartmentalization and (c) GO biological process. Numbers 
indicate proteins per category in the enriched dataset.
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Figure 6.3 Quantitative analysis of single islets by MS-based proteomics. (a) Correlation of peptide 
intensities between direct and replay runs of one single islet measurement.  (b) Comparison of six 
direct and replay runs indicates very high quantitative reproducibility at the protein level. (c) Annotation 
of single islet and pooled-islet proteome to KEGG pathways important for β-cell function. Numbers 
indicate identified proteins within annotated group. The single islet proteome covers most essential 
β-cell processes like glycolysis, TCA cycle and oxidative phosphorylation. (d) Volcano plot showing 
p-values (-log10) versus protein ratio of high / low glucose treated islets (log2) of all 1482 proteins 
fulfilling strict quantitation criteria. (Red, 77 upregulated proteins; blue, 65 downregulated proteins; 
green, not significantly changed upon 24h glucose stimulation; ANOVA with p<0.01).  Gene names of 
proteins discussed in the text: A, ANT1; B, Ero1lα; C, Prdx3; D, Park7; E, Gsn; F, Vil1; G, Actn1; H, Itgb1; 1, 
Pcsk1n; 2, Pdyn; 3, ATP2a2; 4, ATP2a3; 5, Ins2; 6, Sytl4; 7, Vamp2; 8, Vamp8; 9, Scamp3; 10, Rab3b; 11, 
Capza1; 12, Capza2.
β-cell proteins like glucose transporter 2, 
glucokinase, and prohormone convertase 1 
and 2.  Furthermore, we covered the majority 
of proteins involved in classical β-cell 
functions (Figure 6.3c, Supplementary Figure 
6.1e-g); for example, between 40 and 85% 
of the annotated proteins (irrespective of 
tissue) in glycolysis, TCA cycle and oxidative 
phosphorylation, ribosomes, and secretory 
granules (Fig 4). 
Protein expression changes upon hyper-
glycemia
Next we determined changes of the 
proteome after 24h glucose stimulation. 
Quantitative comparison was based on 
proteins identified with ≥ 2 unique peptides 
and detected in ≥ 4 out of 8 runs (1487 
quantifiable proteins). With these stringent 
criteria and ANOVA p<0.01, there were 77 
up- and 65 downregulated proteins. Some of 
b 
d  
a
c  
R = 0.87
D
en
si
ty
54
22
72
20 23 8 8 13
30 25 18 18 16 21 22
1
3
12
11 19 1 1 14
7 5 7 9 10
68
13
25
2
43
2
9
1
1
9
4 1 4 3 7
44
7
total nr of annotated proteins
pooled islet proteome
single islet proteome
104 105 106 107 108
104
105
106
107
108
Peptide intensity of direct run
Pe
p
ti
d
e 
in
te
n
si
ty
 o
f r
ep
la
y 
ru
n
103
104
105
106
107
103 104 105 106 107 108
N
o
rm
. p
ro
te
in
 in
te
n
si
ty
 
o
f r
ep
la
y 
ru
n
Norm. protein intensity of direct run
108
-L
o
g
10
 (p
)
R = 0.98
Log2 (high / low glucose)
1
2
3
4
5
-4 -2 0 2 4
7
9
5
- 8 8
G
H
E
1
2 6
10
12
11
3
4
8
A B
C
D
F
0
Quantitative analysis of single islets109
the most significantly affected proteins are 
highlighted in the volcano plot in Figure 6.3d. 
Many regulated proteins have previously 
been associated with hyperglycemia in 
animal models for diabetes or in patients 
(Supplementary Table 4). Concordant with 
a recently published microarray study23 we 
find a general upregulation of glycolysis, the 
TCA cycle and ATP translocation (Figure 6.4). 
In contrast to elevated insulin transcription, 
we observed reduced insulin protein levels, 
presumably due to depletion of insulin 
from internal stores as a consequence of 
continuous secretion. This assumption 
is indirectly supported by the finding of 
decreased levels of two hormone processing 
inhibitors prodynorphin (Pdyn) and ProSAAS 
(Pcsk1n)25.
Increased glucose catabolism induces 
oxidative stress, a process detrimental to 
β-cells, and we find molecular evidence for 
this, in the form of antioxidant proteins, 
supporting and expanding previous obser-
vations (e.g. ERO1l-α and Prdx3, Figure 6.3 
and 6.4)26. Prdx3, upregulated 2.4 fold, 
protects β-cells from mitochondrial hydrogen 
peroxide stress and mice overexpressing 
Prdx3 are more glucose tolerant upon high-
fat diet feeding and better protected against 
hyperglycemia27. Interestingly, DJ-1 (Park7) 
and Mn2+-superoxide dismutase (Sod2) 
were upregulated 2 and 1.7 fold (p<0.05), 
respectively. DJ-1 is a mitochondrial oxidative 
stress and apoptotic regulator implicated 
in Parkinson’s disease28,29 but has not yet 
been associated with β-cell responses in 
hyperglycemia. It induces mitochondrial 
antioxidant proteins like Sod230. To explore 
DJ-1’s connection to β-cell dysfunction, we 
quantified its expression in mouse islets 
after high-fat diet and found the protein 
upregulated 1.7 fold (Supplementary Figure 
6.1h) – similar to the short term hyper-
glycemic stimulation – suggesting that it is 
involved in β-cell regulation under multiple 
stress conditions. 
In contrast to the increased protein levels 
in glucose catabolism and induced stress 
mechanisms described above, proteins 
associated with vesicle secretion are reduced 
(Figure 6.4). In the case of vesicle-associated 
membrane protein (VAMP)-2, synaptotagmin-
like protein 4 (Sytl4) and Rab3b, who interact 
upon Ca2+ increase, this has been observed 
before31,32. Decreased expression of Sytl4 
reduces the number of docked vesicles to 
the plasma membrane, which is suggested 
to effect insulin secretion24,33. Decreased 
mRNA and protein expression of VAMP2 
and various other secretory proteins have 
also been associated with impaired protein 
secretion in diabetic patients34 and animal 
models for diabetes35. Furthermore, we 
observed depletion of all three members 
of the sarcoplasmic/endoplasmic reticulum 
calcium ATPase (SERCA) complex, which has 
also been correlated with insulin secretion 
deficiencies in diabetic animal models36. 
In contrast, mRNA levels of SERCA increase 
after 18h of glucose stimulation23, possibly 
pointing to a compensatory mechanism for 
acute protein depletion. 
Vesicle access to the plasma membrane 
is thought to be hindered by dense cortical 
F-actin and depolymerization of F-actin 
upon glucose stimulation potentiates insu-
lin secretion37. Supporting this view, we 
observed altered levels of proteins involved 
in remodeling the cortical cytoskeleton 
network – the depolymerizing enzymes Villin 
1 and Gelsolin are up and inhibitory enzymes 
Capza 1 and 2 are downregulated. Gelsolin’s 
role in this process has already been 
demonstrated38. Moreover, α-actinin-1 and 
4 were upregulated. Actinin-1 associates 
with cell adhesion molecules like integrin-β1, 
which was increased three fold and plays 
an important role in β-cell extracellular 
matrix interaction39. β1-integrin is an 
essential factor for β-cell proliferation 
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and communicates with laminins in the 
basement membrane12. Consistently, there 
is a direct relation between its expression 
level and the rate of insulin secretion upon 
glucose stimulation40. Thus, our single islet 
analysis directly supports an important role 
of cytoskeletal remodeling in high glucose 
conditions. 
Figure 6.4 Main differentially expressed proteins upon 24h glucose stimulation in the context of 
physiological processes related to glucose stimulated insulin secretion. (a)  Cellular events leading to 
insulin secretion after normal glucose stimulation. Main affected processes are presented in further 
detail, showing proteins (gene name) with the following color-coding: green = identified, red = 
upregulated, blue = downregulated and white = not identified. (b) Glucose uptake, glycolysis, TCA 
cycle, oxidative phosphorylation and antioxidants. (c) Vesicle transport and cytoskeleton remodeling.
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Conclusions
In conclusion, by optimizing the 
proteomic workflow, using reduced flow 
rates, direct replicate measurements and 
extremely accurate and highly sensitive 
mass spectrometry, in vivo structures 
comprising a few thousand cells can now 
be quantitatively analyzed. Our study 
highlights a beneficial aspect of this directed 
analysis: The functionally relevant proteome 
turns out to be expressed relatively 
highly in these specialized cells and is - 
by avoiding the dilution effect of whole 
tissue analysis - more readily accessible 
to proteomic measurements. Already, the 
method described here could be used to 
evaluate single islets developed from in vitro 
differentiated stem cells or disease control 
of a few islets taken from human biopsies. 
The flow rate and column diameter can be 
significantly lowered41 and MS sensitivity and 
scan speed increased42. Thus a few hundred 
cells are analyzable or alternatively depth 
of coverage can be increased significantly. 
This allows in depth proteomic analysis 
of virtually all features visible by standard 
histological methods. 
Proteome data
Raw data as well as supplementary tables 
containing identified proteins and peptides 
are deposited at Tranche (proteomecom-
mons.org) and are available on request.
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The first subject, covered in Chapter 
2 and 3, deals with the analysis of intact 
proteins by MS, which is commonly referred 
to as top-down MS. Its goal is to characterize 
proteins without prior digestion in order to 
obtain information about (co-occurrence of) 
co- and post-translational modifications, 
splice isoforms and the relative stoichiometry 
of the resulting protein forms. Combinatorial 
modifications are known to influence 
protein signaling, but this information is 
often lost upon digestion. We investigated 
the capabilities of the LTQ-Orbitrap for 
top-down MS analysis, and found that the 
spectral quality is excellent for proteins of 
10 to 25 kDa, with low nanomole sensiti-
vity and full isotopic resolution. With 
mass accuracies in the low ppm range on 
both protein and peptide levels, target 
proteins were confidently identified in the 
databases and fragments could be assigned 
unambiguously. Interestingly, we observed 
several phosphorylated fragment ions in CID 
fragmentation spectra. On the peptide level, 
this labile modification often results in an 
identification hampered by neutral loss.
The observation that the stoichiometry of 
modified protein forms can be determined 
from the respective intensities in the survey 
scan motivated us to explore whether stable 
isotope labeling by amino acids in cell culture 
(SILAC) might work in combination with top-
down MS. This metabolic labeling technique 
allows for direct spectral comparison of 
multiple samples and thereby increases 
quantitation accuracy. First we mathemati-
cally established that the isotopic clusters 
of the differentially labeled proteins would 
be separable at any charge state up to at 
least 146+. Secondly we demonstrated, by 
analyzing the 28-kDa adapter protein Grb2, 
that we could determine the ratio between 
‘light’ and ‘heavy’ labeled forms with 6 % 
accuracy. The labeling furthermore helped 
with fragment assignment, as quantized 
SILAC mass offsets reveal the number of 
labeled amino acids in the sequence.
Although we demonstrated the potential 
of the LTQ-Orbitrap and the applicability 
of SILAC for intact protein characterization, 
we encountered several problems that 
currently prevent the application of top-
down MS to large scale proteomic projects. 
The main bottleneck in this regard is the 
low throughput. At present, there is no LC 
system that allows high-quality separation 
for a wide range of proteins and as a result 
most protein characterizations are done 
on (semi) purified samples. In addition, the 
LTQ-Orbitrap only allows accurate analysis 
Mass spectrometry (MS)-based proteomics is a rapidly maturing technology increasingly demonstrating its large potential in biological 
and medical research. For many biological questions involving identification 
and/or quantitation of proteins, well-established and high-throughput LC-MS 
methods can now be applied. 
However, there are a number of applications for which MS potential is tremendous, but for which standard methods are inappropriate or deliver 
insufficient depth of analysis. In this thesis, we tackled three of these challenging 
subjects either by optimizing existing approaches or by establishing novel ones.
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of small proteins. Proteins larger than 40-60 
kDa cannot be properly resolved, thereby 
hindering accurate mass determination 
and identification. A further complication 
is the lack of appropriate software for data 
analysis. Only recently has software become 
available to identify proteins from top-
down data in a somewhat high-throughput 
fashion. Altogether, despite continued 
progress being made in this field, it will most 
likely take several years before top-down MS 
can be applied side-by-side with bottom-up 
MS.
The second application, discussed in 
Chapter 4, describes the establishment of 
technology aimed at allowing fast and in-
depth analysis of simple peptide mixtures. 
Typically, MALDI-TOF instruments are 
used to characterize purified proteins. 
That instrumentation however, delivers 
inferior spectrum quality and identification 
confidence compared to the LTQ-Orbitrap 
which is – at the same time – more versatile. 
To demonstrate that such analyses can be 
performed on the orbitrap very quickly and 
with low sample consumption, we developed 
a MS method that fully characterizes a 
protein and its modifications using only 
small amounts of sample in 1 or 2 μL of 
spraying liquid. With automated chip-
based nanoelectrospray we collected many 
hundreds to thousands of surveys spectra of 
different m/z regions, and combined them 
into one composite spectrum. This resulted 
in average mass precision in the range of 400 
ppb, and a dynamic range of 6700, enabling 
us to confidently identify 66% of the protein 
sequence from 500 attomole of albumin as 
well as various post-translationally modified 
peptides of histone H3. Since this method can 
be completed in approximately 5 minutes, it 
is appreciably faster than any LC-MS based 
approach and could considerably increase 
the sample throughput in MS facilities.  
To make similar in-depth protein charac-
terization attractive and applicable to 
proteomic studies, it needs to be compatible 
with online LC separation. We thus evaluated 
the possibility of collecting small fractions 
while analyzing the sample by online LC-MS. 
Unfortunately, we observed that due to the 
low flow rates and sample concentrations 
used in nanoLC, sample losses due to 
absorption to collection vessels were detri-
mental. The solution to this problem was 
to employ a fused silica capillary instead. 
This technology represents subject three of 
this thesis (Chapter 5 and 6). As described 
in Chapter 5, we developed a completely 
novel LC-MS set-up, called RePlay, enabling 
the collection of a column effluent inside 
a long capture capillary. This system, 
co-developed by and now commercially 
available from Advion BioSciences, allows 
fully automated direct reanalysis of the 
stored effluent after the normal LC-MS 
measurement has finished. Since the sample 
is stored after chromatographic separation, 
the signal intensity is not compromised and 
with a small focusing column in-line to the 
mass spectrometer, we obtained excellent 
chromatographic separation. Conceptually, 
information obtained in the first run can 
be utilized to specifically target important 
proteins or peptides in the ‘replay’ run. 
During this reanalysis the next sample 
can already be loaded on the first column, 
thereby rendering the LC-MS setup more 
time efficient. 
In Chapter 6 we subsequently described 
a direct application of this novel system: 
analysis of low sample amounts, as is 
often needed when analyzing human tissue 
material. We optimized the sensitivity of the 
system by reducing the effective flow rate to 
50 nL/min, and ran 4h long gradients. Using 
the RePlay system we obtained a ‘built-in’ 
technical replicate of every precious sample. 
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We demonstrated this ultrasensitive setup 
by analyzing single islets of Langerhans 
from mice pancreas, which are composed 
of approximately 2000 to 4000 hormone-
producing cells. We confidently identified 
2013 proteins and showed that with the 
obtained depth we covered at least 40% 
of the proteins in all processes related to 
glucose catabolism and insulin secretion. 
Furthermore, we quantified over 1400 pro-
teins with multiple peptides and confirmed 
the regulation of functionally important 
proteins after 24h glucose stimulation. In 
addition we even found novel, potential 
hyperglycemia markers, including DJ-1. 
Besides doubling the number of proteins 
identified, we also are the first that obtained 
important and solid quantitative information 
from such low sample amounts.
In conclusion, using the novel ultrasensi-
tive setup around the RePlay system, we 
are able to perform in-depth quantitative 
MS analysis using less than a microgram 
of starting material. Thus, by virtue of this 
methodology, proteomics now enters a 
variety of research fields that were until now 
– for reasons of limiting sample amounts – 
restricted to DNA and RNA analysis. 
Although we present a technological 
development that holds great promise, it 
should be noted that the characterization 
of low abundant but biologically important 
proteins such as transcription factors, 
transmembrane receptors etc. from samples 
of limiting protein amounts will still require 
further developments, especially with respect 
to detection sensitivity. Inside the mass 
spectrometer, improvements in hardware and 
electronics may enable collection of spectra 
with fewer ions but with higher dynamic 
range. Faster advances however, seem 
achievable in optimization of the ionization 
process. We observed that at reduced flow 
rates, electrospray ionization was very 
sensitive to the applied voltages, and current 
default settings are not necessarily optimal. 
Further fine tuning of spraying needles in 
combination with the induced field strength 
may increase the ionization efficiency. 
Also on the chromatographic side, the 
system may be further optimized to improve 
sensitivity. Since for small sample amounts 
surface interaction should be minimized, the 
entire peptide separation is ideally performed 
via online LC. In Chapter 6 we used 10 and 
22 cm long columns with 4h gradients. Small 
chromatographic improvements are possible 
by packing longer or smaller diameter 
columns. Robust implementation of an 
orthogonal, second dimension LC (2D-LC) 
would be far from trivial but perhaps has 
even higher potential in this regard..
In conclusion, we have developed three 
different, advanced (LC-)MS methods, all 
with the aim to analyze proteomic samples 
to significant depth. All three methods are 
designed to be used with the latest and 
most sophisticated mass spectrometry in-
strumentation. Nevertheless, as explained 
above, in two out of three applications fur-
ther improvements are desirable. We have 
brought these applications a considerable 
step forward, but they will present exciting 
challenges for years to come.
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De eerste toepassing, besproken in 
Hoofdstuk 2 en 3, behandelt de MS-analyse 
van intacte eiwitten, dat ook wel ‘top-down 
MS’ wordt genoemd. In tegenstelling tot de 
standaard ‘bottom-up’ proteomics methode, 
waarbij de eiwitten voor de meting in stukken 
(peptiden) worden geknipt, is het doel in top-
down MS om de eiwitten intact te meten. Dit 
kan aanvullende informatie opleveren over 
aanwezigheid van specifieke splice varianten 
en/of co- en post-translationele modificaties. 
Vooral wanneer meerdere modificaties op 
een enkel molecuul aanwezig zijn, is de 
kennis over een eventuele wisselwerking 
zeer waardevol. Helaas gaat deze informatie 
vaak verloren bij eiwitdigestie. Bovendien 
kan voor alle moleculaire varianten de 
relatieve stoichiometrie bepaald worden 
op basis van signaalintensiteit. We hebben 
de mogelijkheden van de LTQ-Orbitrap 
massaspectrometer voor top-down  analyses 
onderzocht en stelden vast dat de kwaliteit 
van de orbitrap spectra zeer hoog is voor 
kleine eiwitten (10 tot 25 kDa). Slechts 
honderd femtomol (10-15) eiwit verkregen we 
intense signalen en behaalden we volledige 
isotoopresolutie. Door de nauwkeurige 
massabepaling was het vervolgens mogelijk 
de eiwitten te identificeren in de database 
en konden we de fragmenten (als gevolg 
van geïnduceerde fragmentatie in de 
massaspectrometer) - eveneens zonder 
twijfel - toekennen. Interessant was, dat 
we bovendien verschillende gefosforyleerde 
fragmenten aantroffen. Op peptidenniveau is 
de fosfaatgroep vaak instabiel, resulterend in 
een neutraal massaverlies dat de identificatie 
van dit soort peptiden bemoeilijkt. Bij eiwit-
fragmenten was dit duidelijk minder aan de 
orde.  
De observatie dat de verhouding van de 
gemodificeerde eiwitten vastgesteld kan 
worden aan hand van de respectievelijke 
signaalsterktes in MS spectra, motiveerde 
ons om te testen of eiwitten ook voor top-
down analyse gelabeld kunnen worden met 
‘stabiele isotoop-labeling door aminozuren 
De analyse van alle eiwitten in een cel of weefsel op basis van massaspec-trometrie (MS), aangeduid met de term proteomics, is een snel ontwik-
kelende technologie die veelbelovend is voor biologisch en medisch onderzoek. 
Met behulp van MS kan zowel de identiteit als de hoeveelheid van een eiwit 
worden bepaald, ook wanneer er wordt gewerkt met complexe eiwitmengsels. 
Voor veel kwalitatieve en kwantitatieve eiwitanalyses bestaan daarom inmiddels goed gedocumenteerde preparatietechnieken en geautoma-
tiseerde meetmethoden. Er zijn echter ook een aantal onderzoeksgebieden 
waarvoor MS in principe zeer veel potentieel heeft, maar waarvoor de bestaande 
methoden niet toepasbaar of onvoldoende diepgaand zijn. 
In dit proefschrift wordt beschreven hoe we voor een drietal MS toepassingen de bestaande methoden hebben geoptimaliseerd of nieuwe methoden 
hebben ontwikkeld. Hiermee wordt het groeiende scala aan MS-applicaties 
verder uitgebreid. 
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in cell cultuur’ (SILAC) (Hoofdstuk 3). 
Deze techniek maakt namelijk een directe 
spectrale vergelijking tussen meerdere 
monsters mogelijk en vergroot daardoor 
de nauwkeurigheid van de kwantificering. 
Allereerst hebben we door modellering 
aangetoond dat de isotoopclusters van 
verschillend gelabelde eiwitten niet over-
lappen (tot minimaal 146+ ladingen). Daarna 
demonstreerden we aan de hand van het 
28-kDa grote eiwit Grb2 dat de verhouding 
tussen ‘licht’ en ‘zwaar‘ gelabelde eiwitten 
inderdaad zeer precies kan worden 
vastgesteld (6% onnauwkeurigheid). Boven-
dien stelden we vast dat SILAC helpt bij 
de toekenning van fragmenten: uit het 
massaverschil, geïntroduceerd door de labe-
ling, is het aantal gelabelde aminozuren af 
te leiden. 
Ondanks dat we hebben aangetoond 
dat de LTQ-Orbitrap en SILAC zeer goed 
inzetbaar zijn voor de studie van intacte 
eiwitten, constateerden we ook diverse 
problemen die de toepassing van top-down 
analyse op dit moment beperken. Top-
down MS is op dit moment nog ongeschikt 
voor grootschalige proteomics projecten, 
vanwege de lage ‘throughput’ en het 
ontbreken van chromatografische methoden 
die het brede scala aan eiwitten goed 
kunnen scheiden. Diverse eiwitten slaan 
neer of binden irreversibel aan de kolom. 
Als compromis worden voor top-down MS 
metingen daarom meestal (half)gezuiverde 
monsters gebruikt, maar dit brengt over 
het algemeen veel extra werk met zich mee. 
Daarnaast is de LTQ-Orbitrap niet goed in 
staat om eiwitten groter dan 40 of 60 kDa 
nauwkeurig te meten. Slecht gescheiden 
isotoopclusters beperken een nauwkeurige 
massabepaling en bemoeilijken daardoor de 
eiwitidentificatie. Ten slotte is er een gebrek 
aan goede ‘top-down’-software. Pas sinds 
kort is er een programma beschikbaar dat 
intacte eiwitsignalen op relatief geauto-
matiseerde wijze kan analyseren. Al met al 
verwachten we dat het - ondanks continue 
vooruitgang in dit werkveld – nog zeker 
enkele jaren zal duren voordat top-down 
MS net zo veelvuldig als ‘bottom-up MS’ 
gebruikt zal worden. 
De tweede toepassing in dit proefschrift 
beschrijft een nieuwe methode om simpele 
eiwitmengsels met ‘bottom-up’ methoden 
sneller en toch met meer diepgang te analy-
seren. In Hoofdstuk 4 tonen we aan dat de 
LTQ-Orbitrap ook voor dit type metingen zeer 
geschikt is: beter en tegelijkertijd veelzijdiger 
dan een MALDI-TOF massaspectrometer 
die doorgaans voor dit soort analyses 
wordt gebruikt. We ontwikkelden een 
methode die met 1 of 2 microliter oplossing 
eiwitten en eventuele modificaties volledig 
karakteriseert. Met zogenaamde chip- 
gebaseerde nanoelectrospray verzamelden 
we honderden of duizenden spectra, die 
we vervolgens samenvoegden tot één 
‘composiet-spectrum’. Deze aanpak leverde 
een zeer nauwkeurige massabepaling op 
(gemiddeld ongeveer 400 ppb) en een 
maximaal intensiteitverschil van 6700; 
voldoende om met grote zekerheid 66% 
van de eiwitsequentie van niet meer dan 
500 attomol (10-18) albumine te bepalen. 
Op vergelijkbare wijze karakteriseerden we 
diverse post-translationele modificaties 
op histon H3. Dergelijke metingen kunnen 
worden uitgevoerd in slechts 5 minuten. 
Dit is aanzienlijk sneller dan conventionele 
analyses, waarbij de peptiden direct voor 
MS-bepaling met vloeistofchromatografie 
(LC) worden gescheiden. De hier beschreven 
methode is daarom met name interessant voor 
MS-faciliteiten, die (eenvoudige) monsters 
voor andere onderzoekslaboratoria meten, 
aangezien hiermee veel meer monsters per 
dag kunnen worden gemeten. 
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Diepgaande analyses zoals hierboven 
beschreven voor zuivere eiwitten zijn ook 
wenselijk voor complexe eiwitmengsels in 
typische proteomics projecten. In dit geval 
is echter nog altijd een scheiding op basis 
van vloeistofchromatografie noodzakelijk. 
Daarom testten we het opvangen van 
kleine fracties tijdens de normale ’LC-MS’-
meting, die we vervolgens naderhand op een 
vergelijkbare wijze als in Hoofdstuk 4 zouden 
kunnen analyseren. Helaas constateerden 
we dat met de typische stromingssnelheden 
en geringe concentraties, de verliezen als 
gevolg van absorptie aan de wand van de 
opvangbuisjes te groot waren. De oplossing 
van dit probleem bleek het vervangen van 
deze buisjes door een dun glascapillair. Zoals 
beschreven in Hoofdstuk 5, ontwikkelden we 
een nieuwe set-up waarbij na de scheiding 
van peptiden op een LC kolom een deel van 
het eluaat wordt afgesplitst en opgevangen 
in een zeer lang capillair. Dit zogenaamde 
‘RePlay’ systeem is in samenspraak met 
Advion BioSciences ontwikkeld en via dit 
bedrijf inmiddels verkrijgbaar. De bewaarde 
vloeistof kan na de directe LC-MS meting 
naar de massaspectrometer worden geleid, 
zodat elk monster direct nogmaals gemeten 
kan worden. In deze ‘replay’ meting kan 
informatie van de eerste analyse worden 
gebruikt, zodat de onderzoeker belangrijke 
eiwitten nog eens extra kan bestuderen. 
Bovendien kan tijdens deze tweede meting 
een volgend monster al op de eerste  kolom 
geladen worden, en daardoor wordt de 
meettijd efficiënter benut.
In Hoofdstuk 6 beschrijven we tenslotte een 
directe toepassing van dit nieuwe systeem: 
de analyse van zeer geringe monsters. We 
verbeterden de gevoeligheid van het systeem 
door de stromingssnelheid terug te brengen 
naar 50 nL/min en door in plaats van 2 nu 
4 uur lange gradiënten te meten. De RePlay 
leverde een direct duplo-meting op, waardoor 
we elk monster in acht  uur analyseren. Deze 
aangepaste opstelling hebben we vervolgens 
gebruikt om afzonderlijke  eilandjes van 
Langerhans te bestuderen. Deze ‘mini-
orgaantjes’ bestaan uit slechts 2000 tot 
4000 hormoonproducerende cellen en zijn 
essentieel voor een goede bloedsuikerspiegel. 
In totaal konden we in een enkel eilandje maar 
liefst 2013 verschillende eiwitten aantonen, 
meer dan dubbel zoveel dan dusver in de 
literatuur aangetoond (met vergelijkbaar 
kleine hoeveelheden). Het aantal eiwitten is 
ook dusdanig groot, dat we meer dan 40% 
van de eiwitten die een rol spelen bij het 
glucose metabolisme en insuline secretie, in 
onze dataset aantreffen. Van meer dan 1400 
eiwitten konden we bovendien de hoeveelheid 
vergelijken tussen eilandjes die 24 uur 
blootgesteld waren aan een hoog dan wel 
laag glucose gehalte. Daarmee bevestigden 
we diverse bekende eiwitveranderingen en 
vonden ook nieuwe potentiële hyperglykemie 
markers, waaronder DJ-1. Kortom, de 
nieuwe ultrasensitieve opstelling op basis 
van het RePlay systeem maakt het mogelijk 
om een diepgaande kwantitatieve analyse 
uit te voeren uitgaande van slechts een 
paar honderd nanogram eiwitmateriaal. 
Door deze nieuwe methodologie wordt 
proteomics nu toepasbaar in tal van nieuwe 
onderzoeksvelden, die tot dusver alleen te 
bestuderen waren op DNA of RNA niveau.
Deze technologische ontwikkeling is 
weliswaar zeer veelbelovend, maar verdere 
innovatie blijft noodzakelijk om biologisch 
interessante eiwitten die van nature in zeer 
geringe mate voorkomen (bijvoorbeeld 
transcriptiefactoren en transmembraan-
eiwitten) beter te detecteren. De belangrijk-
ste innovatie zal een verbetering van de 
gevoeligheid (sensitiviteit)  moeten zijn. 
Deze gevoeligheid kan worden vergroot door 
hardware en elektronica-verbeteringen in 
de massaspectrometer, maar waarschijnlijk 
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ook door optimalisatie van het ionisatie 
proces. We constateerden namelijk dat bij 
de lage chromatografiesnelheden kleine 
voltage-veranderingen een grote uitwerking 
hadden op de intensiteit van het signaal. 
De gebruikte instellingen waren niet 
noodzakelijk optimaal en een aanpassing 
van de veldsterkte kan de ionisatie efficiëntie 
daarom mogelijk verhogen. Ten slotte 
pleitten we ervoor dat de peptidenscheiding 
verder wordt geoptimaliseerd. Voor geringe 
hoeveelheden monster is het essentieel 
om het contactoppervlak zo klein mogelijk 
te houden, en dus is chromatografische 
scheiding direct voor de massaspectrometer 
ideaal. Hier gebruikten we één type 
kolom, maar de toevoeging van een extra 
(orthogonale) scheidingsdimensie (2D-LC) 
kan een verbeterde scheiding en daardoor 
hogere sensitiviteit opleveren. Helaas bleek 
dit tot nu toe allesbehalve triviaal. 
Samengevat hebben we drie zeer uiteen-
lopende, geavanceerde LC-MS methoden 
ontwikkeld om eiwitmonsters diepgaand 
te analyseren. Alle drie methoden zijn ont-
worpen op basis van, en voor de – op dit 
moment – meest moderne en hoogwaardige 
massaspectrometrie apparatuur. Niettemin 
zijn voor twee van de drie toepassingen 
verder ontwikkelingen wenselijk. We hebben 
nieuwe toepassingen een aanzienlijke stap 
verder gebracht, maar desondanks blijven 
er nog diverse interessante uitdagingen over 
voor de nabije toekomst.
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